Ventricular arrhythmias are an important cause of morbidity and mortality and come in a variety of forms, from single premature ventricular complexes to sustained ventricular tachycardia and fibrillation. Rapid developments have taken place over the past decade in our understanding of these arrhythmias and in our ability to diagnose and treat them. The field of catheter ablation has progressed with the development of new methods and tools, and with the publication of large clinical trials. Therefore, global cardiac electrophysiology professional societies undertook to outline recommendations and best practices for these procedures in a document that will update and replace the 2009 EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias. An expert writing group, after reviewing and discussing the literature, including a systematic review and meta-analysis published in conjunction with this document, and drawing on their own experience, drafted and voted on recommendations and summarized current knowledge and practice in the field. Each recommendation is presented in knowledge byte format and is accompanied by supportive text and references. Further sections provide a practical synopsis of the various techniques and of the specific ventricular arrhythmia sites and substrates encountered in the electrophysiology lab. The purpose of this document is to help electrophysiologists around the world to appropriately select patients for catheter ablation, to perform procedures in a safe and efficacious manner, and to provide follow-up and adjunctive care in order to obtain the best possible outcomes for patients with ventricular arrhythmias.

Australian National University Canberra Hospital Canberra Australia

Beth Israel Deaconess Medical Center Boston MA USA

Brigham and Women's Hospital Boston MA USA

CardioInfantil Foundation Cardiac Institute Bogota Columbia USA

Centro Privado de Cardiología Tucuman Argentina

Cleveland Clinic Cleveland OH USA

Duke University Medical Center Durham NC USA

Hartford Hospital Hartford CT USA

Heart Institute Teknon Medical Center Barcelona Spain

Herz und Gefäß Klinik Bad Neustadt Germany

Hospital Cardiologico SOS Cardio Florianopolis Brazil

Hospital General de Agudos Cosme Argerich Buenos Aires Argentina

Indiana University School of Medicine Krannert Institute of Cardiology Indianapolis IN USA

Institute for Clinical and Experimental Medicine Prague Czech Republic

Instituto Brasília de Arritmia Brasília Brazil

Jiangsu Province Hospital The 1st Affiliated Hospital of Nanjing Medical University Nanjing China

Kyorin University School of Medicine Tokyo Japan

Leiden University Medical Center Leiden the Netherlands

Northwestern University Feinberg School of Medicine Chicago IL USA

Ospedale San Raffaele Milan Italy

Queen Elizabeth 2 Health Sciences Centre Halifax Canada

Sree Chitra Institute for Medical Sciences and Technology Thiruvananthapuram India

University Hospital Antwerp University of Antwerp Antwerp Belgium

University Hospital Rangueil Toulouse France

University of Alabama at Birmingham Birmingham AL USA

University of California San Francisco Benioff Children's Hospital San Francisco CA USA

University of Colorado Denver Aurora CO USA

University of Maryland Baltimore MD USA

University of Michigan Ann Arbor MI USA

University of Pennsylvania Philadelphia PA USA

University of Queensland The Prince Charles Hospital Chermside Australia

University of Tsukuba Ibaraki Japan

Vanderbilt University Heart and Vascular Center Nashville TN USA

Washington University School of Medicine St Louis MO USA

Zobrazit více v PubMed

Aliot EM, Stevenson WG, Almendral-Garrote JM, et al. EHRA/HRS expert consensus on catheter ablation of ventricular arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm. 2009;6:886–933. PubMed

Hosseini SM, Rozen G, Saleh A, et al. Catheter ablation for cardiac arrhythmias: utilization and in-hospital complications, 2000 to 2013. JACC Clin Electrophysiol. 2017;3:1240–1248. PubMed

Raatikainen MJP, Arnar DO, Merkely B, Nielsen JC, Hindricks G, Heidbuchel H, Camm J. A decade of information on the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2017 report from the European heart rhythm association. Europace. 2017;19(Suppl. 2):ii1–ii90. PubMed

Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/ American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. Heart Rhythm. 2018;15:e73–e189. PubMed

Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. Task force for the Management of Patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the Management of Patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Europace. 2015;17:1601–1687. PubMed

Indik JH, Patton KK, Beardsall M, et al. HRS clinical document development methodology manual and policies: executive summary. Heart Rhythm. 2017;14:e495–e500. PubMed

Halperin JL, Levine GN, Al-Khatib SM, et al. Further evolution of the ACC/ AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2016;67:1572–1574. PubMed

Martinez BK, Baker WL, Konopka A, et al. Systematic review and metaanalysis of catheter ablation of ventricular tachycardia in ischemic heart disease. Heart Rhythm 2019 May 10 [Epub ahead of print]. PubMed

Couch OA., Jr Cardiac aneurysm with ventricular tachycardia and subsequent excision of aneurysm. Circulation. 1959;20:251–253. PubMed

Mason JW, Stinson EB, Winkle RA, et al. Relative efficacy of blind left ventricular aneurysm resection for the treatment of recurrent ventricular tachycardia. Am J Cardiol. 1982;49:241–248. PubMed

Guiraudon G, Fontaine G, Frank R, et al. Encircling endocardial ventriculotomy: a new surgical treatment for life-threatening ventricular tachycardias resistant to medical treatment following myocardial infarction. Ann Thorac Surg. 1978;26:438–444. PubMed

Guiraudon G, Klein GJ, Gulamhusein S, et al. Total disconnection of the right ventricular free wall: surgical treatment of right ventricular tachycardia associated with right ventricular dysplasia. Circulation. 1983;67:463–470. PubMed

Josephson ME, Harken AH, Horowitz LN. Endocardial excision: a new surgical technique for the treatment of recurrent ventricular tachycardia. Circulation. 1979;60:1430–1439. PubMed

Josephson ME, Horowitz LN, Farshidi A, Kastor JA. Recurrent sustained ventricular tachycardia. 1. Mechanisms. Circulation. 1978;57:431–439. PubMed

Josephson ME, Horowitz LN, Farshidi A, Spear JF, Kastor JA, Moore EN. Recurrent sustained ventricular tachycardia. 2. Endocardial mapping. Circulation. 1978;57:440–447. PubMed

Josephson ME, Horowitz LN, Spielman SR, Greenspan AM, VandePol C, Harken AH. Comparison of endocardial catheter mapping with intraoperative mapping of ventricular tachycardia. Circulation. 1980;61:395–404. PubMed

Hargrove WC, 3rd, Miller JM, Vassallo JA, Josephson ME. Improved results in the operative management of ventricular tachycardia related to inferior wall infarction: importance of the annular isthmus. J Thorac Cardiovasc Surg. 1986;92:726–732. PubMed

Caceres J, Werner P, Jazayeri M, Akhtar M, Tchou P. Efficacy of cryosurgery alone for refractory monomorphic sustained ventricular tachycardia due to inferior wall infarction. J Am Coll Cardiol. 1988;11:1254–1259. PubMed

Miller JM, Kienzle MG, Harken AH, Josephson ME. Subendocardial resection for ventricular tachycardia: predictors of surgical success. Circulation. 1984;70:624–631. PubMed

Hartzler GO. Electrode catheter ablation of refractory focal ventricular tachycardia. J Am Coll Cardiol. 1983;2:1107–1113. PubMed

Fontaine G, Tonet JL, Frank R, Rougier I. Clinical experience with fulgaration and antiarrhythmic therapy for the treatment of ventricular tachycardia. Chest. 1989;95:785–797. PubMed

Josephson ME, Horowitz LN, Waxman HL, et al. Sustained ventricular tachycardia: role of the 12-lead electrocardiogram in localizing site of origin. Circulation. 1981;64:257–272. PubMed

Josephson ME, Waxman HL, Cain ME, Gardner MJ, Buxton AE. Ventricular activation during ventricular endocardial pacing. II. Role of pacemapping to localize origin of ventricular tachycardia. Am J Cardiol. 1982;50:11–22. PubMed

Miller J, Marchlinski F, Buxton A, Josephson ME. Relationship between the 12-lead electrocardiogram during ventricular tachycardia and endocardial site of origin in patients with coronary artery disease. Circulation. 1988;77:759–766. PubMed

Levine JH, Spear JF, Weisman HF, et al. The cellular electrophysiologic changes induced by high-energy electrical ablation in canine myocardium. Circulation. 1986;73:818–829. PubMed

Haines DE, Verow AF. Observations on electrode-tissue interface temperature and effect on electrical impedance during radiofrequency ablation of ventricular myocardium. Circulation. 1990;82:1034–1038. PubMed

Klein LS, Shih HT, Hackett FK, Zipes DP, Miles WM. Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease. Circulation. 1992;85:1666–1674. PubMed

Morady F, Harvey M, Kalbfleisch SJ, El-Atassi R, Calkins H, Langberg JJ. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation. 1993;87:363–372. PubMed

Morady F, Kadish A, Rosenheck S, et al. Concealed entrainment as a guide for catheter ablation of ventricular tachycardia in patients with prior myocardial infarction. J Am Coll Cardiol. 1991;17:678–689. PubMed

Stevenson WG, Khan H, Sager P, et al. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation. 1993;88:1647–1670. PubMed

Stevenson WG, Friedman PL, Sager PT, et al. Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping. J Am Coll Cardiol. 1997;29:1180–1189. PubMed

Bogun F, Bahu M, Knight BP, et al. Comparison of effective and ineffective target sites that demonstrate concealed entrainment in patients with coronary artery disease undergoing radiofrequency ablation of ventricular tachycardia. Circulation. 1997;95:183–190. PubMed

El Shalakany A, Hadjis T, Papageorgiou P, et al. Entrainment mapping criteria for the prediction of termination of ventricular tachycardia by single radiofrequency lesion in patients with coronary artery disease. Circulation. 1999;99:2283–2289. PubMed

Callans DJ, Zado E, Sarter BH, Schwartzman D, Gottlieb CD, Marchlinski FE. Efficacy of radiofrequency catheter ablation for ventricular tachycardia in healed myocardial infarction. Am J Cardiol. 1998;82:429–432. PubMed

Stevenson WG, Friedman PL, Kocovic D, Sager PT, Saxon LA, Pavri B. Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction. Circulation. 1998;98:308–314. PubMed

Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation. 2000;101:1288–1296. PubMed

Marchlinski F, Garcia F, Siadatan A, et al. Ventricular tachycardia/ventricular fibrillation ablation in the setting of ischemic heart disease. J Cardiovasc Electrophysiol. 2005;16:S59–S70. PubMed

Arenal A, Glez-Torrecilla E, Ortiz M, et al. Ablation of electrograms with an isolated, delayed component as treatment of unmappable monomorphic ventricular tachycardias in patients with structural heart disease. J Am Coll Cardiol. 2003;41:81–92. PubMed

Bogun F, Good E, Reich S, et al. Isolated potentials during sinus rhythm and pace-mapping within scars as guides for ablation of post-infarction ventricular tachycardia. J Am Coll Cardiol. 2006;47:2013–2019. PubMed

Hsia HH, LinD SWH, Callans DJ, Marchlinski FE. Relationship of late potentials to the ventricular tachycardia circuit defined by entrainment. J Interv Card Electrophysiol. 2009;26:21–29. PubMed

Vergara P, Trevisi N, Ricco A, et al. Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation. J Cardiovasc Electrophysiol. 2012;23:621–627. PubMed

Soejima K, Stevenson WG, Maisel WH, Sapp JL, Epstein LM. Electrically unexcitable scar mapping based on pacing threshold for identification of the reentry circuit isthmus: feasibility for guiding ventricular tachycardia ablation. Circulation. 2002;106:1678–1683. PubMed

Arenal A, del Castillo S, Gonzalez-Torrecilla E, et al. Tachycardia-related channel in the scar tissue in patients with sustainedmonomorphic ventricular tachycardias: influence of the voltage scar definition. Circulation. 2004;110:2568–2574. PubMed

Hsia HH, Lin D, Sauer WH, Callans DJ, Marchlinski FE. Anatomical characterization of endocardial substrate for hemodynamically stable reentrant ventricular tachycardia: identification of endocardial conducting channels. Heart Rhythm. 2006;3:503–512. PubMed

Mountantonakis SE, Park RE, Frankel DS, et al. Relationship between voltage map channels and the location of critical isthmus sites in patients with post-infarction cardiomyopathy and ventricular tachycardia. J Am Coll Cardiol. 2013;61:2088–2095. PubMed

Berruezo A, Fernandez-Armenta J, Andreu D, et al. Scar dechanneling: new method for scar-related left ventricular tachycardia substrate ablation. Circ Arrhythm Electrophysiol. 2015;8:326–336. PubMed

Jais P, Maury P, Khairy P, et al. Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scarrelated ventricular tachycardia. Circulation. 2012;125:2184–2196. PubMed

Tung R, Mathuria N, Michowitz Y, et al. Functional pace-mapping responses for identification of targets for catheter ablation of scar-mediated ventricular tachycardia. Circ Arrhythm Electrophysiol. 2012;5:264–272. PubMed PMC

de Chillou C, Groben L, Magnin-Poull I, et al. Localizing the critical isthmus of postinfarct ventricular tachycardia: the value of pace-mapping during sinus rhythm. Heart Rhythm. 2014;11:175–181. PubMed

Tzou WS, Frankel DS, Hegeman T, et al. Core isolation of critical arrhythmia elements for treatment of multiple scar-based ventricular tachycardias. Circ Arrhythm Electrophysiol. 2015;8:353–361. PubMed

Di Biase L, Santangeli P, Burkhardt DJ, et al. Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol. 2012;60:132–141. PubMed

Hsia HH, Marchlinski FE. Characterization of the electroanatomic substrate for ventricular tachycardia in patients with nonischemic cardiomyopathy. Pacing Clin Electrophysiol. 2002;25:1114–1127. PubMed

Hsia HH, Callans DJ, Marchlinski FE. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation. 2003;108:704–710. PubMed

Marchlinski FE, Zado E, Dixit S, et al. Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. Circulation. 2004;110:2293–2298. PubMed

Haqqani HM, Tschabrunn CM, Tzou WS, et al. Isolated septal substrate for ventricular tachycardia in nonischemic dilated cardiomyopathy: incidence, characterization, and implications. Heart Rhythm. 2011;8:1169–1176. PubMed

Betensky BP, Kapa S, Desjardins B, et al. Characterization of trans-septal activation during septal pacing: criteria for identification of intramural ventricular tachycardia substrate in nonischemic cardiomyopathy. Circ Arrhythm Electrophysiol. 2013;6:1123–1130. PubMed

Oloriz T, Silberbauer J, Maccabelli G, et al. Catheter ablation of ventricular arrhythmia in non-ischaemic cardiomyopathy: antero-septal versus inferolateral scar sub-types. Circ Arrhythm Electrophysiol. 2014;7:414–423. PubMed

Sosa E, Scanavacca M, d’Avila A, Pilleggi F. A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol. 1996;7:531–536. PubMed

Della Bella P, Brugada J, Zeppenfeld K, et al. Epicardial ablation for ventricular tachycardia: a European multicenter study. Circ Arrhythm Electrophysiol. 2011;4:653–659. PubMed

Sacher F, Roberts-Thomson K, Maury P, et al. Epicardial ventricular tachycardia ablation a multicenter safety study. J Am Coll Cardiol. 2010;55:2366–2372. PubMed

Cano O, Hutchinson M, Lin D, et al. Electroanatomic substrate and ablation outcome for suspected epicardial ventricular tachycardia in left ventricular nonischemic cardiomyopathy. J Am Coll Cardiol. 2009;54:799–808. PubMed

Garcia FC, Bazan V, Zado ES, Ren JF, Marchlinski FE. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2009;120:366–375. PubMed

Santangeli P, Zado ES, Supple G, Haqqani HM, Garcia FC, Tschabrunn C, Callans DJ, Lin D, Dixit S, Hutchinson MD, Riley M, Marchlinski FE. Long-term outcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 2015;8:1413–1421. PubMed

Berruezo A, Fernandez-Armenta J, Mont L, et al. Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique. Circ Arrhythm Electrophysiol. 2012;5:111–121. PubMed

Hutchinson MD, Gerstenfeld EP, Desjardins B, et al. Endocardial unipolar voltage mapping to detect epicardial ventricular tachycardia substrate in patients with nonischemic left ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 2011;4:49–55. PubMed PMC

Polin GM, Haqqani H, Tzou W, et al. Endocardial unipolar voltage mapping to identify epicardial substrate in arrhythmogenic right ventricular cardiomyopathy/ dysplasia. Heart Rhythm. 2011;8:76–83. PubMed

Sosa E, Scanavacca M, d’Avila A, Oliveira F, Ramires JA. Nonsurgical transthoracic epicardial catheter ablation to treat recurrent ventricular tachycardia occurring late after myocardial infarction. J Am Coll Cardiol. 2000;35:1442–1449. PubMed

Izquierdo M, Sánchez-Gómez JM, Ferrero de Loma-Osorio A, et al. Endoepicardial versus only-endocardial ablation as a first line strategy for the treatment of ventricular tachycardia in patients with ischemic heart disease. Circ Arrhythm Electrophysiol. 2015;8:882–889. PubMed

Santangeli P, Marchlinski FE, Zado ES, et al. Percutaneous epicardial ablation of ventricular summit: outcomes and electrocardiogram predictors of success. Circ Arrhythmia Electropysiol. 2015;8:337–343. PubMed

Calkins H, Epstein A, Packer D, for the Cooled RF Multi Center Investigators Group et al. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. J Am Coll Cardiol. 2000;35:1905–1914. PubMed

Stevenson WG, Wilber DJ, Natale A, et al. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation. 2008;118:2773–2782. PubMed

Marchlinski FE, Haffajee CI, Beshai JF, et al. Long-term success of irrigated radiofrequency catheter ablation of sustained ventricular tachycardia: post-approval THERMOCOOL VT trial. J Am Coll Cardiol. 2016;67:674–683. PubMed

Tokuda M, Sobieszczyk P, Eisenhauer AC, et al. Transcoronary ethanol ablation for recurrent ventricular tachycardia after failed catheter ablation: an update. Circ Arrhythm Electrophysiol. 2011;4:889–896. PubMed

Sacher F, Sobieszczyk P, Tedrow U, et al. Transcoronary ethanol ventricular tachycardia ablation in the modern electrophysiology era. Heart Rhythm. 2008;5:62–68. PubMed

Koruth JS, Dukkipati S, Miller MA, Neuzil P, d’Avila A, Reddy VY. Bipolar irrigated radiofrequency ablation: a therapeutic option for refractory intramural atrial and ventricular tachycardia circuits. Heart Rhythm. 2012;9:1932–1941. PubMed

Nguyen DT, Gerstenfeld EP, Tzou WS, et al. Radiofrequency ablation using an open irrigated electrode cooled with half-normal saline. JACC Clin Electrophysiol. 2017;3:1103–1110. PubMed

Sapp JL, Beeckler C, Pike R, et al. Initial human feasibility of infusion needle catheter ablation for refractory ventricular tachycardia. Circulation. 2013;128:2289–2295. PubMed

Sternick EB, Gerken LM, Scarpelli RB, Soares FC. Cooling with nearfreezing saline improves efficacy of cool-tip radiofrequency catheter ablation. Heart Rhythm. 2010;7:983–986. PubMed

Della Bella P, Bisceglia C, Tung R. Multielectrode contact mapping to assess scar modification in post-myocardial infarction ventricular tachycardia patients. Europace. 2012;14(Suppl. 2):ii7–ii12. PubMed

Anter E, Tschabrunn CM, Buxton AE, Josephson ME. High-resolutionmapping of post-infarction reentrant ventricular tachycardia-electrophysiological characterization of the circuit. Circulation. 2016;134:314–327. PubMed PMC

Nakahara S, Tung R, Ramirez RJ, et al. Distribution of late potentials within infarct scars assessed by ultra high-density mapping. Heart Rhythm. 2010;7:1817–1824. PubMed

Van Herendael H, Zado ES, Haqqani H, et al. Catheter ablation of ventricular fibrillation: importance of left ventricular outflow tract and papillary muscle triggers. Heart Rhythm. 2014;11:566–573. PubMed

Betensky BP, Park RE, Marchlinski FE, et al. The V(2) transition ratio: a new electrocardiographic criterion for distinguishing left from right ventricular outflow tachycardia origin. J Am Coll Cardiol. 2011;57:2255–2262. PubMed

Mountantonakis SE, Frankel DS, Tschabrunn CM, et al. Ventricular arrhythmias from the coronary venous system: prevalence, mapping, and ablation. Heart Rhythm. 2015;12:1145–1153. PubMed

Kanagaratnam L, Tomassoni G, Schweikert R, et al. Ventricular tachycardia as arising from the aortic sinus of Valsalva: an under recognized variant of left outflow tract ventricular tachycardia. J Am Coll Cardiol. 2001;37:1408–1414. PubMed

Yamada T, Doppalapudi H, McElderry HT, et al. Idiopathic ventricular arrhythmias originating from the papillary muscles in the left ventricle: prevalence, electrocardiographic and electrophysiological characteristics, and results of the radiofrequency catheter ablation. J Cardiovasc Electrophysiol. 2010;21:62–69. PubMed

Yamada T, McElderry HT, Doppalapudi H, et al. Idiopathic ventricular arrhythmias originating from the left ventricular summit: anatomic concepts relevant to ablation. Circ Arrhythm Electrophysiol. 2010;3:616–623. PubMed

Mountantonakis S, Frankel DS, Gerstenfeld EP, et al. Reversal of outflow tract ventricular premature depolarization-induced cardiomyopathy with ablation: effect of residual arrhythmia burden and preexisting cardiomyopathy on outcome. Heart Rhythm. 2011;8:1608–1614. PubMed

Yokokawa M, Good E, Crawford T, et al. Recovery from left ventricular dysfunction after ablation of frequent premature ventricular complexes. Heart Rhythm. 2013;10:172–175. PubMed

Buxton AE, Waxman HL, Marchlinski FE, Simson MB, Cassidy D, Josephson ME. Right ventricular tachycardia: clinical and electrophysiologic characteristics. Circulation. 1983;68:917–927. PubMed

Lerman BB. Response of nonreentrant catecholamine-mediated ventricular tachycardia to endogenous adenosine and acetylcholine: evidence for myocardial receptor-mediated effects. Circulation. 1993;87:382–390. PubMed

Lerman BB, Belardinelli L, West GA, Berne RM, DiMarco JP. Adenosine- sensitive ventricular tachycardia: evidence suggesting cyclic AMPmediated triggered activity. Circulation. 1986;74:270–280. PubMed

Lerman BB, Stein K, Engelstein ED, et al. Mechanism of repetitive monomorphic ventricular tachycardia. Circulation. 1995;92:421–429. PubMed

Sung RJ, Keung EC, Nguyen NX, Huycke EC. Effects of beta-adrenergic blockade on verapamil-responsive and verapamil-irresponsive sustained ventricular tachycardias. J Clin Invest. 1988;81:688–699. PubMed PMC

Tada H, Ito S, Naito S, et al. Idiopathic ventricular arrhythmia arising from the mitral annulus: a distinct subgroup of idiopathic ventricular arrhythmias. J Am Coll Cardiol. 2005;45:877–886. PubMed

Tada H, Tadokoro K, Ito S, et al. Idiopathic ventricular arrhythmias originating from the tricuspid annulus: prevalence, electrocardiographic characteristics, and results of radiofrequency catheter ablation. Heart Rhythm. 2007;4:7–16. PubMed

Tada H, Tadokoro K, Miyaji K, et al. Idiopathic ventricular arrhythmias arising from the pulmonary artery: prevalence, characteristics, and topography of the arrhythmia origin. Heart Rhythm. 2008;5:419–426. PubMed

Sorgente A, Epicoco G, Ali H, et al. Negative concordance pattern in bipolar and unipolar recordings: an additional mapping criterion to localize the site of origin of focal ventricular arrhythmias. Heart Rhythm. 2016;13:519–526. PubMed

Tedrow UB, Stevenson WG. Recording and interpreting unipolar electrograms to guide catheter ablation. Heart Rhythm. 2011;8:791–796. PubMed

Yamada T, Yoshida Y, Inden Y, Murohara T, Kay GN. Idiopathic premature ventricular contractions exhibiting preferential conduction within the aortic root. Pacing Clin Electrophysiol. 2010;33:e10–e13. PubMed

Antzelevitch C, Shimizu W. Cellular mechanisms underlying the long QT syndrome. Curr Opin Cardiol. 2002;17:43–51. PubMed

Haissaguerre M, Extramiana F, Hocini M, et al. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation. 2003;108:925–928. PubMed

Lerman BB. Mechanism of outflow tract tachycardia. Heart Rhythm. 2007;4:973–976. PubMed

Damle RS, Landers M, Kelly PA, Reiter MJ, Mann DE. Radiofrequency catheter ablation of idiopathic left ventricular tachycardia originating in the left anterior fascicle. Pacing Clin Electrophysiol. 1998;21:1155–1158. PubMed

Lopera G, Stevenson WG, Soejima K, et al. Identification and ablation of three types of ventricular tachycardia involving the His-Purkinje system in patients with heart disease. J Cardiovasc Electrophysiol. 2004;15:52–58. PubMed

Bogun F, Good E, Reich S, et al. Role of Purkinje fibers in post-infarction ventricular tachycardia. J Am Coll Cardiol. 2006;48:2500–2507. PubMed

Spitzer KW, Pollard AE, Yang L, Zaniboni M, Cordeiro JM, Huelsing DJ. Cell-to-cell electrical interactions during early and late repolarization. J Cardiovasc Electrophysiol. 2006;17(Suppl. 1):S8–S14. PubMed

Kumar S, Romero J, Mehta NK, et al. Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease. Heart Rhythm. 2016;13:1957–1963. PubMed

Vaseghi M, Hu TY, Tung R, et al. Outcomes of catheter ablation of ventricular tachycardia based on etiology in nonischemic heart disease: an international ventricular tachycardia ablation center collaborative study. JACC Clin Electrophysiol. 2018;4:1141–1150. PubMed PMC

Kumar S, Androulakis AF, Sellal JM, et al. Multicenter experience with catheter ablation for ventricular tachycardia in Lamin a/C cardiomyopathy. Circ Arrhythm Electrophysiol. 2016;9:e004357. PubMed

Kumar S, Barbhaiya C, Nagashima K, et al. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol. 2015;8:87–93. PubMed

Sosa E, Scanavacca M, d’Avila A, Bellotti G, Pilleggi F. Radiofrequency catheter ablation of ventricular tachycardia guided by nonsurgical epicardial mapping in chronic Chagasic heart disease. Pacing Clin Electrophysiol. 1999;22:128–130. PubMed

Kapel GF, Sacher F, Dekkers OM, et al. Arrhythmogenic anatomical isthmuses identified by electroanatomical mapping are the substrate for ventricular tachycardia in repaired tetralogy of Fallot. Eur Heart J. 2017;38:268–276. PubMed

Eckart RE, Hruczkowski TW, Tedrow UB, Koplan BA, Epstein LM, Stevenson WG. Sustained ventricular tachycardia associated with corrective valve surgery. Circulation. 2007;116:2005–2011. PubMed

Wilber DJ, Kopp DE, Glascock DN, Kinder CA, Kall JG. Catheter ablation of the mitral isthmus for ventricular tachycardia associated with inferior infarction. Circulation. 1995;92:3481–3489. PubMed

Nagashima K, Tedrow UB, Koplan BA, et al. Reentrant ventricular tachycardia originating from the periaortic region in the absence of overt structural heart disease. Circ Arrhythm Electrophysiol. 2014;7:99–106. PubMed

Glashan CA, Androulakis AFA, Tao Q, et al. Whole human heart histology to validate electroanatomical voltage mapping in patients with nonischaemic cardiomyopathy and ventricular tachycardia. Eur Heart J. 2018;39:2867–2875. PubMed

Pogwizd SM, Hoyt RH, Saffitz JE, Corr PB, Cox JL, Cain ME. Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart. Circulation. 1992;86:1872–1887. PubMed

Anter E, Kleber AG, Rottmann M, et al. Infarct-related ventricular tachycardia: redefining the electrophysiological substrate of the isthmus during sinus rhythm. JACC Clin Electrophysiol. 2018;4:1033–1048. PubMed

Dillon SM, Allessie MA, Ursell PC, Wit AL. Influences of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine infarcts. Circ Res. 1988;63:182–206. PubMed

Downar E, Kimber S, Harris L, et al. Endocardial mapping of ventricular tachycardia in the intact human heart. II. Evidence for multiuse reentry in a functional sheet of surviving myocardium. J Am Coll Cardiol. 1992;20:869–878. PubMed

de Bakker JM, van Capelle FJ, Janse MJ, et al. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation. 1988;77:589–606. PubMed

Baba S, Dun W, Cabo C, Boyden PA. Remodeling in cells from different regions of the reentrant circuit during ventricular tachycardia. Circulation. 2005;112:2386–2396. PubMed PMC

Peters NS, Wit AL. Myocardial architecture and ventricular arrhythmogenesis. Circulation. 1998;97:1746–1754. PubMed

de Bakker JM, van Capelle FJ, Janse MJ, et al. Slow conduction in the infarcted human heart. ‘zigzag’ course of activation. Circulation. 1993;88:915–926. PubMed

de Bakker JM, Stein M, van Rijen HV. Three-dimensional anatomic structure as substrate for ventricular tachycardia/ventricular fibrillation. Heart Rhythm. 2005;2:777–779. PubMed

Porta-Sanchez A, Jackson N, Lukac P, et al. Multicenter study of ischemic ventricular tachycardia ablation with decrement-evoked potential (DEEP) mapping with extra stimulus. JACC Clin Electrophysiol. 2018;4:307–315. PubMed

Raiman M, Tung R. Automated isochronal late activation mapping to identify deceleration zones: rationale and methodology of a practical electroanatomic mapping approach for ventricular tachycardia ablation. Comput Biol Med. 2018;102:336–340. PubMed

Cheniti G, Vlachos K, Meo M, et al. Mapping and ablation of idiopathic ventricular fibrillation. Front Cardiovasc Med. 2018;5:123. PubMed PMC

Kleber AG, Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev. 2004;84:431–488. PubMed

Caceres J, Jazayeri M, McKinnie J, et al. Sustained bundle branch reentry as a mechanism of clinical tachycardia. Circulation. 1989;79:256–270. PubMed

Crijns HJ, Smeets JL, Rodriguez LM, Meijer A, Wellens HJ. Cure of interfascicular reentrant ventricular tachycardia by ablation of the anterior fascicle of the left bundle branch. J Cardiovasc Electrophysiol. 1995;6:486–492. PubMed

Huang J, Dosdall DJ, Cheng KA, Li L, Rogers JM, Ideker RE. The importance of Purkinje activation in long duration ventricular fibrillation. J Am Heart Assoc. 2014;3:e000495. PubMed PMC

Jeyaratnam J, Umapathy K, Masse S, et al. Relating spatial heterogeneities to rotor formation in studying human ventricular fibrillation. Conf Proc IEEE Eng Med Biol Soc. 2011;2011:231–234. PubMed

Haissaguerre M, Shah DC, Jais P, et al. Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation. Lancet. 2002;359:677–678. PubMed

Kim YH, Xie F, Yashima M, et al. Role of papillary muscle in the generation and maintenance of reentry during ventricular tachycardia and fibrillation in isolated swine right ventricle. Circulation. 1999;100:1450–1459. PubMed

Haissaguerre M, Hocini M, Cheniti G, et al. Localized structural alterations underlying a subset of unexplained sudden cardiac death. Circ Arrhythm Electrophysiol. 2018;11:e006120. PubMed PMC

Crosson JE, Callans DJ, Bradley DJ, et al. PACES/HRS expert consensus statement on the evaluation and management of ventricular arrhythmias in the child with a structurally normal heart. Heart Rhythm. 2014;11:e55–e78. PubMed

Yamada T, Kay GN. Anatomical consideration in catheter ablation of idiopathic ventricular arrhythmias. Arrhythm Electrophysiol Rev. 2016;5:203–209. PubMed PMC

Della Bella P, Maccabelli G, Carbucicchio C. Anatomical assessment for catheter ablation of ventricular tachycardia. In: Auricchio A, editor. Cardiac imaging in electrophysiology. London: Springer-Verlag; 2012. pp. 95–104.

Enriquez A, Malavassi F, Saenz LC, Supple G, Santangeli P, Marchlinski FE, Garcia FC. How to map and ablate left ventricular summit arrhythmias. Heart Rhythm. 2017;14:141–148. PubMed

Saremi F, Muresian H, Sanchez-Quintana D. Coronary veins: comprehensive CT-anatomic classification and review of variants and clinical implications. Radiographics. 2012;32:E1–E32. PubMed

Ho SY. Anatomic insights for catheter ablation of ventricular tachycardia. Heart Rhythm. 2009;6(Suppl. 8):S77–S80. PubMed

Ho SY, Nihoyannopoulos P. Anatomy, echocardiography, and normal right ventricular dimensions. Heart. 2006;92(Suppl. 1):i2–i13. PubMed PMC

Sánchez-Quintana D, Ho SY, Climent V, Murillo M, Cabrera JA. Anatomic evaluation of the left phrenic nerve relevant to epicardial and endocardial catheter ablation: implications for phrenic nerve injury. Heart Rhythm. 2009;6:764–768. PubMed

Yamada T, Litovsky SH, Kay GN. The left ventricular ostium: an anatomic concept relevant to idiopathic ventricular arrhythmias. Circ Arrhythm Electrophysiol. 2008;1:396–404. PubMed

McAlpine WA. Heart and coronary arteries: an anatomical atlas for clinical diagnosis, radiological investigation, and surgical treatment. New York: Springer-Verlag; 1975.

Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2017;70:e39–e110. PubMed

Yarlagadda RK, Iwai S, Stein KM, et al. Reversal of cardiomyopathy in patients with repetitive monomorphic ventricular ectopy originating from the right ventricular outflow tract. Circulation. 2005;112:1092–1097. PubMed

Agarwal V, Vittinghoff E, Whitman IR, Dewland TA, Dukes JW, Marcus GM. Relation between ventricular premature complexes and incident heart failure. Am J Cardiol. 2017;119:1238–1242. PubMed

Heidbüchel H, Tack J, Vanneste L, Ballet A, Ector H, Van de Werf F. Significance of arrhythmias during the first 24 hours of acute myocardial infarction treated with alteplase and effect of early administration of a beta-blocker or a bradycardiac agent on their incidence. Circulation. 1994;89:1051–1059. PubMed

Moss AJ, Zareba W, Hall WJ, et al. Multicenter automatic defibrillator implantation trial II investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–883. PubMed

Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in may 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10:1932–1963. PubMed

Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2011;58:e212–e260. PubMed

Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010;121:1533–1541. PubMed PMC

Pedersen CT, Kay GN, Kalman J, et al. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Heart Rhythm. 2014;11:e166–e196. PubMed

Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305–1323. PubMed

Ehret GB, Voide C, Gex-Fabry M, et al. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors. Arch Intern Med. 2006;166:1280–1287. PubMed

Choy AM, Lang CC, Chomsky DM, Rayos GH, Wilson JR, Roden DM. Normalization of acquired QT prolongation in humans by intravenous potassium. Circulation. 1997;96:2149–2154. PubMed

Bardy GH, Lee KL, Mark DB, et al. Sudden cardiac death in heart failure trial (SCD-HeFT) investigators. Amiodarone or an implantable cardioverter- defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–237. PubMed

Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576–1583. PubMed

Calkins H, Shyr Y, Frumin H, Schork A, Morady F. The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope. Am J Med. 1995;98:365–373. PubMed

Zimetbaum P, Josephson ME. Evaluation of patients with palpitations. N Engl J Med. 1998;338:1369–1373. PubMed

Brugada P, Brugada J, Mont L, Smeets J, Andries EW. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation. 1991;83:1649–1659. PubMed

Wellens HJ, Bar FW, Lie KI. The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex. Am J Med. 1978;64:27–33. PubMed

Vereckei A, Duray G, Szenasi G, Altemose GT, Miller JM. New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia. Heart Rhythm. 2008;5:89–98. PubMed

Ohe T, Shimomura K, Aihara N, et al. Idiopathic sustained left ventricular tachycardia: clinical and electrophysiologic characteristics. Circulation. 1988;77:560–568. PubMed

Dixit S, Gerstenfeld EP, Callans DJ, Marchlinski FE. Electrocardiographic patterns of superior right ventricular outflow tract tachycardias: distinguishing septal and free-wall sites of origin. J Cardiovasc Electrophysiol. 2003;14:1–7. PubMed

Callans DJ, Menz V, Schwartzman D, Gottlieb CD, Marchlinski FE. Repetitive monomorphic tachycardia from the left ventricular outflow tract: electrocardiographic patterns consistent with a left ventricular site of origin. J Am Coll Cardiol. 1997;29:1023–1027. PubMed

Kanagaratnam L, Tomassoni G, Schweikert R, et al. Ventricular tachycardias arising from the aortic sinus of valsalva: an under-recognized variant of left outflow tract ventricular tachycardia. J Am Coll Cardiol. 2001;37:1408–1414. PubMed

Crawford T, Mueller G, Good E, et al. Ventricular arrhythmias originating from papillary muscles in the right ventricle. Heart Rhythm. 2010;7:725–730. PubMed

Yamada T, McElderry HT, Okada T, et al. Idiopathic focal ventricular arrhythmias originating from the anterior papillary muscle in the left ventricle. J Cardiovasc Electrophysiol. 2009;20:866–872. PubMed

Li S, Wang Z, Shan Z, et al. Surface electrocardiography characteristics and radiofrequency catheter ablation of idiopathic ventricular arrhythmias originating from the left infero-septal papillary muscles: differences from those originating from the left posterior fascicle. Europace. 2018;20:1028–1034. PubMed

Berruezo A, Mont L, Nava S, Chueca E, Bartholomay E, Brugada J. Electrocardiographic recognition of the epicardial origin of ventricular tachycardias. Circulation. 2004;109:1842–1847. PubMed

Daniels DV, Lu YY, Morton JB, et al. Idiopathic epicardial left ventricular tachycardia originating remote from the sinus of Valsalva: electrophysiological characteristics, catheter ablation, and identification from the 12- lead electrocardiogram. Circulation. 2006;113:1659–1666. PubMed

Bazan V, Gerstenfeld EP, Garcia FC, et al. Site-specific twelve-lead ECG features to identify an epicardial origin for left ventricular tachycardia in the absence of myocardial infarction. Heart Rhythm. 2007;4:1403–1410. PubMed

Valles E, Bazan V, Marchlinski FE. ECG criteria to identify epicardial ventricular tachycardia in nonischemic cardiomyopathy. Circ Arrhythm Electrophysiol. 2010;3:63–71. PubMed

Bazan V, Bala R, Garcia FC, et al. Twelve-lead ECG features to identify ventricular tachycardia arising from the epicardial right ventricle. Heart Rhythm. 2006;3:1132–1139. PubMed

Perez-Rodon J, Martinez-Alday J, Baron-Esquivias G, et al. Prognostic value of the electrocardiogram in patients with syncope: data from the group for syncope study in the emergency room (GESINUR) Heart Rhythm. 2014;11:2035–2044. PubMed

Baldasseroni S, Opasich C, Gorini M, et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J. 2002;143:398–405. PubMed

Desai AD, Yaw TS, Yamazaki T, Kaykha A, Chun S, Froelicher VF. Prognostic significance of quantitative QRS duration. Am J Med. 2006;119:600–606. PubMed

Dhar R, Alsheikh-Ali AA, Estes NA, 3rd, et al. Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the multicenter automatic defibrillator implantation trial II (MADITII) Heart Rhythm. 2008;5:807–813. PubMed PMC

Freedman RA, Alderman EL, Sheffield LT, Saporito M, Fisher LD. Bundle branch block in patients with chronic coronary artery disease: angiographic correlates and prognostic significance. J Am Coll Cardiol. 1987;10:73–80. PubMed

Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN. QRS duration and mortality in patients with congestive heart failure. Am Heart J. 2002;143:1085–1091. PubMed

Zimetbaum PJ, Buxton AE, Batsford W, et al. Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Circulation. 2004;110:766–769. PubMed

Solomon SD, Zelenkofske S, McMurray JJ, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med. 2005;352:2581–2588. PubMed

Gula LJ, Klein GJ, Hellkamp AS, et al. Ejection fraction assessment and survival: an analysis of the sudden cardiac death in heart failure trial (SCD-HeFT) Am Heart J. 2008;156:1196–1200. PubMed PMC

Yoon Y, Ktagawa K, Kato S, et al. Prognostic value of unrecognised myocardial infarction detected by late gadolinium-enhanced MRI in diabetic patients with normal global and regional left ventricular systolic function. Eur Radiol. 2013;23:2101–2108. PubMed

Olivotto I, Maron M, Autore C, et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008;52:559–566. PubMed

Desjardins B, Yokokawa M, Good E, et al. Characteristics of intramural scar in patients with nonischemic cardiomyopathy and relation to intramural ventricular arrhythmias. Circ Arrhythm Electrophysiol. 2013;6:891–897. PubMed

Dweck M, Abgral R, Trivieri M, et al. Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis. JACC Cardiovasc Imaging. 2018;11:94–107. PubMed PMC

Piers SR, Tao Q, van Huls van Taxis CF, Schalij MJ, van der Geest RJ, Zeppenfeld K. Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy. Circ Arrhythm Electrophysiol. 2013;6:875–883. PubMed

Brugada J, Aguinaga L, Mont L, Betriu A, Mulet J, Sanz G. Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome. J Am Coll Cardiol. 2001;37:529–533. PubMed

Nageh M, Kim J, Chen L, Yao JF. Implantable defibrillators for secondary prevention of sudden cardiac death in cardiac surgery patients with perioperative ventricular arrhythmias. J Am Heart Assoc. 2014;3:e000686. PubMed PMC

Elsokkari I, Parkash R, Gray C, et al. Effect of coronary revascularization on long-term clinical outcomes in patients with ischemic cardiomyopathy and recurrent ventricular arrhythmia. Pacing Clin Electrophysiol. 2018;41:775–779. PubMed

Contijoch F, Rogers K, Rears H, et al. Quantification of left ventricular function with premature ventricular complexes reveals variable hemodynamics. Circ Arrhythm Electrophysiol. 2016;9:e003520. PubMed PMC

White JA, Fine NM, Gula L, et al. Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias. Circ Cardiovasc Imaging. 2012;5:12–20. PubMed

Berntsen RF, Gunnes P, Lie M, Rasmussen K. Surgical revascularization in the treatment of ventricular tachycardia and fibrillation exposed by exercise- induced ischaemia. Eur Heart J. 1993;14:1297–1303. PubMed

Aquaro GD, Pingitore A, Strata E, Di Bella G, Molinaro S, Lombardi M. Cardiac magnetic resonance predicts outcome in patients with premature ventricular complexes of left bundle branch block morphology. J Am Col Cardiol. 2010;56:1235–1243. PubMed

Yokokawa M, Siontis KC, Kim HM, et al. Value of cardiac magnetic resonance imaging and programmed ventricular stimulation in patients with frequent premature ventricular complexes undergoing radiofrequency ablation. Heart Rhythm. 2017;14:1695–1701. PubMed

Scott PA, Rosengarten JA, Curzen NP, Morgan JM. Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysis. Eur J Heart Fail. 2013;15:1019–1027. PubMed

Kuruvilla S, Adenaw N, Katwal AB, Lipinski MJ, Kramer CM, Salerno M. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis. Circ Cardiovasc Imaging. 2014;7:250–258. PubMed PMC

Di Marco A, Anguera I, Schmitt M, et al. Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis. JACC Heart Fail. 2017;5:28–38. PubMed

Ganesan AN, Gunton J, Nucifora G, McGavigan AD, Selvanayagam JB. Impact of late gadolinium enhancement on mortality, sudden death and major adverse cardiovascular events in ischemic and nonischemic cardiomyopathy: a systematic review and meta-analysis. Int J Cardiol. 2018;254:230–237. PubMed

Becker M, Cornel J, van de Ven P, van Rossum AC, Allaart CP, Germans T. The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: a review and meta-analysis. JACC Cardiovasc Imaging. 2018;11:1274–1284. PubMed

Disertori M, Rigoni M, Pace N, et al. Myocardial fibrosis assessment by LGE is a powerful predictor of ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction: a meta-analysis. JACC Cardiovasc Imaging. 2016;9:1046–1055. PubMed

Hasdemir C, Yuksel A, Camli D, et al. Late gadolinium enhancement CMR in patients with tachycardia-induced cardiomyopathy caused by idiopathic ventricular arrhythmias. Pacing Clin Electrophysiol. 2012;35:465–470. PubMed

Sarrazin JF, Labounty T, Kuhne M, et al. Impact of radiofrequency ablation of frequent post-infarction premature ventricular complexes on left ventricular ejection fraction. Heart Rhythm. 2009;6:1543–1549. PubMed PMC

El Kadri M, Yokokawa M, Labounty T, et al. Effect of ablation of frequent premature ventricular complexes on left ventricular function in patients with nonischemic cardiomyopathy. Heart Rhythm. 2015;12:706–713. PubMed

Oebel S, Dinov B, Arya A, et al. ECG morphology of premature ventricular contractions predicts the presence of myocardial fibrotic substrate on cardiac magnetic resonance imaging in patients undergoing ablation. J Cardiovasc Electrophysiol. 2017;28:1316–1323. PubMed

Perez-David E, Arenal A, Rubio-Guivernau J, et al. Noninvasive identification of ventricular tachycardia-related conducting channels using contrast-enhanced magnetic resonance imaging in patients with chronic myocardial infarction: comparison of signal intensity scar mapping and endocardial voltage mapping. J Am Coll Cardiol. 2011;57:184–194. PubMed

Xie S, Desjardins B, Kubala M, et al. Association of regional epicardial right ventricular electrogram voltage amplitude and late gadolinium enhancement distribution on cardiac magnetic resonance in patients with arrhythmogenic right ventricular cardiomyopathy: implications for ventricular tachycardia ablation. Heart Rhythm. 2018;15:987–993. PubMed PMC

Wang Z, Zhang H, Peng H, et al. Voltage combined with pace mapping is simple and effective for ablation of noninducible premature ventricular contractions originating from the right ventricular outflow tract. Clin Cardiol. 2016;39:733–738. PubMed PMC

Niwano SY, Wakisaka H, Niwano H, et al. Prognostic significance of frequent premature ventricular contractions originating from the ventricular outflow tract in patients with normal left ventricular function. Heart. 2009;95:1230–1237. PubMed

Baman TS, Lange DC, Ilg KJ, et al. Relationship between burden of premature ventricular complexes and left ventricular function. Heart Rhythm. 2010;7:865–869. PubMed

Halperin JL, Levine GN, Al-Khatib SM, et al. Further evolution of the ACC/ AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology Foundation/American Heart Association task force on clinical practice guidelines. Circulation. 2016;133:1426–1428. PubMed

Ling Z, Liu Z, Su L, et al. Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study. Circ Arrhythm Electrophysiol. 2014;7:237–243. PubMed

Zhang F, Yang B, Chen H, Ju W, Kojodjojo P, Cao K, Chen M. Magnetic versus manual catheter navigation for mapping and ablation of right ventricular outflow tract ventricular arrhythmias: a randomized controlled study. Heart Rhythm. 2013;10:1178–1183. PubMed

Krittayaphong R, Sriratanasathavorn C, Dumavibhat C, et al. Electrocardiographic predictors of long term outcomes after radiofrequency ablation in patients with right-ventricular outflow tract tachycardia. Europace. 2006;8:601–606. PubMed

Vestal M, Wen MS, Yeh SJ, Wang CC, Lin FC, Wu D. Electrocardiographic predictors of failure and recurrence in patients with idiopathic right ventricular outflow tract tachycardia and ectopy who underwent radiofrequency catheter ablation. J Electrocardiol. 2003;36:327–332. PubMed

Miyazawa K, Ueda M, Kondo Y, Hayashi T, Nakano M, Ishimura M, Nakano M, Kobayashi Y. Rapid mapping and differentiation in ventricular outflow tract arrhythmia using non-contact mapping. J Interv Card Electrophysiol. 2017;49:41–49. PubMed

Akdeniz C, Gul EE, Celik N, Karacan M, Tuzcu V. Catheter ablation of idiopathic right ventricular arrhythmias in children with limited fluoroscopy. J Interv Card Electrophysiol. 2016;46:355–360. PubMed

Morady F, Kadish AH, DiCarlo L, Kou WH, Winston S, deBuitlier M, Calkins H, Rosenheck S, Sousa J. Long-term results of catheter ablation of idiopathic right ventricular tachycardia. Circulation. 1990;82:2093–2099. PubMed

Liao Z, Zhan X, Wu S, et al. Idiopathic ventricular arrhythmias originating from the pulmonary sinus cusp: prevalence, electrocardiographic/electrophysiological characteristics, and catheter ablation. J Am Coll Cardiol. 2015;66:2633–2644. PubMed

Bogun F, Crawford T, Reich S, Koelling TM, Armstrong W, Good E, Jongnarangsin K, Marine JE, Chugh A, Pelosi F, Oral H, Morady F. Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: comparison with a control group without intervention. Heart Rhythm. 2007;4:863–867. PubMed

Chen H, Shehata M, Swerdlow C, et al. Intramural outflow tract ventricular tachycardia: anatomy, mapping, and ablation. Circ Arrhythm Electrophysiol. 2014;7:978–981. PubMed

Teh AW, Reddy VY, Koruth JS, et al. Bipolar radiofrequency catheter ablation for refractory ventricular outflow tract arrhythmias. J Cardiovasc Electrophysiol. 2014;25:1093–1099. PubMed

Lamba J, Redfearn DP, Michael KA, Simpson CS, Abdollah H, Baranchuk A. Radiofrequency catheter ablation for the treatment of idiopathic premature ventricular contractions originating from the right ventricular outflow tract: a systematic review and meta-analysis. Pacing Clin Electrophysiol. 2014;37:73–78. PubMed

Calkins H, Kalbfleisch J, El-Atassi R, Langberg J, Morady F. Relation between efficacy of radiofrequency catheter ablation and site of origin of idiopathic ventricular tachycardia. Am J Cardiol. 1993;71:827–833. PubMed

Rodriguez LM, Smeets JL, Timmermans C, Wellens HJ. Predictors for successful ablation of right- and left-sided idiopathic ventricular tachycardia. Am J Cardiol. 1997;79:309–314. PubMed

Coggins DL, Lee RJ, Sweeney J, et al. Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin. J Am Coll Cardiol. 1994;23:1333–1341. PubMed

Wen MS, Yeh SJ, Wang CC, Lin FC, Chen IC, Wu D. Radiofrequency ablation therapy in idiopathic left ventricular tachycardia with no obvious structural heart disease. Circulation. 1994;89:1690–1696. PubMed

Movsowitz C, Schwartzman D, Callans DJ, et al. Idiopathic right ventricular outflow tract tachycardia: narrowing the anatomic location for successful ablation. Am Heart J. 1996;131:930–936. PubMed

Frey B, Kreiner G, Fritsch S, Veit F, Gossinger HD. Successful treatment of idiopathic left ventricular outflow tract tachycardia by catheter ablation or minimally invasive surgical cryoablation. Pacing Clin Electrophysiol. 2000;23:870–876. PubMed

Krebs ME, Krause PC, Engelstein ED, Zipes DP, Miles WM. Ventricular tachycardiasmimicking those arising from the right ventricular outflow tract. J Cardiovasc Electrophysiol. 2000;11:45–51. PubMed

Kumagai K, Fukuda K, Wakayama Y, et al. Electrocardiographic characteristics of the variants of idiopathic left ventricular outflow tract ventricular tachyarrhythmias. J Cardiovasc Electrophysiol. 2008;19:495–501. PubMed

Latchamsetty R, Yokokawa M, Morady F, et al. Multicenter outcomes for catheter ablation of idiopathic premature ventricular complexes. JACC Clin Electrophysiol. 2015;1:116–123. PubMed

Kamakura S, Shimizu W, Matsuo K, et al. Localization of optimal ablation site of idiopathic ventricular tachycardia from right and left ventricular outflow tract by body surface ECG. Circulation. 1998;98:1525–1533. PubMed

Yamada T, Yoshida N, Murakami Y, et al. Electrocardiographic characteristics of ventricular arrhythmias originating from the junction of the left and right coronary sinuses of Valsalva in the aorta: the activation pattern as a rationale for the electrocardiographic characteristics. Heart Rhythm. 2008;5:184–192. PubMed

Tada H, Naito S, Ito S, et al. Significance of two potentials for predicting successful catheter ablation from the left sinus of Valsalva for left ventricular epicardial tachycardia. Pacing Clin Electrophysiol. 2004;27:1053–1059. PubMed

Ouyang F, Fotuhi P, Ho SY, et al. Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation. J Am Coll Cardiol. 2002;39:500–508. PubMed

Bala R, Garcia FC, Hutchinson MD, et al. Electrocardiographic and electrophysiologic features of ventricular arrhythmias originating from the right/left coronary cusp commissure. Heart Rhythm. 2010;7:312–322. PubMed

Tada H, Nogami A, Naito S, et al. Left ventricular epicardial outflow tract tachycardia: a new distinct subgroup of outflow tract tachycardia. Jpn Circ J. 2001;65:723–730. PubMed

Baman TS, Ilg KJ, Gupta SK, et al. Mapping and ablation of epicardial idiopathic ventricular arrhythmias from within the coronary venous system. Circ Arrhythm Electrophysiol. 2010;3:274–279. PubMed

Carrigan T, Patel S, Yokokawa M, et al. Anatomic relationships between the coronary venous system, surrounding structures, and the site of origin of epicardial ventricular arrhythmias. J Cardiovasc Electrophysiol. 2014;25:1336–1342. PubMed

Santangeli P, Marchlinski FE, Zado ES, et al. Percutaneous epicardial ablation of ventricular arrhythmias arising from the left ventricular summit: outcomes and electrocardiogram correlates of success. Circ Arrhythm Electrophysiol. 2015;8:337–343. PubMed

Nagashima K, Choi EK, Lin KY, et al. Ventricular arrhythmias near the distal great cardiac vein: challenging arrhythmia for ablation. Circ Arrhythm Electrophysiol. 2014;7:906–912. PubMed

Yamada T, Murakami Y, Yoshida N, et al. Efficacy of electroanatomic mapping in the catheter ablation of premature ventricular contractions originating from the right ventricular outflow tract. J Interv Card Electrophysiol. 2007;19:187–194. PubMed

Zhong L, Lee YH, Huang XM, et al. Relative efficacy of catheter ablation vs antiarrhythmic drugs in treating premature ventricular contractions: a singlecenter retrospective study. Heart Rhythm. 2014;11:187–193. PubMed

Van Herendael H, Garcia F, Lin D, et al. Idiopathic right ventricular arrhythmias not arising from the outflow tract: prevalence, electrocardiographic characteristics, and outcome of catheter ablation. Heart Rhythm. 2011;8:511–518. PubMed

Sadek MM, Benhayon D, Sureddi R, et al. Idiopathic ventricular arrhythmias originating from the moderator band: electrocardiographic characteristics and treatment by catheter ablation. Heart Rhythm. 2015;12:67–75. PubMed

Santoro F, DiBiase L, Hranitzky P, et al. Ventricular tachycardia originating from the septal papillary muscle of the right ventricle: electrocardiographic and electrophysiological characteristics. J Cardiovasc Electrophysiol. 2015;26:145–150. PubMed

Sasaki K, Sasaki S, Kimura M, et al. Catheter ablation of ventricular arrhythmias arising from the basal septum of the right ventricle: characteristics and significance of junctional rhythm appearing during ablation. J Interv Card Electrophysiol. 2016;45:159–167. PubMed

Yue-Chun L, Wen-Wu Z, Na-Dan Z, et al. Idiopathic premature ventricular contractions and ventricular tachycardias originating from the vicinity of tricuspid annulus: results of radiofrequency catheter ablation in thirty-five patients. BMC Cardiovasc Disord. 2012;10:12–32. PubMed PMC

Yamada T, Yoshida N, Itoh T, Litovsky SH, Doppalapudi H, McElderry HT, Kay GN. Idiopathic ventricular arrhythmias originating from the parietal band: electrocardiographic and electrophysiological characteristics and outcome of catheter ablation. Circ Arrhythm Electrophysiol. 2017;10:e005099. PubMed

Ceresnak SR, Pass RH, Krumerman AK, Kim SG, Nappo L, Fisher JD. Characteristics of ventricular tachycardia arising from the inflow region of the right ventricle. J Electrocardiol. 2012;45:385–390. PubMed

Yamada T, Yoshida N, Litovsky SH, Itoh T, Doppalapudi H, Kay GN. Idiopathic ventricular arrhythmias originating fromthe infundibularmuscles: prevalence, electrocardiographic and electrophysiological characteristics, and outcome of catheter ablation. Circ ArrhythmElectrophysiol. 2018;11:e005749. PubMed

Li T, Zhan XZ, Xue YM, et al. Combined approach improves the outcomes of catheter ablation of idiopathic ventricular arrhythmias originating from the vicinity of tricuspid annulus. Pacing Clin Electrophysiol. 2014;37:624–629. PubMed

Lian-Pin W, Yue-Chun L, Jing-Lin Z, et al. Catheter ablation of idiopathic premature ventricular contractions and ventricular tachycardias originating from right ventricular septum. PLoS One. 2013;8:e67038. PubMed PMC

Enriquez A, Pathak RK, Santangeli P, et al. Inferior lead discordance in ventricular arrhythmias: a specific marker for certain arrhythmia locations. J Cardiovasc Electrophysiol. 2017;28:1179–1186. PubMed

Doppalapudi H, Yamada T, McElderry HT, Plumb VJ, Epstein AE, Kay GN. Ventricular tachycardia originating from the posterior papillary muscle in the left ventricle: a distinct clinical syndrome. Circ Arrhythm Electrophysiol. 2008;1:23–29. PubMed

Yamada T, Doppalapudi H, McElderry HT, et al. Electrocardiographic and electrophysiological characteristics in idiopathic ventricular arrhythmias originating from the papillary muscles in the left ventricle: relevance for catheter ablation. Circ Arrhythm Electrophysiol. 2010;3:324–331. PubMed

Bassil G, Liu CF, Markowitz SM, et al. Comparison of robotic magnetic navigation-guided and manual catheter ablation of ventricular arrhythmias arising from the papillary muscles. Europace. 2018;20(Suppl. 2):ii5–ii10. PubMed

Ban JE, Lee HS, Lee DI, et al. Electrophysiological characteristics related to outcome after catheter ablation of idiopathic ventricular arrhythmia originating fromthe papillarymuscle in the left ventricle. Korean Circ J. 2013;43:811–818. PubMed PMC

Yokokawa M, Good E, Desjardins B, et al. Predictors of successful catheter ablation of ventricular arrhythmias arising from the papillary muscles. Heart Rhythm. 2010;7:1654–1659. PubMed PMC

Rivera S, Ricapito Mde L, Tomas L, et al. Results of cryoenergy and radiofrequency- based catheter ablation for treating ventricular arrhythmias arising fromthe papillary muscles of the left ventricle, guided by intracardiac echocardiography and image integration. Circ Arrhythm Electrophysiol. 2016;9:e003874. PubMed

Al’Aref SJ, Ip JE, Markowitz SM, et al. Differentiation of papillary muscle from fascicular and mitral annular ventricular arrhythmias in patients with and without structural heart disease. Circ Arrhythm Electrophysiol. 2015;8:616–624. PubMed

Wasmer K, Köbe J, Dechering DG, et al. Ventricular arrhythmias from the mitral annulus: patient characteristics, electrophysiological findings, ablation, and prognosis. Heart Rhythm. 2013;10:783–788. PubMed

Kumagai K, Yamauchi Y, Takahashi A, et al. Idiopathic left ventricular tachycardia originating from the mitral annulus. J Cardiovasc Electrophysiol. 2005;16:1029–1036. PubMed

Yue-Chun L, Cheng Z, Jun H, Jun-Hua C, Jing-Lin Z, Jia-Feng L. Catheter ablation of idiopathic premature ventricular contractions and ventricular tachycardias originating from the vicinity of endocardial and epicardial mitral annulus. PLoS One. 2013;8:e80777. PubMed PMC

Yamada T, Doppalapudi H, McElderry HT, Kay GN. Idiopathic mitral annular PVCs with multiple breakouts and preferential conduction unmasked by radiofrequency catheter ablation. Pacing Clin Electrophysiol. 2012;35:e112–e115. PubMed

Chen J, Hoff PI, Rossvoll O, et al. Ventricular arrhythmias originating from the aortomitral continuity: an uncommon variant of left ventricular outflow tract tachycardia. Europace. 2012;14:388–395. PubMed

Hai JJ, Chahal AA, Friedman PA, et al. Electrophysiologic characteristics of ventricular arrhythmias arising from the aortic mitral continuity-potential role of the conduction system. J Cardiovasc Electrophysiol. 2015;26:158–163. PubMed PMC

Meininger GR, Berger RD. Idiopathic ventricular tachycardia originating in the great cardiac vein. Heart Rhythm. 2006;3:464–466. PubMed

Yamada T, Doppalapudi H, Litovsky SH, McElderry HT, Kay GN. Challenging radiofrequency catheter ablation of idiopathic ventricular arrhythmias originating from the left ventricular summit near the left main coronary artery. Circ Arrhythm Electrophysiol. 2016;9:e004202. PubMed

Yokokawa M, Latchamsetty R, Good E, et al. Ablation of epicardial ventricular arrhythmias from nonepicardial sites. Heart Rhythm. 2011;8:1525–1529. PubMed

Jauregui Abularach ME, Campos B, Park KM, et al. Ablation of ventricular arrhythmias arising near the anterior epicardial veins from the left sinus of Valsalva region: ECG features, anatomic distance, and outcome. Heart Rhythm. 2012;9:865–873. PubMed

Yokokawa M, Good E, Chugh A, et al. Intramural idiopathic ventricular arrhythmias originating in the intraventricular septum: mapping and ablation. Circ Arrhythm Electrophysiol. 2012;5:258–263. PubMed

Doppalapudi H, Yamada T, Ramaswamy K, Ahn J, Kay GN. Idiopathic focal epicardial ventricular tachycardia originating from the crux of the heart. Heart Rhythm. 2009;6:44–50. PubMed

Kawamura M, Gerstenfeld EP, Vedantham V, et al. Idiopathic ventricular arrhythmia originating from the cardiac crux or inferior septum. Circ Arrhythm Electrophysiol. 2014;7:1152–1158. PubMed

Larroussi L, Badhwar N. Ventricular tachycardia arising from cardiac crux: electrocardiogram recognition and site of ablation. Card Electrophysiol Clin. 2016;8:109–113. PubMed

Yui Y, Sekiguchi Y, Nogami A, et al. Electrophysiological characteristics and radiofrequency catheter ablation treatment of idiopathic ventricular arrhythmias successfully ablated from the ostium of the coronary sinus. Circ J. 2017;81:1807–1815. PubMed

Komatsu Y, Otomo K, Taniguchi H, et al. Catheter ablation of ventricular arrhythmias arising from the right ventricular septum close to the His bundle: features of the local electrogram at the optimal ablation site. J Cardiovasc Electrophysiol. 2011;22:878–885. PubMed

Yamada T, Plumb VJ, McElderry HT, Doppalapudi H, Epstein AE, Kay GN. Focal ventricular arrhythmias originating from the left ventricle adjacent to the membranous septum. Europace. 2010;12:1467–1474. PubMed

Wei HQ, Guo XG, Liu X, et al. Safety and efficacy of catheter ablation of ventricular arrhythmias with Para-Hisian origin via a systematic direct approach from the aortic sinus cusp. Heart Rhythm. 2018;15:1626–1633. PubMed

Yamauchi Y, Aonuma K, Takahashi A, et al. Electrocardiographic characteristics of repetitive monomorphic right ventricular tachycardia originating near the His-bundle. J Cardiovasc Electrophysiol. 2005;16:1041–1048. PubMed

Komatsu Y, Taniguchi H, Miyazaki S, et al. Two distinct electrocardiographic forms of idiopathic ventricular arrhythmia originating in the vicinity of the His bundle. Europace. 2012;14:1778–1785. PubMed

Enriquez A, Tapias C, Rodriguez D, et al. How to map and ablate parahisian ventricular arrhythmias. Heart Rhythm. 2018;15:1268–1274. PubMed

Santangeli P, Hutchinson MD, Supple GE, Callans DJ, Marchlinski FE, Garcia FC. Right atrial approach for ablation of ventricular arrhythmias arising from the left posterior-superior process of the left ventricle. Circ Arrhythm Electrophysiol. 2016;9:e004048. PubMed

Li A, Zuberi Z, Bradfield JS, et al. Endocardial ablation of ventricular ectopic beats arising from the basal inferoseptal process of the left ventricle. Heart Rhythm. 2018;15:1356–1362. PubMed

Tavares L, Dave A, Valderrábano M. Successful ablation of premature ventricular contractions originating from the inferoseptal process of the left ventricle using a coronary sinus approach. HeartRhythm Case Rep. 2018;4:371–374. PubMed PMC

Luo S, Zhan X, Ouyang F, et al. Catheter ablation of right-sided Para-Hisian ventricular arrhythmias using a simple pacing strategy. Heart Rhythm. 2019;16:380–387. PubMed

Latchamsetty RY, Morady M, Kim F, et al. Multicenter outcomes for catheter ablation of idiopathic premature ventricular complexes. JACC Clinical Electrophysiol. 2015;1:116–123. PubMed

Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia: survival trial of antiarrhythmic therapy in congestive heart failure. N Engl J Med. 1995;333:77–82. PubMed

Zang M, Zhang T, Mao J, Zhou S, He B. Beneficial effects of catheter ablation of frequent premature ventricular complexes on left ventricular function. Heart. 2014;100:787–793. PubMed

Lee A, Denman R, Haqqani HM. Ventricular ectopy in the context of left ventricular systolic dysfunction: risk factors and outcomes following catheter ablation. Heart Lung Circ. 2019;28:379–388. PubMed

Takemoto M, Yoshimura H, Ohba Y, et al. Radiofrequency catheter ablation of premature ventricular complexes from right ventricular outflow tract improves left ventricular dilation and clinical status in patients without structural heart disease. J Am Coll Cardiol. 2005;45:1259–1265. PubMed

Wijnmaalen AP, Delgado V, Schalij MJ, et al. Beneficial effects of catheter ablation on left ventricular and right ventricular function in patients with frequent premature ventricular contractions and preserved ejection fraction. Heart. 2010;96:1275–1280. PubMed

Haïssaguerre M, Shoda M, Jaïs P, et al. Mapping and ablation of idiopathic ventricular fibrillation. Circulation. 2002;106:962–967. PubMed

Knecht S, Sacher F, Wright M, et al. Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study. J Am Coll Cardiol. 2009;54:522–528. PubMed

Peichl P, Cihák R, Kozeluhová M, Wichterle D, Vancura V, Kautzner J. Catheter ablation of arrhythmic storm triggered by monomorphic ectopic beats in patients with coronary artery disease. J Interv Card Electrophysiol. 2010;27:51–59. PubMed

Lakkireddy D, Di Biase L, Ryschon K, et al. Radiofrequency ablation of premature ventricular ectopy improves the efficacy of cardiac resynchronization therapy in nonresponders. J Am Coll Cardiol. 2012;60:1531–1539. PubMed

Kanei Y, Friedman M, Ogawa N, Hanon S, Lam P, Schweitzer P. Frequent premature ventricular complexes originating from the right ventricular outflow tract are associated with left ventricular dysfunction. Ann Noninvasive Electrocardiol. 2008;13:81–85. PubMed PMC

Shanmugam N, Chua TP, Ward D. ‘Frequent’ ventricular bigeminy—a reversible cause of dilated cardiomyopathy. How frequent is ‘frequent’? Eur J Heart Fail. 2006;8:869–873. PubMed

Yokokawa M, Kim HM, Good E, et al. Relation of symptoms and symptom duration to premature ventricular complex-induced cardiomyopathy. Heart Rhythm. 2012;9:92–95. PubMed

Olgun H, Yokokawa M, Baman T, et al. The role of interpolation in PVCinduced cardiomyopathy. Heart Rhythm. 2011;8:1046–1049. PubMed

Sapp JL, Wells GA, Parkash R, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375:111–121. PubMed

Stevenson WG, Wilber DJ, Natale A, et al. Multicenter Thermocool VT ablation trial investigators. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation. 2008;118:2773–2782. PubMed

Tanner H, Hindricks G, Volkmer M, et al. Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter euro- VT-study. J Cardiovasc Electrophysiol. 2010;21:47–53. PubMed

Marchlinski FE, Haffajee CI, Beshai JF, et al. Long-term success of irrigated radiofrequency catheter ablation of sustained ventricular tachycardia: postapproval THERMOCOOL VT trial. J Am Coll Cardiol. 2016;67:674–683. PubMed

Carbucicchio C, Santamaria M, Trevisi N, et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study. Circulation. 2008;117:462–469. PubMed

Deneke T, Shin D, Lawo T, et al. Catheter ablation of electrical storm in a collaborative hospital network. Am J Cardiol. 2011;108:233–239. PubMed

Muser D, Liang JJ, Pathak RK, et al. Long-term outcomes of catheter ablation of electrical storm in nonischemic dilated cardiomyopathy compared with ischemic cardiomyopathy. JACC Clin Electrophysiol. 2017;3:767–778. PubMed

Kumar S, Fujii A, Kapur S, et al. Beyond the storm: comparison of clinical factors, arrhythmogenic substrate, and catheter ablation outcomes in structural heart disease patients with versus those without a history of ventricular tachycardia storm. J Cardiovasc Electrophysiol. 2017;28:56–67. PubMed

Nayyar S, Ganesan AN, Brooks AG, Sullivan T, Roberts-Thomson KC, Sanders P. Venturing into ventricular arrhythmia storm: a systematic review and meta-analysis. Eur Heart J. 2013;34:560–569. PubMed

Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357:2657–2665. PubMed PMC

Kuck KH, Schaumann A, Eckhardt L, for the VTACH Study Group et al. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010;375:31–40. PubMed

Al-Khatib SM, Daubert JP, Anstrom KJ, et al. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial. J Cardiovasc Electrophysiol. 2015;26:151–157. PubMed

Kuck KH, Tilz RR, Deneke T, et al. SMS investigators. Impact of substrate modification by catheter ablation on implantable cardioverter–defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (substrate modification study) Circ Arrhythm Electrophysiol. 2017;10:e004422. PubMed

Littmann L, Svenson RH, Gallagher JJ, et al. Functional role of the epicardium in postinfarction ventricular tachycardia: observations derived from computerized epicardial activation mapping, entrainment, and epicardial laser photoablation. Circulation. 1991;83:1577–1591. PubMed

Schmidt B, Chun KR, Baensch D, Antz M, Koektuerk B, Tilz RR, Metzner A, Ouyang F, Kuck KH. Catheter ablation for ventricular tachycardia after failed endocardial ablation: epicardial substrate or inappropriate endocardial ablation? Heart Rhythm. 2010;7:1746–1752. PubMed

Di Biase L, Santangeli P, Burkhardt DJ, et al. Endo-epicardial homogenization of the scar versus limited endocardial substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol. 2012;60:132–141. PubMed

Deyell MW, Steinberg C, Doucette S, et al. Mexiletine or catheter ablation after amiodarone failure in the VANISH trial. J Cardiovasc Electrophysiol. 2018;29:603–608. PubMed

Izquierdo M, Ruiz-Granell R, Ferrero A, et al. Ablation or conservative management of electrical storm due to monomorphic ventricular tachycardia: differences in outcome. Europace. 2012;14:1734–1739. PubMed

Morawski S, Pruszkowska P, Sredniawa B, Lenarczyk R, Kalarus Z. Longterm outcome of catheter ablation and other form of therapy for electrical storm in patients with implantable cardioverter-defibrillators. J Interv Card Electrophysiol. 2017;50:227–234. PubMed PMC

Palaniswamy C, Kolte D, Harikrishnan P, et al. Catheter ablation of postinfarction ventricular tachycardia: ten-year trends in utilization, in-hospital complications, and in-hospital mortality in the United States. Heart Rhythm. 2014;11:2056–2063. PubMed

Sapp J, Nova Scotia Health Authority. Antiarrhythmics or Ablation for Ventricular Tachycardia 2 (VANISH2). Available at https://clinicaltrials.gov/show/NCT02830360.

Maury P, Baratto F, Zeppenfeld K, et al. Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30% Eur Heart J. 2014;35:1479–1485. PubMed

Pauriah M, Cismaru G, Magnin-Poull I, et al. A stepwise approach to the management of postinfarct ventricular tachycardia using catheter ablation as the first-line treatment: a single-center experience. Circ Arrhythm Electrophysiol. 2013;6:351–356. PubMed

Della Bella P, De Ponti R, Uriarte JA, et al. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia: long-term outcome in relation to acute electrophysiological findings. Eur Heart J. 2002;23:414–424. PubMed

Tung R, Michowitz Y, Yu R, et al. Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy. Heart Rhythm. 2013;10:490–498. PubMed

Sarkozy A, Tokuda M, Tedrow UB, et al. Epicardial ablation of ventricular tachycardia in ischemic heart disease. Circ Arrhythm Electrophysiol. 2013;6:1115–1122. PubMed

Hendriks AA, Khan M, Geller L, et al. Ventricular tachycardia in ischemic cardiomyopathy; a combined endo-epicardial ablation as the first procedure versus a stepwise approach (EPILOGUE)—study protocol for a randomized controlled trial. Trials. 2015;16:487. PubMed PMC

Acosta J, Fernández-Armenta J, Penela D, et al. Infarct transmurality as a criterion for first-line endo-epicardial substrate-guided ventricular tachycardia ablation in ischemic cardiomyopathy. Heart Rhythm. 2016;13:85–95. PubMed

Muser D, Santangeli P, Castro SA, et al. Long-term outcome after catheter ablation of ventricular tachycardia in patients with nonischemic dilated cardiomyopathy. Circ Arrhythm Electrophysiol. 2016;9:e004328. PubMed

Proietti R, Essebag V, Beardsall J, et al. Substrate-guided ablation of haemodynamically tolerated and untolerated ventricular tachycardia in patients with structural heart disease: effect of cardiomyopathy type and acute success on long-term outcome. Europace. 2015;17:461–467. PubMed

Dinov B, Arya A, Bertagnolli L, et al. Early referral for ablation of scarrelated ventricular tachycardia is associated with improved acute and long-term outcomes: results from the heart Center of Leipzig ventricular tachycardia registry. Circ Arrhythm Electrophysiol. 2014;7:1144–1151. PubMed

Dinov B, Fiedler L, Schönbauer R, et al. Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the prospective heart Centre of Leipzig VT (HELP-VT) study. Circulation. 2014;129:728–736. PubMed

Tokuda M, Tedrow UB, Kojodjojo P, et al. Catheter ablation of ventricular tachycardia in nonischemic heart disease. Circ Arrhythm Electrophysiol. 2012;5:992–1000. PubMed

Tung R, Vaseghi M, Frankel DS, et al. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an international VT ablation center collaborative group study. Heart Rhythm. 2015;12:1997–2007. PubMed PMC

Arya A, Bode K, Piorkowski C, et al. Catheter ablation of electrical storm due to monomorphic ventricular tachycardia in patients with nonischemic cardiomyopathy: acute results and its effect on long-term survival. Pacing Clin Electrophysiol. 2010;33:1504–1509. PubMed

Carbucicchio C, Santamaria M, Trevisi N, et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverterdefibrillators: short- and long-term outcomes in a prospective single-center study. Circulation. 2008;117:462–469. PubMed

Hu J, Zeng S, Zhou Q, et al. Can ventricular tachycardia non-inducibility after ablation predict reduced ventricular tachycardia recurrence and mortality in patients with non-ischemic cardiomyopathy? A meta-analysis of twentyfour observational studies. Int J Cardiol. 2016;222:689–695. PubMed

Jefic D, Joel B, Good E, et al. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry. Heart Rhythm. 2009;6:189–195. PubMed

Naruse Y, Sekiguchi Y, Nogami A, et al. Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis. Circ Arrhythm Electrophysiol. 2014;7:407–413. PubMed

Muser D, Santangeli P, Pathak RK, et al. Long-term outcomes of catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis. Circ Arrhythm Electrophysiol. 2016;9:e004333. PubMed

Papageorgiou N, Providência R, Bronis K, et al. Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review. Europace. 2018;20:682–691. PubMed

Delacretaz E, Stevenson WG, Ellison KE, Maisel WH, Friedman PL. Mapping and radiofrequency catheter ablation of the three types of sustained monomorphic ventricular tachycardia in nonischemic heart disease. J Cardiovasc Electrophysiol. 2000;11:11–17. PubMed

Soejima K, Stevenson WG, Sapp JL, Selwyn AP, Couper G, Epstein LM. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. J Am Coll Cardiol. 2004;43:1834–1842. PubMed

Nakahara S, Tung R, Ramirez RJ, et al. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia. J Am Coll Cardiol. 2010;55:2355–2365. PubMed PMC

Liuba I, Marchlinski FE. The substrate and ablation of ventricular tachycardia in patients with nonischemic cardiomyopathy. Circ J. 2013;77:1957–1966. PubMed

Bänsch D, Böcker D, Brunn J, Weber M, Breithardt G, Block M. Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators. J Am Coll Cardiol. 2000;36:566–573. PubMed

Hohnloser SH, Al-Khalidi HR, Pratt CM, et al. Shock inhibition evaluation with AzimiLiDe (SHIELD) investigators. Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. Eur Heart J. 2006;27:3027–3032. PubMed

Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009–1017. PubMed PMC

Gasparini M, Menozzi C, Proclemer A, et al. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [role of long dEtection window programming in patients with LEft VentriculAr dysfunction, non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. Eur Heart J. 2009;30:2758–2767. PubMed PMC

Santangeli P, Muser D, Maeda S, et al. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials. Heart Rhythm. 2016;13:1552–1559. PubMed

Packer DL, Prutkin JM, Hellkamp AS, et al. Impact of implantable cardioverter- defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation. 2009;120:2170–2176. PubMed PMC

Gökoğlan Y, Mohanty S, Gianni C, et al. Scar homogenization versus limited-substrate ablation in patients with nonischemic cardiomyopathy and ventricular tachycardia. J Am Coll Cardiol. 2016;68:1990–1998. PubMed

Della Bella P, Baratto F, Tsiachris D, et al. Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: long-term outcome after ablation. Circulation. 2013;127:1359–1368. PubMed

Komatsu Y, Maury P, Sacher F, et al. Impact of substrate-based ablation of ventricular tachycardia on cardiac mortality in patients with implantable cardioverter-defibrillators. J Cardiovasc Electrophysiol. 2015;26:1230–1238. PubMed

Pasotti M, Klersy C, Pilotto A, et al. Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol. 2008;52:1250–1260. PubMed

Kumar S, Baldinger SH, Gandjbakhch E, et al. Long-term arrhythmic and nonarrhythmic outcomes of Lamin a/C mutation carriers. J Am Coll Cardiol. 2016;68:2299–2307. PubMed

Cohen TJ, Chien WW, Lurie KG, et al. Radiofrequency catheter ablation for treatment of bundle branch reentrant ventricular tachycardia: results and long-term follow-up. J Am Coll Cardiol. 1991;18:1767–1773. PubMed

Blank Z, Dhala A, Deshpande S, Sra J, Jazayeri M, Akhtar M. Bundle branch reentrant ventricular tachycardia: cumulative experience in 48 patients. J Cardiovasc Electrophysiol. 1993;4:253–262. PubMed

Mehdirad AA, Keim S, Rist K, Tchou P. Long-term clinical outcome of right bundle branch radiofrequency catheter ablation for treatment of bundle branch reentrant ventricular tachycardia. Pacing Clin Electrophysiol. 1995;18(12 Pt 1):2135–2143. PubMed

Pathak RK, Fahed J, Santangeli P, et al. Long-term outcome of catheter ablation for treatment of bundle branch re-entrant tachycardia. JACC Clin Electrophysiol. 2018;4:331–338. PubMed

Narasimhan C, Jazayeri MR, Sra J, et al. Ventricular tachycardia in valvular heart disease: facilitation of bundle-branch reentry by valve surgery. Circulation. 1997;96:4307–4313. PubMed

Li YG, Grönefeld G, Israel C, Bogun F, Hohnloser SH. Bundle branch reentrant tachycardia in patients with apparent normal His-Purkinje conduction: the role of functional conduction impairment. J Cardiovasc Electrophysiol. 2002;13:1233–1239. PubMed

Schmidt B, Tang M, Chun KR, et al. Left bundle branch-Purkinje system in patients with bundle branch reentrant tachycardia: lessons from catheter ablation and electroanatomic mapping. Heart Rhythm. 2009;6:51–58. PubMed

Blanck Z, Jazayeri M, Dhala A, Deshpande S, Sra J, Akhtar M. Bundle branch reentry: a mechanism of ventricular tachycardia in the absence of myocardial or valvular dysfunction. J Am Coll Cardiol. 1993;22:1718–1722. PubMed

Chen H, Shi L, Yang B, et al. Electrophysiological characteristics of bundle branch reentry ventricular tachycardia in patients without structural heart disease. Circ Arrhythm Electrophysiol. 2018;11:e006049. PubMed

Nogami A, Naito S, Tada H, et al. Demonstration of diastolic and presystolic Purkinje potentials as critical potentials in a macroreentry circuit of verapamil- sensitive idiopathic left ventricular tachycardia. J Am Coll Cardiol. 2000;36:811–823. PubMed

Ouyang F, Cappato R, Ernst S, et al. Electroanatomic substrate of idiopathic left ventricular tachycardia: unidirectional block and macroreentry within the Purkinje network. Circulation. 2002;105:462–469. PubMed

Liu Y, Fang Z, Yang B, et al. Catheter ablation of fascicular ventricular tachycardia: long-term clinical outcomes and mechanisms of recurrence. Circ Arrhythm Electrophysiol. 2015;8:1443–1451. PubMed PMC

Nakagawa H, Beckman KJ, McClelland JH, et al. Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential. Circulation. 1993;88:2607–2617. PubMed

Chen M, Yang B, Zou J, et al. Non-contact mapping and linear ablation of the left posterior fascicle during sinus rhythm in the treatment of idiopathic left ventricular tachycardia. Europace. 2005;7:138–144. PubMed

Kottkamp H, Chen X, Hindricks G, et al. Idiopathic left ventricular tachycardia: new insights into electrophysiological characteristics and radiofrequency catheter ablation. Pacing Clin Electrophysiol. 1995;18:1285–1297. PubMed

Lin D, Hsia HH, Gerstenfeld EP, et al. Idiopathic fascicular left ventricular tachycardia: linear ablation lesion strategy for noninducible or nonsustained tachycardia. Heart Rhythm. 2005;2:934–939. PubMed

Tada H, Nogami A, Naito S, et al. Retrograde Purkinje potential activation during sinus rhythm following catheter ablation of idiopathic left ventricular tachycardia. J Cardiovasc Electrophysiol. 1998;9:1218–1224. PubMed

Tsuchiya T, Okumura K, Honda T, et al. Significance of late diastolic potential preceding Purkinje potential in verapamil-sensitive idiopathic left ventricular tachycardia. Circulation. 1999;99:2408–2413. PubMed

Wen MS, Yeh SJ, Wang CC, Lin FC, Wu D. Successful radiofrequency ablation of idiopathic left ventricular tachycardia at a site away from the tachycardia exit. J Am Coll Cardiol. 1997;30:1024–1031. PubMed

Arya A, Haghjoo M, Emkanjoo Z, et al. Comparison of presystolic Purkinje and late diastolic potentials for selection of ablation site in idiopathic verapamil sensitive left ventricular tachycardia. J Interv Card Electrophysiol. 2004;11:135–141. PubMed

Liu Q, Shehata M, Jiang R, et al. Macroreentrant loop in ventricular tachycardia from the left posterior fascicle: new implications for mapping and ablation. Circ Arrhythm Electrophysiol. 2016;9:e004272. PubMed

Guo XG, Liu X, Zhou GB, et al. Clinical, electrocardiographic, and electrophysiological characteristics of left upper septal fascicular ventricular tachycardia. Europace. 2018;20:673–681. PubMed

Collins KK, Schaffer MS, Liberman L, et al. Fascicular and nonfascicular left ventricular tachycardias in the young: an international multicenter study. J Cardiovasc Electrophysiol. 2013;24:640–648. PubMed

Suzuki T, Nakamura Y, Yoshida S, et al. Radiofrequency catheter ablation of idiopathic left anterior fascicular ventricular tachycardia in children. Heart Rhythm. 2014;11:1948–1956. PubMed

Fishberger SB, Olen MM, Rollinson NL, Rossi AF. Creation of partial fascicular block: an approach to ablation of idiopathic left ventricular tachycardia in the pediatric population. Pacing Clin Electrophysiol. 2015;38:209–215. PubMed

Saul JP, Kanter RJ, Abrams D, et al. PACES/HRS expert consensus statement on the use of catheter ablation in children and patients with congenital heart disease: developed in partnership with the pediatric and congenital electrophysiology society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American Academy of Pediatrics (AAP), the American Heart Association (AHA), and the Association for European Pediatric and Congenital Cardiology (AEPC) Heart Rhythm. 2016;13:e251–e289. PubMed

Talib AK, Nogami A, Morishima I, et al. Non-reentrant fascicular tachycardia: clinical and electrophysiological characteristics of a distinct type of idiopathic ventricular tachycardia. Circ Arrhythm Electrophysiol. 2016;9:e004177. PubMed

Gonzalez RP, Scheinman MM, Lesh MD, Helmy I, Torres V, Van Hare GF. Clinical and electrophysiologic spectrum of fascicular tachycardias. Am Heart J. 1994;128:147–156. PubMed

Nogami A. Purkinje-related arrhythmias. Part I: monomorphic ventricular tachycardias. Pacing Clin Electrophysiol. 2011;34:624–650. PubMed

Hayashi M, Kobayashi Y, Iwasaki YK, et al. Novel mechanism of postinfarction ventricular tachycardia originating in surviving left posterior Purkinje fibers. Heart Rhythm. 2006;3:908–918. PubMed

Ozer S, Allen S, Schaffer MS. Adenosine- and verapamil-sensitive ventricular tachycardia in the newborn. Pacing Clin Electrophysiol. 2001;24:898–901. PubMed

Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995;92:231–237. PubMed

Harrison DA, Harris L, Siu SC, et al. Sustained ventricular tachycadia in adult patients late after repair of tetralogy of Fallot. J Am Coll Cardiol. 1997;30:1368–1373. PubMed

Knauth AL, Gauvreau K, Powell AJ, et al. Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair. Heart. 2008;94:211–216. PubMed

Diller GP, Kempny A, Liodakis E, et al. Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of Fallot. Circulation. 2012;125:2440–2446. PubMed

Koyak Z, Harris L, de Groot JR, et al. Sudden cardiac death in adult congenital heart disease. Circulation. 2012;126:1944–1954. PubMed

Koyak Z, deGroot JR, Bouma BJ, et al. Sudden cardiac death in adult congenital heart disease: can the unpredictable be foreseen? Europace. 2017;19:401–406. PubMed

Deal BJ, Scagliotti D, Miller SM, Gallastegui JL, Hariman RJ, Levitsky S. Electrophysiologic drug testing in symptomatic ventricular arrhythmias after repair of tetralogy of Fallot. Am J Cardiol. 1987;59:1380–1385. PubMed

Oechslin EN, Harrison DA, Harris L, et al. Reoperation in adults with repair of tetralogy of Fallot: indications and outcomes. J Thorac Cardiovasc Surg. 1999;118:245–251. PubMed

Therrien J, Siu SC, Harris L, et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation. 2001;103:2489–2494. PubMed

Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol. 2005;95:779–782. PubMed

Mavroudis C, Deal BJ, Backer CL, Tsao S. Arrhythmia surgery in patients with andwithout congenital heart disease. Ann Thorac Surg. 2008;86:857–868. PubMed

Adamson L, Vohra HA, Haw MP. Does pulmonary valve replacement post repair of tetralogy of Fallot improve right ventricular function? Interact Cardiovasc Thorac Surg. 2009;9:520–527. PubMed

Miyazaki A, Sakaguchi H, Ohuchi H, et al. Efficacy of hemodynamic-based management of tachyarrhythmia after repair of tetralogy of Fallot. Circ J. 2012;76:2855–2862. PubMed

Khairy P, Van Hare GF, Balaji S, et al. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the pediatric and congenital electrophysiology society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European heart rhythm association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD) Heart Rhythm. 2014;11:e102–e165. PubMed

Lin YS, Liu PH, Wu LS, Chen YM, Chang CJ, Chu PH. Major adverse cardiovascular events in adult congenital heart disease: a population-based follow-up study from Taiwan. BMC Cardiovasc Disord. 2014;14:38. PubMed PMC

Sabate Rotes A, Connolly HM, Warnes CA, et al. Ventricular arrhythmia risk stratification in patients with tetralogy of Fallot at the time of pulmonary valve replacement. Circ Arrhythm Electrophysiol. 2015;8:110–116. PubMed

Gonska BD, Cao K, Raab J, Eigster G, Kreuzer H. Radiofrequency catheter ablation of right ventricular tachycardia late after repair of congenital heart defects. Circulation. 1996;94:1902–1908. PubMed

Morwood JG, Triedman JK, Berul CI, et al. Radiofrequency catheter ablation of ventricular tachycardia in children and young adults with congenital heart disease. Heart Rhythm. 2004;1:301–308. PubMed

Zeppenfeld K, Schalij MJ, Bartelings MM, et al. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus. Circulation. 2007;116:2241–2252. PubMed

Kriebel T, Saul JP, Schneider H, Sigler M, Paul T. Noncontact mapping and radiofrequency catheter ablation of fast and hemodynamically unstable ventricular tachycardia after surgical repair of tetralogy of Fallot. J Am Coll Cardiol. 2007;50:2162–2168. PubMed

Kapel GF, Reichlin T, Wijnmaalen AP, et al. Left-sided ablation of ventricular tachycardia in adults with repaired tetralogy of Fallot: a case series. Circ Arrhythm Electrophysiol. 2014;7:889–897. PubMed

Kapel GF, Reichlin T, Wijnmaalen AP, et al. Re-entry using anatomically determined isthmuses: a curable ventricular tachycardia in repaired congenital heart disease. Circ Arrhythm Electrophysiol. 2015;8:102–109. PubMed

van Zyl M, Kapa S, Padmanabhan D, et al. Mechanism and outcomes of catheter ablation for ventricular tachycardia in adults with repaired congenital heart disease. Heart Rhythm. 2016;13:1449–1454. PubMed

Kapel GF, Sacher F, Dekkers OM, et al. Arrhythmogenic anatomical isthmuses identified by electroanatomicalmapping are the substrate for ventricular tachycardia in repaired tetralogy of Fallot. Eur Heart J. 2017;38:268–276. PubMed

Sandhu A, Ruckdeschel E, Sauer WH, et al. Perioperative electrophysiology study in patients with tetralogy of Fallot undergoing pulmonary valve replacement will identify those at high risk of subsequent ventricular tachycardia. Heart Rhythm. 2018;15:679–685. PubMed

Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/ American Heart Association task force on practice guidelines. Heart Rhythm. 2012;9:1737–1753. PubMed

Furushima H, Chinushi M, Sugiura H, et al. Ventricular tachycardia late after repair of congenital heart disease: efficacy of combination therapy with radiofrequency catheter ablation and class III antiarrhythmic agents and long-term outcome. J Electrocardiol. 2006;39:219–224. PubMed

Laredo M, Frank R, Waintraub X, et al. Ten-year outcomes of monomorphic ventricular tachycardia catheter ablation in repaired tetralogy of Fallot. Arch Cardiovasc Dis. 2017;110:292–302. PubMed

Harrild DM, Berul CI, Cecchin F, et al. Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation. 2009;119:445–451. PubMed PMC

Berruezo A, Acosta J, Fernández-Armenta J, et al. Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study Europace. 2017;19:607–616. PubMed

Jiang H, Zhang X, Yang Q, et al. Catheter ablation for ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: a systematic review and meta-analysis. Acta Cardiol. 2016;71:639–649. PubMed

Philips B, te Riele AS, Sawant A, et al. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Rhythm. 2015;12:716–725. PubMed

Santangeli P, Zado ES, Supple GE, et al. Long-termoutcome with catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 2015;8:1413–1421. PubMed

Philips B, Madhavan S, James C, et al. Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Arrhythm Electrophysiol. 2012;5:499–505. PubMed

Bai R, Di Biase L, Shivkumar K, et al. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmiafree survival after endo-epicardial substrate based mapping and ablation. Circ Arrhythm Electrophysiol. 2011;4:478–485. PubMed

Dalal D, Jain R, Tandri H, et al. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2007;50:432–440. PubMed

Verma A, Kilicaslan F, Schweikert RA, et al. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. Circulation. 2005;111:3209–3216. PubMed

Nogami A, Sugiyasu A, Tada H, et al. Changes in the isolated delayed component as an endpoint of catheter ablation in arrhythmogenic right ventricular cardiomyopathy: predictor for long-term success. J Cardiovasc Electrophysiol. 2008;19:681–688. PubMed

Müssigbrodt A, Efimova E, Knopp H, et al. Should all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergo epicardial catheter ablation? J Interv Card Electrophysiol. 2017;48:193–199. PubMed

Pokushalov E, Romanov A, Turov A, Artyomenko S, Shirokova N, Karaskov A. Percutaneous epicardial ablation of ventricular tachycardia after failure of endocardial approach in the pediatric population with arrhythmogenic right ventricular dysplasia. Heart Rhythm. 2010;7:1406–1410. PubMed

Pappone C, Brugada J, Vicedomini G, et al. Electrical substrate elimination in 135 consecutive patients with Brugada syndrome. Circ Arrhythm Electrophysiol. 2017;10:e005053. PubMed

Brugada J, Pappone C, Berruezo A, et al. Brugada syndrome phenotype elimination by epicardial substrate ablation. Circ Arrhythm Electrophysiol. 2015;8:1373–1381. PubMed

Zhang P, Tung R, Zhang Z, et al. Characterization of the epicardial substrate for catheter ablation of Brugada syndrome. Heart Rhythm. 2016;13:2151–2158. PubMed

Nademanee K, Veerakul G, Chandanamattha P, et al. Prevention of ventricular fibrillation episodes inBrugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation. 2011;123:1270–1279. PubMed

Towbin JA, McKenna WJ, Abrams DJ, et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm 2019 May 9 [Epub ahead of print]. PubMed

Orgeron GM, James CA, Te Riele A, et al. Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular dysplasia/cardiomyopathy: predictors of appropriate therapy, outcomes, and complications. J Am Heart Assoc. 2017;6:e006242. PubMed PMC

Riley MP, Zado E, Bala R, et al. Lack of uniform progression of endocardial scar in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and ventricular tachycardia. Circ Arrhythm Electrophysiol. 2010;3:332–338. PubMed

Berte B, Sacher F, Venlet J, et al. VT recurrence after ablation: incomplete ablation or disease progression? A multicentric European study. J Cardiovasc Electrophysiol. 2016;27:80–87. PubMed

Link MS, Laidlaw D, Polonsky B, et al. Ventricular arrhythmias in the north American multidisciplinary study of ARVC: predictors, characteristics, and treatment. J Am Coll Cardiol. 2014;64:119–125. PubMed PMC

Corrado D, Leoni L, Link MS, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2003;108:3084–3091. PubMed

Corrado D, Calkins H, Link MS, et al. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation. 2010;122:1144–1152. PubMed

Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation. 2004;110:1731–1737. PubMed

Dukkipati SR, d’Avila A, Soejima K, et al. Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricular tachycardia related to hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol. 2011;4:185–194. PubMed

Santangeli P, Di Biase L, Lakkireddy D, et al. Radiofrequency catheter ablation of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: safety and feasibility. Heart Rhythm. 2010;7:1036–1042. PubMed

Ueda A, Fukamizu S, Soejima K, et al. Clinical and electrophysiological characteristics in patients with sustained monomorphic reentrant ventricular tachycardia associated with dilated-phase hypertrophic cardiomyopathy. Europace. 2012;14:734–740. PubMed

Inada K, Seiler J, Roberts-Thomson KC, et al. Substrate characterization and catheter ablation formonomorphic ventricular tachycardia in patients with apical hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2011;22:41–48. PubMed

Igarashi M, Nogami A, Kurosaki K, et al. Radiofrequency catheter ablation of ventricular tachycardia in patients with hypertrophic cardiomyopathy and apical aneurysm. JACC Clin Electrophysiol. 2018;4:339–350. PubMed

Santangeli P, Muser D, Zado ES, et al. Acute hemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality. Circ Arrhythm Electrophysiol. 2015;8:68–75. PubMed

Santangeli P, Frankel DS, Tung R, et al. Early mortality after catheter ablation of ventricular tachycardia in patients with structural heart disease. J Am Coll Cardiol. 2017;69:2105–2115. PubMed

Tzou WS, Tung R, Frankel DS, et al. Ventricular tachycardia ablation in severe heart failure: an international ventricular tachycardia ablation center collaboration analysis. Circ Arrhythm Electrophysiol. 2017;10:e004494. PubMed

Enriquez A, Liang J, Gentile J, et al. Outcomes of rescue cardiopulmonary support for periprocedural acute hemodynamic decompensation in patients undergoing catheter ablation of electrical storm. Heart Rhythm. 2018;15:75–80. PubMed

Mathuria N, Wu G, Rojas-Delgado F, et al. Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol. 2017;48:27–34. PubMed

Iwasawa J, Koruth JS, Choudry S, et al. Independent assessment of the PAINESD risk stratification tool for predicting adverse outcomes after VT ablation. Heart Rhythm. 2018;15:S623.

Muser D, Liang JJ, Castro SA, et al. Outcomes with prophylactic use of percutaneous left ventricular assist devices in high-risk patients undergoing catheter ablation of scar-related ventricular tachycardia: a propensity-score matched analysis. Heart Rhythm. 2018;15:1500–1506. PubMed

Vakil KP, Roukoz H, Tung R, et al. Mortality prediction using a modified Seattle heart failure model may improve patient selection for ventricular tachycardia ablation. Am Heart J. 2015;170:1099–1104. PubMed

Baratto F, Pappalardo F, Oloriz T, et al. Extracorporeal membrane oxygenation for hemodynamic support of ventricular tachycardia ablation. Circ Arrhythm Electrophysiol. 2016;12:e004492. PubMed

Tanner H, Hindricks G, Schirdewahn P, et al. Outflow tract tachycardia with R/S transition in lead V3: six different anatomic approaches for successful ablation. J Am Coll Cardiol. 2005;45:418–423. PubMed

Good E, Desjardins B, Jongnarangsin K, et al. Ventricular arrhythmias originating from a papillary muscle in patients without prior infarction: a comparison with fascicular arrhythmias. Heart Rhythm. 2008;5:1530–1537. PubMed

Betensky BP, Park RE, Marchlinski FE, et al. The V(2) transition ratio: a new electrocardiographic criterion for distinguishing left from right ventricular outflow tract tachycardia origin. J Am Coll Cardiol. 2011;57:2255–2262. PubMed

Kumagai K. Idiopathic ventricular arrhythmias arising from the left ventricular outflow tract: tips and tricks. J Arrhythmia. 2014;30:211–221.

Kuchar DL, Ruskin JN, Garan H. Electrocardiographic localization of the site of origin of ventricular tachycardia in patients with prior myocardial infarction. J Am Coll Cardiol. 1989;13:893–903. PubMed

Segal OR, Chow AW, Wong T, et al. A novel algorithm for determining endocardial VT exit site from 12-lead surface ECG characteristics in human, infarct-related ventricular tachycardia. J Cardiovasc Electrophysiol. 2007;18:161–168. PubMed

de Riva M, Watanabe M, Zeppenfeld K. Twelve-lead ECG of ventricular tachycardia in structural heart disease. Circ Arrhythm Electrophysiol. 2015;8:951–962. PubMed

YokokawaM LTY, Yoshida K, et al. Automated analysis of the 12-lead electrocardiogram to identify the exit site of postinfarction ventricular tachycardia. Heart Rhythm. 2012;9:330–334. PubMed

Yokokawa M, Jung DY, Joseph KK, Hero AO, 3rd, Morady F, Bogun F. Computerized analysis of the 12-lead electrocardiogram to identify epicardial ventricular tachycardia exit sites. Heart Rhythm. 2014;11:1966–1973. PubMed

Sapp JL, Bar-Tal M, Howes AJ, et al. Real-time localization of ventricular tachycardia origin from the 12-lead electrocardiogram. JACC Clin Electrophysiol. 2017;3:687–699. PubMed

Piers SR, de Riva SM, Kapel GF, Trines SA, Schalij MJ, Zeppenfeld K. Endocardial or epicardial ventricular tachycardia in nonischemic cardiomyopathy? The role of 12-lead ECG criteria in clinical practice. Heart Rhythm. 2014;11:1031–1039. PubMed

Oloriz T, Silberbauer J, Maccabelli G, et al. Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types. Circ Arrhythm Electrophysiol. 2014;7:414–423. PubMed

Yoshida K, Liu TY, Scott C, et al. The value of defibrillator electrograms for recognition of clinical ventricular tachycardias and for pace mapping of post-infarction ventricular tachycardia. J Am Coll Cardiol. 2010;56:969–979. PubMed

Wang Y, Cuculich PS, Zhang J, et al. Nonninvasive electroanatomic mapping of human ventricular arrhythmias with electrocardiographic imaging. Sci Transl Med. 2011;3:98ra84. PubMed PMC

Rudy Y. Noninvasive electrocardiographic imaging (ECGI) of arrhythmogenic substrates in humans. Circ Res. 2013;112:863–874. PubMed PMC

Varma N, Strom M, Chung MK. Noninvasive voltage and activation mapping of ARVD/C using ECG imaging. JACC Cardiovasc Imaging. 2013;6:1346–1347. PubMed

Zhang J, Cooper DH, Desouza KA, et al. Electrophysiologic scar substrate in relation to VT: noninvasive high-resolution mapping and risk assessment with ECGI. Pacing Clin Electrophysiol. 2016;39:781–791. PubMed PMC

Sapp JL, Dawoud F, Clements JC, Horácek BM. Inverse solution mapping of epicardial potentials: quantitative comparison with epicardial contact mapping. Circ Arrhythm Electrophysiol. 2012;5:1001–1009. PubMed

Haines DE, Beheiry S, Akar JG, et al. Heart Rhythm Society expert consensus statement on electrophysiology laboratory standards: process, protocols, equipment, personnel, and safety. Heart Rhythm. 2014;11:e9–e51. PubMed PMC

Miller MA, Dukkipati SR, Mittnacht AJ, et al. Activation and entrainment mapping of hemodynamically unstable ventricular tachycardia using a percutaneous left ventricular assist devices. J Am Coll Cardiol. 2011;58:1363–1371. PubMed

Lü F, Eckman PM, Liao KK, et al. Catheter ablation of hemodynamically unstable ventricular tachycardia with mechanical circulatory support. Int J Cardiol. 2013;168:3859–3865. PubMed

Servatius H, Höfeler T, Hoffmann BA, et al. Propofol sedation administered by cardiologists for patients undergoing catheter ablation for ventricular tachycardia. Europace. 2016;18:1245–1251. PubMed

American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology. 2002;96:1004–1017. PubMed

Conway A, Rolley J, Page K, Fullbrook P. Clinical practice guidelines for nurse-administered propcedural sedation and analgesia in the cardiac catheterization laboratory: a modified Delphi study. J Adv Nurs. 2014;70:1040–1053. PubMed

Visser CA, Kan G, David GK, Lie KI, Durrer D. Two dimensional echocardiography in the diagnosis of left ventricular thrombus: a prospective study of 67 patients with anatomic validation. Chest. 1983;83:228–232. PubMed

Ezekowitz MD, Wilson DA, Smith EO, et al. Comparison of Indium-111 platelet scintigraphy and two-dimensional echocardiography in the diagnosis of left ventricular thrombi. N Engl J Med. 1982;306:1509–1513. PubMed

Stratton JR, Lighty GW, Jr, Pearlman AS, Ritchie JL. Detection of left ventricular thrombus by two-dimensional echocardiography: sensitivity, specificity, and causes of uncertainty. Circulation. 1982;66:156–166. PubMed

Thanigaraj S, Schechtman KB, Perez JE. Improved echocardiographic delineation of left ventricular thrombus with the use of intravenous second- generation contrast image enhancement. J Am Soc Echocardiogr. 1999;12:1022–1026. PubMed

Weinsaft JW, Kim HW, Shah DJ, et al. Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. J Am Coll Cardiol. 2008;52:148–157. PubMed

Weinsaft JW, Kim RJ, Ross M, et al. Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus. JACC Cardiovasc Imaging. 2009;2:969–979. PubMed PMC

Siontis KC, Kim HM, Sharaf Dabbagh G, et al. Association of preprocedural cardiac magnetic resonance imaging with outcomes of ventricular tachycardia ablation in patients with idiopathic dilated cardiomyopathy. Heart Rhythm. 2017;14:1487–1493. PubMed

Zghaib T, Ipek EG, Hansford R, et al. Standard ablation versus magnetic resonance imaging-guided ablation in the treatment of ventricular tachycardia. Circ Arrhythm Electrophysiol. 2018;11:e005973. PubMed PMC

Andreu D, Penela D, Acosta J, et al. Cardiac magnetic resonance-aided scar dechanneling: influence on acute and long-term outcomes. Heart Rhythm. 2017;14:1121–1128. PubMed

Codreanu A, Odille F, Aliot E, et al. Electroanatomic characterization of postinfarct scars comparison with 3-dimensional myocardial scar reconstruction based on magnetic resonance imaging. J Am Coll Cardiol. 2008;52:839–842. PubMed

Desjardins B, Crawford T, Good E, et al. Infarct architecture and characteristics on delayed enhancedmagnetic resonance imaging and electroanatomic mapping in patients with postinfarction ventricular arrhythmia. Heart Rhythm. 2009;6:644–651. PubMed PMC

Bogun FM, Desjardins B, Good E, et al. Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate. J Am Coll Cardiol. 2009;53:1138–1145. PubMed PMC

Dickfeld T, Tian J, Ahmad G, et al. MRI-guided ventricular tachycardia ablation: integration of late gadolinium-enhanced 3D scar in patients with implantable cardioverter-defibrillators. CircArrhythm Electrophysiol. 2011;4:172–184. PubMed

Fernandez-Armenta J, Berruezo A, Andreu D, et al. Three-dimensional architecture of scar and conducting channels based on high resolution ce- CMR: insights for ventricular tachycardia ablation. Circ Arrhythm Electrophysiol. 2013;6:528–537. PubMed

Gupta S, Desjardins B, Baman T, et al. Delayed-enhanced MR scar imaging and intraprocedural registration into an electroanatomical mapping system in post-infarction patients. JACC Cardiovasc Imaging. 2012;5:207–210. PubMed PMC

Marra MP, Leoni L, Bauce B, et al. Imaging study of ventricular scar in arrhythmogenic right ventricular cardiomyopathy: comparison of 3D standard electroanatomical voltage mapping and contrast-enhanced cardiac magnetic resonance. Circ Arrhythm Electrophysiol. 2012;5:91–100. PubMed

Nakahara S, Vaseghi M, Ramirez RJ, et al. Characterization of myocardial scars: electrophysiological imaging correlates in a porcine infarct model. Heart Rhythm. 2011;8:1060–1067. PubMed

Ghannam M, Cochet H, Jais P, et al. Correlation between computer tomography- derived scar topography and critical ablation sites in postinfarction ventricular tachycardia. J Cardiovasc Electrophysiol. 2018;29:438–445. PubMed

Esposito A, Palmisano A, Antunes S, et al. Cardiac CT with delayed enhancement in the characterization of ventricular tachycardia structural substrate: relationship between CT-segmented scar and electro-anatomic mapping. JACC Cardiovasc Imaging. 2016;9:822–832. PubMed

Tian J, Jeudy J, Smith MF, et al. Three-dimensional contrast-enhanced multidetector CT for anatomic, dynamic, and perfusion characterization of abnormal myocardium to guide ventricular tachycardia ablations. Circ Arrhythm Electrophysiol. 2010;3:496–504. PubMed

Yamashita S, Sacher F, Mahida S, et al. Image integration to guide catheter ablation in scar-related ventricular tachycardia. J Cardiovasc Electrophysiol. 2016;27:699–708. PubMed

Komatsu Y, Cochet H, Jadidi A, et al. Regional myocardial wall thinning at multidetector computed tomography correlates to arrhythmogenic substrate in postinfarction ventricular tachycardia: assessment of structural and electrical substrate. Circ Arrhythm Electrophysiol. 2013;6:342–350. PubMed

Dickfeld T, Lei P, Dilsizian V, et al. Integration of three-dimensional scar maps for ventricular tachycardia ablation with positron emission tomography- computed tomography. JACC Cardiovasc Imaging. 2008;1:73–82. PubMed

Tian J, Smith MF, Chinnadurai P, et al. Clinical application of PET/CT fusion imaging for three-dimensional myocardial scar and left ventricular anatomy during ventricular tachycardia ablation. J Cardiovasc Electrophysiol. 2009;20:567–604. PubMed

Andreu D, Ortiz-Perez JT, Boussy T, et al. Usefulness of contrast-enhanced cardiac magnetic resonance in identifying the ventricular arrhythmia substrate and the approach needed for ablation. Eur Heart J. 2014;35:1316–1326. PubMed

Soto-Iglesias D, Acosta J, Penela D, et al. Image-based criteria to identify the presence of epicardial arrhythmogenic substrate in patients with transmural myocardial infarction. Heart Rhythm. 2018;15:814–821. PubMed

Cheitlin MD, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the clinical application of echocardiography: executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on clinical application of echocardiography). Developed in collaboration with the American Society of Echocardiography. J Am Coll Cardiol. 1997;29:862–879. PubMed

Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography—summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/ASE Committee to update the 1997 guidelines for the clinical application of echocardiography) J Am Coll Cardiol. 2003;42:954–970. PubMed

Mansencal N, Nasr IA, Pilliere R, et al. Usefulness of contrast echocardiography for assessment of left ventricular thrombus after acute myocardial infarction. Am J Cardiol. 2007;99:1667–1670. PubMed

Srichai MB, Junor C, Rodriguez LL, et al. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrastenhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J. 2006;152:75–84. PubMed

Russo RJ, Costa HS, Silva PD, et al. Assessing the risks associated withMRI in patients with a pacemaker or defibrillator. N Engl J Med. 2017;376:755–764. PubMed

Nazarian S, Hansford R, Roguin A, et al. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med. 2011;155:415–424. PubMed PMC

Horwood L, Attili A, Luba F, et al. Magnetic resonance imaging in patients with cardiac implanted electronic devices: focus on contraindications to magnetic resonance imaging protocols. Europace. 2017;19:812–817. PubMed

Indik JH, Gimbel JR, Abe H, et al. 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. Heart Rhythm. 2017;14:e97–e153. PubMed

Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2013;62:e147–e239. PubMed

Schelbert EB, Hsu LY, Anderson SA, et al. Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart. Circ Cardiovasc Imaging. 2010;3:743–752. PubMed PMC

Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992–2002. PubMed

Yan AT, Shayne AJ, Brown KA, et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation. 2006;114:32–39. PubMed

Schmidt A, Azevedo CF, Cheng A, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007;115:2006–2014. PubMed PMC

Roes SD, Borleffs CJ, van der Geest RJ, et al. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter- defibrillator. Circ Cardiovasc Imaging. 2009;2:183–190. PubMed

Perez-David E, Arenal A, Rubio-Guivernau JL, et al. Noninvasive identification of ventricular tachycardia-related conducting channels using contrastenhanced magnetic resonance imaging in patients with chronic myocardial infarction: comparison of signal intensity scar mapping and endocardial voltage mapping. J Am Coll Cardiol. 2011;57:184–194. PubMed

Sasaki T, Hansford R, Zviman MM, et al. Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators. Circ Cardiovasc Imaging. 2011;4:662–670. PubMed PMC

Rashid S, Rapacchi S, Vaseghi M, et al. Improved late gadolinium enhancement MR imaging for patients with implanted cardiac devices. Radiology. 2014;270:269–274. PubMed PMC

Cochet H, Komatsu Y, Sacher F, et al. Integration of merged delayed-enhanced magnetic resonance imaging and multidetector computed tomography for the guidance of ventricular tachycardia ablation: a pilot study. J Cardiovasc Electrophysiol. 2013;24:419–426. PubMed

Desjardins B, Morady F, Bogun F. Effect of epicardial fat on electroanatomical mapping and epicardial catheter ablation. J Am Coll Cardiol. 2010;56:1320–1327. PubMed

Yamashita S, Sacher F, Mahida S, et al. Role of high-resolution image integration to visualize left phrenic nerve and coronary arteries during epicardial ventricular tachycardia ablation. Circ Arrhythm Electrophysiol. 2015;8:371–380. PubMed

Tian J, Smith MF, Ahmad G, Dilsizian V, Jimenez A, Dickfeld T. Integration of 3-dimensional scar models from SPECT to guide ventricular tachycardia ablation. J Nucl Med. 2012;53:894–901. PubMed

Fallavollita JA, Heavey BM, Luisi AJ, Jr, et al. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol. 2014;63:141–149. PubMed PMC

Kammerling JJ, Green FJ, Watanabe AM, et al. Denervation supersensitivity of refractoriness in noninfarcted areas apical to transmural myocardial infarction. Circulation. 1987;76:383–393. PubMed

Simoes MV, Barthel P, Matsunari I, et al. Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction. Eur Heart J. 2004;25:551–557. PubMed

Klein T, Abdulghani M, Smith M, et al. Three-dimensional 123I-meta-iodobenzylguanidine cardiac innervation maps to assess substrate and successful ablation sites for ventricular tachycardia: feasibility study for a novel paradigm of innervation imaging. Circ Arrhythm Electrophysiol. 2015;8:583–591. PubMed

Peichl P, Wichterle D, Cihak R, Aldhoon B, Kautzner J. Catheter ablation of ventricular tachycardia in the presence of an old endocavitary thrombus guided by intracardiac echocardiography. Pacing Clin Electrophysiol. 2016;39:581–587. PubMed

Douketis JD, Spyropoulos AC, Kaatz S, BRIDGE Investigators et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med. 2015;373:823–833. PubMed PMC

Smith I, Kranke P, Murat I, et al. Perioperative fasting in adults and children: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2011;28:556–569. PubMed

American Society of Anesthesiologists Task Force on Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists Task Force on preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration. Anesthesiology. 2017;126:376–393. PubMed

Wutzler A, Mueller A, Loehr L, et al. Minimal and deep sedation during ablation of ventricular tachycardia. Int J Cardiol. 2014;172:161–164. PubMed

Nazer B, Woods C, Dewland T, Moyers B, Badhwar N, Gerstenfeld EP. Importance of ventricular tachycardia induction andmapping for patients referred for epicardial ablation. Pacing Clin Electrophysiol. 2015;38:1333–1342. PubMed

American Society of Anesthesiologists Committee on Quality Management and Departmental Administration. Continuum of depth of sedation: definition of general anesthesia and levels of sedation/analgesia. Available at https://www.asahq.org/standards-and-guidelines/continuum-of-depth-ofsedation-definition-of-general-anesthesia-and-levels-of-sedationanalgesia. Accessed 12 Oct 2018.

Lü F, Lin J, Benditt DG. Conscious sedation and anesthesia in the cardiac electrophysiology laboratory. J Cardiovasc Electrophysiol. 2013;24:237–245. PubMed

Gallagher JD. Electrophysiological mechanisms for ventricular arrhythmias in patients with myocardial ischemia: anesthesiologic considerations, Pt II. J Cardiothorac Vasc Anesth. 1997;11:641–656. PubMed

Mulpuru SK, Patel DV, Wilbur SL, Vasavada BC, Furqan T. Electrical storm and termination with propofol therapy: a case report. Int J Cardiol. 2008;128:e6–e8. PubMed

King S, Banker D. Etomidate as an antiarrhythmic. Br J Anaesth. 2005;95:425. PubMed

Mandel JE, Hutchinson MD, Marchlinski FE. Remifentanil–midazolam sedation provides hemodynamic stability and comfort during epicardial ablation of ventricular tachycardia. J Cardiovasc Electrophysiol. 2011;22:464–466. PubMed

Nof E, Reichlin T, Enriquez AD, et al. The impact of general anesthesia on initiation and stability of VT during catheter ablation. Heart Rhythm. 2015;12:2213–2220. PubMed

Ramoul K, Tafer N, Sacher F, et al. Conscious sedation with sufentanil and midazolam for epicardial VT ablation. J Innov Card Rhythm Manag. 2012;3:849–853.

Sharma PS, Padala SK, Gunda S, Koneru JN, Ellenbogen KA. Vascular complications during catheter ablation of cardiac arrhythmias: a comparison between vascular ultrasound guided access and conventional vascular access. J Cardiovasc Electrophysiol. 2016;27:1160–1166. PubMed

Tanaka-Esposito CC, Chung MK, Abraham JM, Cantillon DJ, Abi-Saleh B, Tchou PJ. Real-time ultrasound guidance reduces total and major vascular complications in patients undergoing pulmonary vein antral isolation on therapeutic warfarin. J Interv Card Electrophysiol. 2013;37:163–168. PubMed PMC

Yamagata K, Wichterle D, Roubíček T, et al. Ultrasound-guided versus conventional femoral venipuncture for catheter ablation of atrial fibrillation: a multicentre randomized efficacy and safety trial (ULTRA-FAST trial) Europace. 2018;20:1107–1114. PubMed

Sobolev M, Shiloh AL, Di Biase L, Slovut DP. Ultrasound-guided cannulation of the femoral vein in electrophysiological procedures: a systematic review and meta-analysis. Europace. 2017;19:850–855. PubMed

Seto AH, Abu-Fadel MS, Sparling JM, et al. Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (femoral arterial access with ultrasound trial) JACC Cardiovasc Interv. 2010;3:751–758. PubMed

Bohnen M, Stevenson WG, Tedrow UB, et al. Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. Heart Rhythm. 2011;8:1661–1666. PubMed

Tilz RR, Makimoto H, Lin T, et al. In vivo left-ventricular contact force analysis: comparison of antegrade transseptal with retrograde transaortic mapping strategies and correlation of impedance and electrical amplitude with contact force. Europace. 2014;16:1387–1395. PubMed PMC

d’Avila A, Gutierrez P, Scanavacca M, et al. Effects of radiofrequency pulses delivered in the vicinity of the coronary arteries: implications for nonsurgical transthoracic epicardial catheter ablation to treat ventricular tachycardia. Pacing Clin Electrophysiol. 2002;25:1488–1495. PubMed

Kawamura M, Kobayashi Y, Ito H, et al. Epicardial ablation with cooled tip catheter close to the coronary arteries is effective and safe in the porcine heart if the ventricular potential is being monitored in the epicardium and endocardium. Circ J. 2006;70:926–932. PubMed

Viles-Gonzalez JF, de Castro MR, Scanavacca M, Sosa E, d’Avila A. Acute and chronic effects of epicardial radiofrequency applications delivered on epicardial coronary arteries. Circ Arrhythm Electrophysiol. 2011;4:526–531. PubMed

Roberts-Thomson KC, Seiler J, Steven D, et al. Percutaneous access of the epicardial space for mapping ventricular and supraventricular arrhythmias in patients with and without prior cardiac surgery. J Cardiovasc Electrophysiol. 2010;21:406–411. PubMed

Tschabrunn CM, Haqqani HM, Cooper JM, et al. Percutaneous epicardial ventricular tachycardia ablation after noncoronary cardiac surgery or pericarditis. Heart Rhythm. 2013;10:165–169. PubMed

Killu AM, Ebrille E, Asirvatham SJ, et al. Percutaneous epicardial access for mapping and ablation is feasible in patients with prior cardiac surgery, including coronary bypass surgery. Circ Arrhythm Electrophysiol. 2015;8:94–101. PubMed

Soejima K, Couper G, Cooper JM, Sapp JL, Epstein LM, Stevenson WG. Subxiphoid surgical approach for epicardial catheter-based mapping and ablation in patients with prior cardiac surgery or difficult pericardial access. Circulation. 2004;110:1197–1201. PubMed

Michowitz Y, Mathuria N, Tung R, et al. Hybrid procedures for epicardial catheter ablation of ventricular tachycardia: value of surgical access. Heart Rhythm. 2010;7:1635–1643. PubMed

Bai R, Patel D, Di Biase L, et al. Phrenic nerve injury after catheter ablation: should we worry about this complication? J Cardiovasc Electrophysiol. 2006;17:944–948. PubMed

Di Biase L, Burkhardt JD, Pelargonio G, et al. Prevention of phrenic nerve injury during epicardial ablation: comparison of methods for separating the phrenic nerve from the epicardial surface. Heart Rhythm. 2009;6:957–961. PubMed

Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation. 1996;94:983–991. PubMed

Wichter T, Paul TM, Eckardt L, et al. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD? Herz. 2005;30:91–101. PubMed

Bai R, Di Biase L, Shivkumar K, et al. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation. Circ Arrhythm Electrophysiol. 2011;4:478–485. PubMed

Dello Russo A, Casella M, Pieroni M, et al. Drug-refractory ventricular tachycardias after myocarditis: endocardial and epicardial radiofrequency catheter ablation. Circ Arrhythm Electrophysiol. 2012;5:492–498. PubMed

Koplan BA, Soejima K, Baughman K, Epstein LM, Stevenson WG. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm. 2006;3:924–929. PubMed

Sosa E, Scanavacca M, d’Avila A, et al. Endocardial and epicardial ablation guided by nonsurgical transthoracic epicardial mapping to treat recurrent ventricular tachycardia. J Cardiovasc Electrophysiol. 1998;9:229–239. PubMed

Scanavacca M. Epicardial ablation for ventricular tachycardia in chronic Chagas heart disease. Arq Bras Cardiol. 2014;102:524–528. PubMed PMC

Henz BD, do Nascimento TA, Dietrich CO, et al. Simultaneous epicardial and endocardial substrate mapping and radiofrequency catheter ablation as first-line treatment for ventricular tachycardia and frequent ICD shocks in chronic Chagasic cardiomyopathy. J Interv Card Electrophysiol. 2009;26:195–205. PubMed

Nademanee K, Veerakul G, Chandanamattha P, et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outfiow tract epicardium. Circulation. 2011;123:1270–1279. PubMed

Szel T, Antzelevitch C. Abnormal repolarization as the basis for late potentials and fractionated electrograms recorded from epicardium in experimental models of Brugada syndrome. J Am Coll Cardiol. 2014;63:2037–2045. PubMed PMC

Fernandes GC, Fernandes A, Cardoso R, et al. Ablation strategies for the management of symptomatic Brugada syndrome: a systematic review. Heart Rhythm. 2018;15:1140–1147. PubMed

Downar E, Parson ID, Mickleborough LL, Cameron DA, Yao LC, Waxman MB. On-line epicardial mapping of intraoperative ventricular arrhythmias: initial clinical experience. J Am Coll Cardiol. 1984;4:703–714. PubMed

Kaltenbrunner W, Cardinal R, Dubuc M, et al. Epicardial and endocardial mapping of ventricular tachycardia in patients with myocardial infarction. Is the origin of the tachycardia always subendocardially localized? Circulation. 1991;84:1058–1071. PubMed

Blanchard SM, Walcott GP, Wharton JM, Ideker RE. Why is catheter ablation less successful than surgery for treating ventricular tachycardia that results from coronary artery disease? Pacing Clin Electrophysiol. 1994;17:2315–2335. PubMed

Gonska BD, Cao K, Schaumann A, Dorszewski A, von zur Mühlen F, Kreuzer H. Catheter ablation of ventricular tachycardia in 136 patients with coronary artery disease: results and long-term follow-up. J Am Coll Cardiol. 1994;24:1506–1514. PubMed

Tung R, Nakahara S, Ramirez R, Lai C, Fishbein MC, Shivkumar K. Distinguishing epicardial fat from scar: analysis of electrograms using highdensity electroanatomic mapping in a novel porcine infarct model. Heart Rhythm. 2010;7:389–395. PubMed PMC

Svenson RH, Littmann L, Gallagher JJ, et al. Termination of ventricular tachycardia with epicardial laser photocoagulation: a clinical comparison with patients undergoing successful endocardial photocoagulation alone. J Am Coll Cardiol. 1990;15:163–170. PubMed

Wijnmaalen AP, van der Geest RJ, van Huls van Taxis CF, et al. Head-tohead comparison of contrast-enhanced magnetic resonance imaging and electroanatomical voltage mapping to assess post-infarct scar characteristics in patients with ventricular tachycardias: real-time image integration and reversed registration. Eur Heart J. 2011;32:104–114. PubMed

Andreu D, Berruezo A, Ortiz-Pérez JT, et al. Integration of 3D electroanatomic maps and magnetic resonance scar characterization into the navigation system to guide ventricular tachycardia ablation. Circ Arrhythm Electrophysiol. 2011;4:674–683. PubMed

Martinek M, Stevenson WG, Inada K, Tokuda M, Tedrow UB. QRS characteristics fail to reliably identify ventricular tachycardias that require epicardial ablation in ischemic heart disease. J Cardiovasc Electrophysiol. 2012;23:188–193. PubMed

Bala R, Ren JF, Hutchinson MD, et al. Assessing epicardial substrate using intracardiac echocardiography during VT ablation. Circ Arrhythm Electrophysiol. 2011;4:667–673. PubMed PMC

Gunda S, Reddy M, Pillarisetti J, et al. Differences in complication rates between large bore needle and a long micropuncture needle during epicardial access: time to change clinical practice? Circ Arrhythm Electrophysiol. 2015;8:890–895. PubMed

Kumar S, Bazaz R, Barbhaiya CR, et al. “Needle-in-needle” epicardial access: preliminary observations with a modified technique for facilitating epicardial interventional procedures. Heart Rhythm. 2015;12:1691–1697. PubMed

Cronin EM, Zweibel SL. Transatrial pericardial insufflation of carbon dioxide to facilitate percutaneous pericardial access for ablation of ventricular tachycardia. J Cardiovasc Electrophysiol. 2016;27:615. PubMed

Silberbauer J, Gomes J, O’Nunain S, Kirubakaran S, Hildick-Smith D, McCready J. Coronary vein exit and carbon dioxide insufflation to facilitate subxiphoid epicardial access for ventricular mapping and ablation: first experience. JACC Clin Electrophysiol. 2017;3:514–521. PubMed

d’Avila A, Houghtaling C, Gutierrez P, et al. Catheter ablation of ventricular epicardial tissue: a comparison of standard and cooled-tip radiofrequency energy. Circulation. 2004;109:2363–2369. PubMed

Aryana A, O’Neill PG, Pujara DK, et al. Impact of irrigation flow rate and intrapericardial fluid on cooled-tip epicardial radiofrequency ablation. Heart Rhythm. 2016;13:1602–1611. PubMed

Lustgarten DL, Bell S, Hardin N, Calame J, Spector PS. Safety and efficacy of epicardial cryoablation in a canine model. Heart Rhythm. 2005;2:82–90. PubMed

d’Avila A, Aryana A, Thiagalingam A, et al. Focal and linear endocardial and epicardial catheter-based cryoablation of normal and infarcted ventricular tissue. Pacing Clin Electrophysiol. 2008;31:1322–1331. PubMed

Di Biase L, Al-Ahamad A, Santangeli P, et al. Safety and outcomes of cryoablation for ventricular tachyarrhythmias: results from a multicenter experience. Heart Rhythm. 2011;8:968–974. PubMed

Sacher F, Wright M, Derval N, et al. Endocardial versus epicardial ventricular radiofrequency ablation: utility of in vivo contact force assessment. Circ Arrhythm Electrophysiol. 2013;6:144–150. PubMed

Wong MC, Edwards G, Spence SJ, et al. Characterization of catheter-tissue contact force during epicardial radiofrequency ablation in an ovine model. Circ Arrhythm Electrophysiol. 2013;6:1222–1228. PubMed

Jesel L, Sacher F, Komatsu Y, et al. Characterization of contact force during endocardial and epicardial ventricular mapping. Circ Arrhythm Electrophysiol. 2014;7:1168–1173. PubMed

Saba MM, Akella J, Gammie J, et al. The influence of fat thickness on the human epicardial bipolar electrogram characteristics:measurements on patients undergoing open-heart surgery. Europace. 2009;11:949–953. PubMed

Abbara S, Desai JC, Cury RC, Butler J, Nieman K, Reddy V. Mapping epicardial fat with multi-detector computed tomography to facilitate percutaneous transepicardial arrhythmia ablation. Eur J Radiol. 2006;57:417–422. PubMed

Silaghi A, Piercecchi-Marti MD, Grino M, et al. Epicardial adipose tissue extent: relationship with age, body fat distribution, and coronaropathy. Obesity (Silver Spring) 2008;16:2424–2430. PubMed

Ahn SG, Lim HS, Joe DY, et al. Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart. 2008;94:e7. PubMed

Hong KN, Russo MJ, Liberman EA, et al. Effect of epicardial fat on ablation performance: a three-energy source comparison. J Card Surg. 2007;22:521–524. PubMed

Koruth JS, Aryana A, Dukkipati SR, et al. Unusual complications of percutaneous epicardial access and epicardial mapping and ablation of cardiac arrhythmias. Circ Arrhythm Electrophysiol. 2011;4:882–888. PubMed

Kumar S, Barbhaiya CR, Baldinger SH, et al. Epicardial phrenic nerve displacement during catheter ablation of atrial and ventricular arrhythmias: procedural experience and outcomes. Circ Arrhythm Electrophysiol. 2015;8:896–904. PubMed

Yamada T, McElderry HT, Platonov M, Doppalapudi H, Kay GN. Aspirated air in the pericardial space during epicardial catheterization may elevate the defibrillation threshold. Int J Cardiol. 2009;135:e34–e35. PubMed

de Moura EG, Silva GL, de Moura ET, et al. Esophageal perforation after epicardial ablation: an endoscopic approach. Endoscopy. 2015;47:E592–E593. PubMed

Koruth JS, Chu EW, Bhardwaj R, Dukkipati S, Reddy VY. Esophageal damage during epicardial ventricular tachycardia ablation. JACC Clin Electrophysiol. 2017;3:1470–1471. PubMed

Pisani CF, de Medeiros Lopes MAA, Bellotti H, Kopel L, Lage SG, Scanavacca MI. Oesophagopleural fistula following epicardial ventricular tachycardia catheter ablation. Europace. 2018;20:672. PubMed

Miller MA, Dukkipati SR, Mittnacht AJ, et al. Activation and entrainment mapping of hemodynamically unstable ventricular tachycardia using a percutaneous left ventricular assist device. J Am Coll Cardiol. 2011;58:1363–1371. PubMed

Reddy YM, Chinitz L, Mansour M, et al. Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience. Circ Arrhythm Electrophysiol. 2014;7:244–250. PubMed PMC

Kusa S, Miller MA, Whang W, et al. Outcomes of ventricular tachycardia ablation using percutaneous left ventricular assist devices. Circ Arrhythm Electrophysiol. 2017;10:e004717. PubMed

Turagam MK, Vuddanda V, Atkins D, et al. Hemodynamic support in ventricular tachycardia ablation: an international VT ablation center collaborative group study. JACC Clin Electrophysiol. 2017;3:1534–1543. PubMed

Calkins H, Epstein A, Packer D, et al. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. Cooled RF multi center investigators group. J Am Coll Cardiol. 2000;35:1905–1914. PubMed

Siontis KC, Jamé S, Sharaf Dabbagh G, et al. Thromboembolic prophylaxis protocol with warfarin after radiofrequency catheter ablation of infarctrelated ventricular tachycardia. J Cardiovasc Electrophysiol. 2018;29:584–590. PubMed

Peichl P, Wichterle D, Pavlu L, Cihak R, Aldhoon B, Kautzner J. Complications of catheter ablation of ventricular tachycardia: a single-center experience. Circ Arrhythm Electrophysiol. 2014;7:684–690. PubMed

Whitman IR, Gladstone RA, Badhwar N, et al. Brain emboli after left ventricular endocardial ablation. Circulation. 2017;135:867–877. PubMed

Baetz BE, Gerstenfeld EP, Kolansky DM, Spinler SA. Bivalirudin use during radiofrequency catheter ablation procedures in two patients with a history of heparin-induced thrombocytopenia. Pharmacotherapy. 2010;30:952. PubMed

Di Biase L, Burkhardt JD, Lakkireddy D, et al. Ablation of stable VTs versus substrate ablation in ischemic cardiomyopathy: the VISTA randomized multicenter trial. J Am Coll Cardiol. 2015;66:2872–2882. PubMed

Page SP, Duncan ER, Thomas G, et al. Epicardial catheter ablation for ventricular tachycardia in heparinized patients. Europace. 2013;15:284–289. PubMed

Sawhney V, Breitenstein A, Ullah W, et al. Epicardial catheter ablation for ventricular tachycardia on uninterrupted warfarin: a safe approach for those with a strong indication for peri-procedural anticoagulation? Int J Cardiol. 2016;222:57–61. PubMed

Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association rheumatic fever, endocarditis, and Kawasaki disease committee, council on cardiovascular disease in the Young, and the council on clinical cardiology, council on cardiovascular surgery and anesthesia, and the quality of care and outcomes research interdisciplinary working group. Circulation. 2007;116:1736–1754. PubMed

Lerman BB, Belardinelli L, West GA, Berne RM, DiMarco JP. Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-triggered activity. Circulation. 1986;74:270–280. PubMed

Lerman BB. Mechanism, diagnosis and treatment of outflow tract tachycardia. Nat Rev Cardiol. 2015;12:597–608. PubMed

Buxton AE, Waxman HL, Marchlinski FE, Untereker WJ, Waspe LE, Josephson ME. Role of triple ventricular extrastimuli during electrophysiologic study of patients with documented sustained ventricular arrhythmias. Circulation. 1984;69:532–540. PubMed

Hummel JD, Strickberger SA, Daoud E, et al. Results and efficiency of programmed ventricular stimulation with four extrastimuli compared with one, two and three extrastimuli. Circulation. 1994;90:2827–2832. PubMed

Josephson ME. Clinical Cardiac Electrophysiology: Techniques and Interpretations, 5th ed. Philadelphia: Wolters Kluwer; 2015, Chapter 11, p. 479.

Yoshida K, Liu TY, Scott C, et al. The value of defibrillator electrograms for recognition of clinical ventricular tachycardias and for pace mapping of postinfarction ventricular tachycardia. J Am Coll Cardiol. 2010;56:969–979. PubMed

de Riva M, Piers SR, Kapel GF, et al. Reassessing noninducibility as ablation endpoint of post-infarction ventricular tachycardia: the impact of left ventricular function. Circ Arrhythm Electrophysiol. 2015;8:853–862. PubMed

Silberbauer J, Oloriz T, Maccabelli G, et al. Noninducibility and late potential abolition: a novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia. Circ Arrhythm Electrophysiol. 2014;7:424–435. PubMed

Wolf M, Sacher F, Cochet H, et al. Long-term outcome of substrate modification in ablation of post-myocardial infarction ventricular tachycardia. Circ Arrhythm Electrophysiol. 2018;11:e005635. PubMed

Kuck KH, Tilz RR, Deneke T, et al. Impact of substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (substrate modification study) Circ Arrhythm Electrophysiol. 2017;10:e004422. PubMed

Ghanbari H, Baser K, Yokokawa M, et al. Noninducibility in postinfarction ventricular tachycardia as an end point for ventricular tachycardia ablation and its effects on outcomes: a meta-analysis. Circ Arrhythm Electrophysiol. 2014;7:677–683. PubMed

Yokokawa M, Kim HM, Baser K, et al. Predictive value of programmed ventricular stimulation after catheter ablation of post-infarction ventricular tachycardia. J Am Coll Cardiol. 2015;65:1954–1959. PubMed

Rothman SA, Hsia HH, Cossu SF, Chmielewski IL, Buxton AE, Miller JM. Radiofrequency catheter ablation of postinfarction ventricular tachycardia: long-term success and the significance of inducible nonclinical arrhythmias. Circulation. 1997;96:3499–3508. PubMed

Frankel DS, Mountantonakis SE, Zado ES, et al. Noninvasive programmed ventricular stimulation early after ventricular tachycardia ablation to predict risk of late recurrence. J Am Coll Cardiol. 2012;59:1529–1535. PubMed

Piers SR, Leong DP, van Huls van Taxis CF, et al. Outcome of ventricular tachycardia ablation in patients with nonischemic cardiomyopathy: the impact of noninducibility. Circ Arrhythm Electrophysiol. 2013;6:513–521. PubMed

Lerman BB. Response of nonreentrant catecholamine-mediated ventricular tachycardia to endogenous adenosine and acetycholine: evidence for myocardial receptor-mediated effects. Circulation. 1993;87:382–390. PubMed

Tschabrunn CM, Roujol S, Dorman NC, Nezafat R, Josephson ME, Anter E. High-resolution mapping of ventricular scar: comparison between single and multielectrode catheters. Circ Arrhythm Electrophysiol. 2016;9:e003841. PubMed PMC

Leshem E, Tschabrunn CM, Jang J, et al. High-resolution mapping of ventricular scar: evaluation of a novel integrated multielectrode mapping and ablation catheter. JACC Clin Electrophysiol. 2017;3:220–231. PubMed

Berte B, Relan J, Sacher F, et al. Impact of electrode type on mapping of scar-related VT. J Cardiovasc Electrophysiol. 2015;26:1213–1223. PubMed

Anter E, Tschabrunn CM, Josephson ME. High-resolution mapping of scar-related atrial arrhythmias using smaller electrodes with closer interelectrode spacing. Circ Arrhythm Electrophysiol. 2015;8:537–545. PubMed

Anter E, Tschabrunn CM, Buxton AE, Josephson ME. High-resolution mapping of postinfarction reentrant ventricular tachycardia: electrophysiological characterization of the circuit. Circulation. 2016;134:314–327. PubMed PMC

Josephson ME, Anter E. Substrate mapping for ventricular tachycardia: assumptions and misconceptions. JACC Clin Electrophysiol. 2015;1:341–352. PubMed

Ciaccio EJ, Coromilas J, Wit AL, Peters NS, Garan H. Formation of reentrant circuits in the mid-myocardial infarct border zone. Comput Biol Med. 2016;71:205–213. PubMed

Tung R, Nakahara S, Maccabelli G, et al. Ultra high-density multipolar mapping with double ventricular access: a novel technique for ablation of ventricular tachycardia. J Cardiovasc Electrophysiol. 2011;22:49–56. PubMed

Tung R, Nakahara S, Ramirez R, et al. Accuracy of combined endocardial and epicardial electroanatomic mapping of a reperfused porcine infarct model: a comparison of electrofield and magnetic systems with histopathologic correlation. Heart Rhythm. 2011;8:439–447. PubMed

Magtibay K, Massé S, Asta J, et al. Physiological assessment of ventricular myocardial voltage using omnipolar electrograms. J Am Heart Assoc. 2017;6:e006447. PubMed PMC

Viswanathan K, Mantziari L, Butcher C, et al. Evaluation of a novel high-resolutionmapping system for catheter ablation of ventricular arrhythmias. Heart Rhythm. 2017;14:176–183. PubMed

Josephson ME. Recurrent ventricular tachycardia, Clinical Cardiac Electrophysiology: Techniques and Interpretations. 5. Philadelphia: Wolters Kluwer; 2015.

Miller JM, Harken AH, Hargrove WC, Josephson ME. Pattern of endocardial activation during sustained ventricular tachycardia. J Am Coll Cardiol. 1985;6:1280–1287. PubMed

Kadish AH, Childs K, Schmaltz S, Morady F. Differences in QRS configuration during unipolar pacing from adjacent sites: implications for the spatial resolution of pace-mapping. J Am Coll Cardiol. 1991;17:143–151. PubMed

Kalbfleisch SJ, Sousa J, El-Atassi R, Calkins H, Langberg J, Morady F. Repolarization abnormalities after catheter ablation of accessory atrioventricular connections with radiofrequency current. J Am Coll Cardiol. 1991;18:1761–1766. PubMed

Fontaine G, Frank R, Tonet J, Grosgogeat Y. Identification of a zone of slow conduction appropriate for VT ablation: theoretical and practical considerations. Pacing Clin Electrophysiol. 1989;12:262–267. PubMed

Bogun F, Kim HM, Han J, et al. Comparison of mapping criteria for hemodynamically tolerated, postinfarction ventricular tachycardia. Heart Rhythm. 2006;3:20–26. PubMed

Bogun F, Bahu M, Knight B, et al. Response to pacing at sites of isolated diastolic potentials during ventricular tachycardia in patients with previous myocardial infarction. J Am Coll Cardiol. 1997;30:505–513. PubMed

Bogun F, Knight B, Goyal R, et al. Discrete systolic potentials during ventricular tachycardia in patients with prior myocardial infarction. J Cardiovasc Electrophysiol. 1999;10:364–369. PubMed

Tung S, Soejima K, Maisel WH, Suzuki M, Epstein L, Stevenson WG. Recognition of far-field electrograms during entrainment mapping of ventricular tachycardia. J Am Coll Cardiol. 2003;42:110–115. PubMed

Sarrazin JF, Kuehne M, Wells D, et al. High-output pacing in mapping of postinfarction ventricular tachycardia. Heart Rhythm. 2008;5:1709–1714. PubMed

Stevenson WG, Weiss J, Wiener I, Wohlgelernter D, Yeatman L. Localization of slow conduction in a ventricular tachycardia circuit: implications for catheter ablation. Am Heart J. 1987;114:1253–1258. PubMed

Kumar S, Baldinger SH, Romero J, et al. Substrate-based ablation versus ablation guided by activation and entrainment mapping for ventricular tachycardia: a systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2016;27:1437–1447. PubMed

Gerstenfeld EP, Dixit S, Callans DJ, Rajawat Y, Rho R, Marchlinski FE. Quantitative comparison of spontaneous and paced 12-lead electrocardiogram during right ventricular outflow tract ventricular tachycardia. J Am Coll Cardiol. 2003;41:2046–2053. PubMed

Kurosaki K, Nogami A, Sakamaki M, et al. Automated template matching to pinpoint the origin of right ventricular outflow tract tachycardia. Pacing Clin Electrophysiol. 2009;32:S47–S51. PubMed

Bogun F, Taj M, Ting M, et al. Spatial resolution of pace mapping of idiopathic ventricular tachycardia/ectopy originating in the right ventricular outflow tract. Heart Rhythm. 2008;5:339–344. PubMed

Brunckhorst CB, Stevenson WG, Soejima K, et al. Relationship of slow conduction detected by pace-mapping to ventricular tachycardia re-entry circuit sites after infarction. J Am Coll Cardiol. 2003;41:802–809. PubMed

Stevenson WG, Sager PT, Natterson PD, Saxon LA, Middlekauff HR, Wiener I. Relation of pace mapping QRS configuration and conduction delay to ventricular tachycardia reentry circuits in human infarct scars. J Am Coll Cardiol. 1995;26:481–488. PubMed

Brunckhorst CB, Delacretaz E, Soejima K, Maisel WH, Friedman PL, Stevenson WG. Identification of the ventricular tachycardia isthmus after infarction by pace mapping. Circulation. 2004;110:652–659. PubMed

Josephson ME, Waxman HL, Cain ME, Gardner MJ, Buxton AE. Ventricular activation during ventricular endocardial pacing: II. Role of pace-mapping to localize origin of ventricular tachycardia. Am J Cardiol. 1982;50:11–22. PubMed

Goyal R, Harvey M, Daoud EG, et al. Effect of coupling interval and pacing cycle length on morphology of paced ventricular complexes. Circulation. 1996;94:2843–2849. PubMed

Yoshida K, Liu TY, Scott C, et al. The value of defibrillator electrograms for recognition of clinical ventricular tachycardias and for pacemapping of postinfarction ventricular tachycardia. J Am Coll Cardiol. 2010;56:969–979. PubMed

Azegami K, Wilber DJ, Arruda M, Lin AC, Denman RA. Spatial resolution of pacemapping and activation mapping in patients with idiopathic right ventricular outflow tract tachycardia. J Cardiovasc Electrophysiol. 2005;16:823–829. PubMed

Kadish AH, Schmaltz S, Morady F. A comparison of QRS complexes resulting fromunipolar and bipolar pacing: implications for pace-mapping. Pacing Clin Electrophysiol. 1991;14:823–832. PubMed

Volkmer M, Ouyang F, Deger F, et al. Substrate mapping vs. tachycardia mapping using CARTO in patients with coronary artery disease and ventricular tachycardia: impact on outcome of catheter ablation. Europace. 2006;8:968–976. PubMed

Makimoto H, Nakajima I, Miyamoto K, et al. Clinical impact of mapping strategies for treatment of ventricular tachycardias in patients with structural heart disease. Pacing Clin Electrophysiol. 2015;38:630–640. PubMed

Carbucicchio C, Ahmad Raja N, Di Biase L, et al. High-density substrateguided ventricular tachycardia ablation: role of activation mapping in an attempt to improve procedural effectiveness. Heart Rhythm. 2013;10:1850–1858. PubMed

Briceño DF, Romero J, Villablanca PA, et al. Long-term outcomes of different ablation strategies for ventricular tachycardia in patients with structural heart disease: systematic review and meta-analysis. Europace. 2018;20:104–115. PubMed

Acosta J, Penela D, Andreu D, et al. Multielectrode vs. point-by-point mapping for ventricular tachycardia substrate ablation: a randomized study. Europace. 2018;20:512–519. PubMed

Yamashita S, Cochet H, Sacher F, et al. Impact of new technologies and approaches for post-myocardial infarction ventricular tachycardia ablation during long-term follow-up. Circ Arrhythm Electrophysiol. 2016;9:e003901. PubMed

Chopra N, Tokuda M, Ng J, et al. Relation of the unipolar low-voltage penumbra surrounding the endocardial low-voltage scar to ventricular tachycardia circuit sites and ablation outcomes in ischemic cardiomyopathy. J Cardiovasc Electrophysiol. 2014;25:602–608. PubMed

Soto-Becerra R, Bazan V, Bautista W, et al. Ventricular tachycardia in the setting of Chagasic cardiomyopathy. Circ Arrhythm Electrophysiol. 2017;10:e004950. PubMed

Callans DJ, Ren JF, Michele J, Marchlinski FE, Dillon SM. Electroanatomic left ventricular mapping in the porcine model of healed anterior myocardial infarction: correlation with intracardiac echocardiography and pathological analysis. Circulation. 1999;100:1744–1750. PubMed

Tung R, Josephson ME, Bradfield JS, Shivkumar K. Directional influences of ventricular activation on myocardial scar characterization: voltage mapping with multiple wavefronts during ventricular tachycardia ablation. Circ Arrhythm Electrophysiol. 2016;9:e004155. PubMed

Santangeli P, Marchlinski FE. Substrate mapping for unstable ventricular tachycardia. Heart Rhythm. 2016;13:569–583. PubMed

Jaïs P, Maury P, Khairy P, et al. Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation. 2012;125:2184–2196. PubMed

Acosta J, Andreu D, Penela D, et al. Elucidation of hidden slow conduction by double ventricular extrastimuli: a method for further arrhythmic substrate identification in ventricular tachycardia ablation procedures. Europace. 2018;20:337–346. PubMed

de Riva M, Naruse Y, Ebert M, et al. Targeting the hidden substrate unmasked by right ventricular extrastimulation improves ventricular tachycardia ablation outcome after myocardial infarction. JACC Clin Electrophysiol. 2018;4:316–327. PubMed

Irie T, Yu R, Bradfield JS, et al. Relationship between sinus rhythm late activation zones and critical sites for scar-related ventricular tachycardia: systematic analysis of isochronal late activation mapping. Circ Arrhythm Electrophysiol. 2015;8:390–399. PubMed PMC

Tilz RR, Makimoto H, Lin T, et al. Electrical isolation of a substrate after myocardial infarction: a novel ablation strategy for unmappable ventricular tachycardias—feasibility and clinical outcome. Europace. 2014;16:1040–1052. PubMed

Ouyang F, Fotuhi P, Ho SY, et al. Repetitivemonomorphic ventricular tachycardia originating fromthe aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation. J Am Coll Cardiol. 2002;39:500–508. PubMed

Hoffmayer KS, Dewland TA, Hsia HH, et al. Safety of radiofrequency catheter ablation without coronary angiography in aortic cusp ventricular arrhythmias. Heart Rhythm. 2014;11:1117–1121. PubMed

Hachiya H, Aonuma K, Yamauchi Y, IgawaM NA, Iesaka Y. How to diagnose, locate, and ablate coronary cusp ventricular tachycardia. J Cardiovasc Electrophysiol. 2002;13:551–556. PubMed

Yamada T, McElderry HT, Doppalapudi H, et al. Idiopathic ventricular arrhythmias originating from the aortic root prevalence, electrocardiographic and electrophysiologic characteristics, and results of radiofrequency catheter ablation. J Am Coll Cardiol. 2008;52:139–147. PubMed

Ban JE, Lee HS, Lee DI, et al. Electrophysiological characteristics related to outcome after catheter ablation of idiopathic ventricular arrhythmia originating from the papillary muscle in the left ventricle. Korean Circ J. 2013;43:811–818. PubMed PMC

Rivera S, Ricapito Mde L, Tomas L, et al. Results of cryoenergy and radiofrequency- based catheter ablation for treating ventricular arrhythmias arising from the papillary muscles of the left ventricle, guided by intracardiac echocardiography and image integration. Circ Arrhythm Electrophysiol. 2016;9:e003874. PubMed

Proietti R, Rivera S, Dussault C, et al. Intracardiac echo-facilitated 3D electroanatomical mapping of ventricular arrhythmias from the papillary muscles: assessing the ‘fourth dimension’ during ablation. Europace. 2017;19:21–28. PubMed PMC

Peichl P, Baran J, Wichterle D, et al. The tip of the muscle is a dominant location of ventricular ectopy originating from papillary muscles in the left ventricle. J Cardiovasc Electrophysiol. 2018;29:64–70. PubMed

Lee A, Hamilton-Craig C, Denman R, Haqqani HM. Catheter ablation of papillary muscle arrhythmias: implications of mitral valve prolapse and systolic dysfunction. Pacing Clin Electrophysiol. 2018;41:750–758. PubMed

Ren JF, Marchlinski FE. Early detection of iatrogenic pericardial effusion: importance of intracardiac echocardiography. JACC Cardiovasc Interv. 2010;3:127. PubMed

Filgueiras-Rama D, de Torres-Alba F, Castrejón-Castrejón S, et al. Utility of intracardiac echocardiography for catheter ablation of complex cardiac arrhythmias in a medium-volume training center. Echocardiography. 2015;32:660–670. PubMed

Weintraub AR, Schwartz SL, Smith J, Hsu TL, Pandian NG. Intracardiac two-dimensional echocardiography in patients with pericardial effusion and cardiac tamponade. J Am Soc Echocardiogr. 1991;4:571–576. PubMed

Nguyen DT, Zipse M, Borne RT, Zheng L, Tzou WS, Sauer WH. Use of tissue electric and ultrasound characteristics to predict and prevent steamgenerated cavitation during high-power radiofrequency ablation. JACC Clin Electrophysiol. 2018;4:491–500. PubMed

Von Bergen NH, Bansal S, Gingerich J, Law IH. Nonfluoroscopic and radiation- limited ablation of ventricular arrhythmias in children and young adults: a case series. Pediatr Cardiol. 2011;32:743–747. PubMed

Tuzcu V. Significant reduction of fluoroscopy in pediatric catheter ablation procedures: long-term experience from a single center. Pacing Clin Electrophysiol. 2012;35:1067–1073. PubMed

Cano O, Alonso P, Osca J, et al. Initial experience with a new image integration module designed for reducing radiation exposure during electrophysiological ablation procedures. J Cardiovasc Electrophysiol. 2015;26:662–670. PubMed

Reents T, Buiatti A, Ammar S, et al. Catheter ablation of ventricular arrhythmias using a fluoroscopy image integration module. Pacing Clin Electrophysiol. 2015;38:700–705. PubMed

Cano O, Andres A, Osca J, et al. Safety and feasibility of a minimally fluoroscopic approach for ventricular tachycardia ablation in patients with structural heart disease: influence of the ventricular tachycardia substrate. Circ Arrhythm Electrophysiol. 2016;9:e003706. PubMed

Cheitlin MD, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the clinical application of echocardiography: executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on clinical application of echocardiography) J Am Coll Cardiol. 1997;29:862–879. PubMed

Eitel C, Piorkowski C, Hindricks G, Gutberlet M. Electrophysiology study guided by real-time magnetic resonance imaging. Eur Heart J. 2012;33:1975. PubMed

Piorkowski C, Grothoff M, Gaspar T, et al. Cavotricuspid isthmus ablation guided by real-time magnetic resonance imaging. Circ Arrhythm Electrophysiol. 2013;6:e7–e10. PubMed

Grant EK, Berul CI, Cross RR, et al. Acute cardiac MRI assessment of radiofrequency ablation lesions for pediatric ventricular arrhythmia: feasibility and clinical correlation. J Cardiovasc Electrophysiol. 2017;28:517–522. PubMed PMC

Nazarian S, Kantsevoy SV, Zviman MM, et al. Feasibility of endoscopic guidance for nonsurgical transthoracic atrial and ventricular epicardial ablation. Heart Rhythm. 2008;5:1115–1119. PubMed PMC

Khaykin Y, Skanes A, Whaley B, et al. Real-time integration of 2D intracardiac echocardiography and 3D electroanatomical mapping to guide ventricular tachycardia ablation. Heart Rhythm. 2008;5:1396–1402. PubMed

Sporton SC, Earley MJ, Nathan AW, Schilling RJ. Electroanatomic versus fluoroscopic mapping for catheter ablation procedures: a prospective randomized study. J Cardiovasc Electrophysiol. 2004;15:310–315. PubMed

Earley MJ, Showkathali R, Alzetani M, et al. Radiofrequency ablation of arrhythmias guided by non-fluoroscopic catheter location: a prospective randomized trial. Eur Heart J. 2006;27:1223–1229. PubMed

Khongphatthanayothin A, Kosar E, Nademanee K. Nonfluoroscopic threedimensional mapping for arrhythmia ablation: tool or toy? J Cardiovasc Electrophysiol. 2000;11:239–243. PubMed

Reithmann C, Hahnefeld A, Remp T, et al. Electroanatomic mapping of endocardial right ventricular activation as a guide for catheter ablation in patients with arrhythmogenic right ventricular dysplasia. Pacing Clin Electrophysiol. 2003;26:1308–1316. PubMed

Zeppenfeld K, Schalij MJ, Bartelings MM, et al. Catheter ablation of ventricular tachycardia after repair of congenital heart disease. Circulation. 2007;116:2241–2252. PubMed

Codreanu A, Odille F, Aliot E, et al. Electroanatomic characterization of post-infarct scars comparison with 3-dimensional myocardial scar reconstruction based on magnetic resonance imaging. J Am Coll Cardiol. 2008;52:839–842. PubMed

Dinov B, Schoenbauer R, Wojdyla-Horodynska A, et al. Long-term efficacy of single procedure remote magnetic catheter navigation for ablation of ischemic ventricular tachycardia: a retrospective study. J Cardiovasc Electrophysiol. 2012;23:499–505. PubMed

Szili-Torok T, Schwagten B, Akca F, et al. Catheter ablation of ventricular tachycardias using remote magnetic navigation: a consecutive case-control study. J Cardiovasc Electrophysiol. 2012;23:948–954. PubMed

Akca F, Theuns DA, Abkenari LD, de Groot NM, Jordaens L, Szili-Torok T. Outcomes of repeat catheter ablation using magnetic navigation or conventional ablation. Europace. 2013;15:1426–1431. PubMed

Bauernfeind T, Akca F, Schwagten B, et al. The magnetic navigation system allows safety and high efficacy for ablation of arrhythmias. Europace. 2011;13:1015–1021. PubMed PMC

Gepstein L, Hayam G, Ben-Haim SA. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart. in vitro and in vivo accuracy results. Circulation. 1997;95:1611–1622. PubMed

Krummen DE, Hayase J, Vampola SP, et al. Modifying ventricular fibrillation by targeted rotor substrate ablation: proof-of-concept from experimental studies to clinical VF. J Cardiovasc Electrophysiol. 2015;26:1117–1126. PubMed PMC

Nademanee K, Kosar EM. A nonfluoroscopic catheter-based mapping technique to ablate focal ventricular tachycardia. Pacing Clin Electrophysiol. 1998;21:1442–1447. PubMed

Stevenson WG, Delacretaz E, Friedman PL, Ellison KE. Identification and ablation of macroreentrant ventricular tachycardia with the CARTO electroanatomical mapping system. Pacing Clin Electrophysiol. 1998;21:1448–1456. PubMed

Tomassoni G, Stanton M, Richey M, Leonelli FM, Beheiry S, Natale A. Epicardial mapping and radiofrequency catheter ablation of ischemic ventricular tachycardia using a three-dimensional nonfluoroscopic mapping system. J Cardiovasc Electrophysiol. 1999;10:1643–1648. PubMed

Soejima K, Suzuki M, Maisel W, et al. Catheter ablation in patients with multiple and unstable ventricular tachycardias after myocardial infarction: short ablation lines guided by reentry circuit isthmuses and sinus rhythm mapping. Circulation. 2001;104:664–669. PubMed

Reddy VY, Neuzil P, Taborsky M, Ruskin JN. Short-term results of substrate mapping and radiofrequency ablation of ischemic ventricular tachycardia using a saline-irrigated catheter. J Am Coll Cardiol. 2003;41:2228–2236. PubMed

Faddis MN, Blume W, Finney J, et al. Novel, magnetically guided catheter for endocardial mapping and radiofrequency catheter ablation. Circulation. 2002;106:2980–2985. PubMed

Shauer A, De Vries L, Akca F, et al. Clinical research: remote magnetic navigation vs. manually controlled catheter ablation of right ventricular outflow tract arrhythmias: a retrospective study. Europace. 2018;20(Suppl. 2):ii28–ii32. PubMed

Skoda J, Arya A, Garcia F, et al. Catheter ablation of ischemic ventricular tachycardia with remote magnetic navigation: STOP-VT multicenter trial. J Cardiovasc Electrophysiol. 2016;27(Suppl. 1):S29–S37. PubMed

Kawamura M, Scheinman MM, Tseng ZH, Lee BK, Marcus GM, Badhwar N. Comparison of remote magnetic navigation ablation and manual ablation of idiopathic ventricular arrhythmia after failed manual ablation. J Interv Card Electrophysiol. 2017;48:35–42. PubMed

Jin Q, Jacobsen PK, Pehrson S, Chen X. Acute and long term outcomes of catheter ablation using remote magnetic navigation for the treatment of electrical storm in patients with severe ischemic heart failure. Int J Cardiol. 2015;183:11–16. PubMed

Arya A, Eitel C, Bollmann A, et al. Catheter ablation of scar-related ventricular tachycardia in patients with electrical storm using remote magnetic catheter navigation. Pacing Clin Electrophysiol. 2010;33:1312–1318. PubMed

Haghjoo M, Hindricks G, Bode K, Piorkowski C, Bollmann A, Arya A. Initial clinical experience with the new irrigated tip magnetic catheter for ablation of scar-related sustained ventricular tachycardia: a small case series. J Cardiovasc Electrophysiol. 2009;20:935–939. PubMed

Di Biase L, Santangeli P, Astudillo V, et al. Endo-epicardial ablation of ventricular arrhythmias in the left ventricle with the remote magnetic navigation system and the 3.5-mm open irrigated magnetic catheter: results from a large single-center case-control series. Heart Rhythm. 2010;7:1029–1035. PubMed

Aryana A, d’Avila A, Heist EK, et al. Remote magnetic navigation to guide endocardial and epicardial catheter mapping of scar-related ventricular tachycardia. Circulation. 2007;115:1191–1200. PubMed

Qian P, De Silva K, Kumar S, et al. Early and long-term outcomes after manual and remote magnetic navigation-guided catheter ablation for ventricular tachycardia. Europace. 2018;20(Suppl. 2):ii11–ii21. PubMed

Di Biase L, Tung R, Szili-Torok T, MAGNETIC VT Investigators et al. MAGNETIC VT study: a prospective, multicenter, post-market randomized controlled trial comparing VT ablation outcomes using remote magnetic navigation-guided substrate mapping and ablation versus manual approach in a low LVEF population. J Interv Card Electrophysiol. 2017;48:237–245. PubMed

Tokuda M, Kojodjojo P, Tung S, et al. Characteristics of clinical and induced ventricular tachycardia throughout multiple ablation procedures. J Cardiovasc Electrophysiol. 2016;27:88–94. PubMed

Kumar S, Barbhaiya CR, Sobieszczyk P, et al. Role of alternative interventional procedures when endo- and epicardial catheter ablation attempts for ventricular arrhythmias fail. Circ Arrhythm Electrophysiol. 2015;8:606–615. PubMed

Tokuda M, Kojodjojo P, Tung S, et al. Acute failure of catheter ablation for ventricular tachycardia due to structural heart disease: causes and significance. J Am Heart Assoc. 2013;2:e000072. PubMed PMC

Demolin JM, Eick OJ, Munch K, Koullick E, Nakagawa H, Wittkampf FH. Soft thrombus formation in radiofrequency catheter ablation. Pacing Clin Electrophysiol. 2002;25:1219–1222. PubMed

Matsudaira K, Nakagawa H, Wittkampf FH, et al. High incidence of thrombus formation without impedance rise during radiofrequency ablation using electrode temperature control. Pacing Clin Electrophysiol. 2003;26:1227–1237. PubMed

Nakagawa H, Yamanashi WS, Pitha JV, et al. Comparison of in vivo tissue temperature profile and lesion geometry for radiofrequency ablation with a saline-irrigated electrode versus temperature control in a canine thigh muscle preparation. Circulation. 1995;91:2264–2273. PubMed

Weiss C, Antz M, Eick O, Eshagzaiy K, Meinertz T, Willems S. Radiofrequency catheter ablation using cooled electrodes: impact of irrigation flow rate and catheter contact pressure on lesion dimensions. Pacing Clin Electrophysiol. 2002;25:463–469. PubMed

Yokoyama K, Nakagawa H, Wittkampf FH, Pitha JV, Lazzara R, Jackman WM. Comparison of electrode cooling between internal and open irrigation in radiofrequency ablation lesion depth and incidence of thrombus and steam pop. Circulation. 2006;113:11–19. PubMed

Guerra JM, Jorge E, Raga S, et al. Effects of open-irrigated radiofrequency ablation catheter design on lesion formation and complications: in vitro comparison of 6 different devices. J Cardiovasc Electrophysiol. 2013;24:1157–1162. PubMed

Gonzalez-Suarez A, Berjano E, Guerra JM, Gerardo-Giorda L. Computational modeling of open-irrigated electrodes for radiofrequency cardiac ablation including blood motion-saline flow interaction. PLoS One. 2016;11:e0150356. PubMed PMC

Skrumeda LL, Mehra R. Comparison of standard and irrigated radiofrequency ablation in the canine ventricle. J Cardiovasc Electrophysiol. 1998;9:1196–1205. PubMed

Matsumoto N, Kishi R, Kasugai H, et al. Experimental study on the effectiveness and safety of radiofrequency catheter ablation with the cooled ablation system. Circ J. 2003;67:154–158. PubMed

Cooper JM, Sapp JL, Tedrow U, et al. Ablation with an internally irrigated radiofrequency catheter: learning how to avoid steam pops. Heart Rhythm. 2004;1:329–333. PubMed

Seiler J, Roberts-Thomson KC, Raymond JM, Vest J, Delacretaz E, Stevenson WG. Steam pops during irrigated radiofrequency ablation: feasibility of impedance monitoring for prevention. Heart Rhythm. 2008;5:1411–1416. PubMed

Ikeda A, Nakagawa H, Lambert H, et al. Relationship between catheter contact force and radiofrequency lesion size and incidence of steam pop in the beating canine heart: electrogram amplitude, impedance, and electrode temperature are poor predictors of electrode-tissue contact force and lesion size. Circ Arrhythm Electrophysiol. 2014;7:1174–1180. PubMed

Hendriks AA, Akca F, Dabiri Abkenari L, et al. Safety and clinical outcome of catheter ablation of ventricular arrhythmias using contact force sensing: consecutive case series. J Cardiovasc Electrophysiol. 2015;26:1224–1229. PubMed

Elsokkari I, Sapp JL, Doucette S, et al. Role of contact force in ischemic scar-related ventricular tachycardia ablation; optimal force required and impact of left ventricular access route. J Interv Card Electrophysiol. 2018;53:323–331. PubMed

Ariyarathna N, Kumar S, Thomas SP, Stevenson WG, Michaud GF. Role of contact force sensing in catheter ablation of cardiac arrhythmias: evolution or history repeating itself? JACC Clin Electrophysiol. 2018;4:707–723. PubMed

Nakagawa H, Wittkampf FH, Yamanashi WS, et al. Inverse relationship between electrode size and lesion size during radiofrequency ablation with active electrode cooling. Circulation. 1998;98:458–465. PubMed

Nguyen DT, Olson M, Zheng L, Barham W, Moss JD, Sauer WH. Effect of irrigant characteristics on lesion formation after radiofrequency energy delivery using ablation catheters with actively cooled tips. J Cardiovasc Electrophysiol. 2015;26:792–798. PubMed

Nguyen DT, Tzou WS, Sandhu A, et al. Prospective multicenter experience with cooled radiofrequency ablation using high impedance irrigant to target deep myocardial substrate refractory to standard ablation. JACC Clin Electrophysiol. 2018;4:1176–1185. PubMed

Yamada T, Maddox WR, McElderry HT, Doppalapudi H, Plumb VJ, Kay GN. Radiofrequency catheter ablation of idiopathic ventricular arrhythmias originating from intramural foci in the left ventricular outflow tract: efficacy of sequential versus simultaneous unipolar catheter ablation. Circ Arrhythm Electrophysiol. 2015;8:344–352. PubMed

Sivagangabalan G, Barry MA, Huang K, et al. Bipolar ablation of the interventricular septum is more efficient at creating a transmural line than sequential unipolar ablation. Pacing Clin Electrophysiol. 2010;33:16–26. PubMed

Ring ME, Huang SK, Graham AR, Gorman G, Bharati S, Lev M. Catheter ablation of the ventricular septum with radiofrequency energy. Am Heart J. 1989;117:1233–1240. PubMed

Piers SR, Dyrda K, Tao Q, Zeppenfeld K. Bipolar ablation of ventricular tachycardia in a patient after atrial switch operation for dextro-transposition of the great arteries. Circ Arrhythm Electrophysiol. 2012;5:e38–e40. PubMed

Nguyen DT, Tzou WS, Brunnquell M, et al. Clinical and biophysical evaluation of variable bipolar configurations during radiofrequency ablation for treatment of ventricular arrhythmias. Heart Rhythm. 2016;13:2161–2171. PubMed

Sapp JL, Cooper JM, Soejima K, et al. Deep myocardial ablation lesions can be created with a retractable needle-tipped catheter. Pacing Clin Electrophysiol. 2004;27:594–599. PubMed

Sapp JL, Cooper JM, Zei P, Stevenson WG. Large radiofrequency ablation lesions can be created with a retractable infusion-needle catheter. J Cardiovasc Electrophysiol. 2006;17:657–661. PubMed

Berte B, Cochet H, Magat J, et al. Irrigated needle ablation creates larger and more transmural ventricular lesions compared with standard unipolar ablation in an ovine model. Circ Arrhythm Electrophysiol. 2015;8:1498–1506. PubMed

John RM, Connell J, Termin P, et al. Characterization of warm salineenhanced radiofrequency ablation lesions in the infarcted porcine ventricular myocardium. J Cardiovasc Electrophysiol. 2014;25:309–316. PubMed

Khairy P, Rivard L, Guerra PG, et al. Morphometric ablation lesion characteristics comparing 4, 6, and 8 mm electrode-tip cryocatheters. J Cardiovasc Electrophysiol. 2008;19:1203–1207. PubMed

Deisenhofer I, Zrenner B, Yin YH, et al. Cryoablation versus radiofrequency energy for the ablation of atrioventricular nodal reentrant tachycardia (the CYRANO study): results from a large multicenter prospective randomized trial. Circulation. 2010;122:2239–2245. PubMed

Opel A, Murray S, Kamath N, et al. Cryoablation versus radiofrequency ablation for treatment of atrioventricular nodal reentrant tachycardia: cryoablation with 6-mm-tip catheters is still less effective than radiofrequency ablation. Heart Rhythm. 2010;7:340–343. PubMed

Gordon JP, Liang JJ, Pathak RK, et al. Percutaneous cryoablation for papillary muscle ventricular arrhythmias after failed radiofrequency catheter ablation. J Cardiovasc Electrophysiol. 2018;29:1654–1663. PubMed

Guiraudon GM, Thakur RK, Klein GJ, Yee R, Guiraudon CM, Sharma A. Encircling endocardial cryoablation for ventricular tachycardia after myocardial infarction: experience with 33 patients. Am Heart J. 1994;128:982–989. PubMed

Frapier JM, Hubaut JJ, Pasquie JL, Chaptal PA. Large encircling cryoablation without mapping for ventricular tachycardia after anterior myocardial infarction: long-term outcome. J Thorac Cardiovasc Surg. 1998;116:578–583. PubMed

Baust JM, Robilotto A, Guerra P, et al. Assessment of a novel cryoablation device for the endovascular treatment of cardiac tachyarrhythmias. SAGE Open Med. 2018;6:2050312118769797. PubMed PMC

Brugada P, de Swart H, Smeets JL, Bar FW, Wellens HJ. Termination of tachycardias by interrupting blood flow to the arrhythmogenic area. Am J Cardiol. 1988;62:387–392. PubMed

Kay GN, Epstein AE, Bubien RS, Anderson PG, Dailey SM, Plumb VJ. Intracoronary ethanol ablation for the treatment of recurrent sustained ventricular tachycardia. J Am Coll Cardiol. 1992;19:159–168. PubMed

Segal OR, Wong T, Chow AW, et al. Intra-coronary guidewire mapping-a novel technique to guide ablation of human ventricular tachycardia. J Interv Card Electrophysiol. 2007;18:143–154. PubMed

Kreidieh B, Rodriguez-Manero M, Schurmann P, Ibarra-Cortez SH, Dave AS, Valderrabano M. Retrograde coronary venous ethanol infusion for ablation of refractory ventricular tachycardia. Circ Arrhythm Electrophysiol. 2016;9:e004352. PubMed PMC

Baher A, Shah DJ, Valderrabano M. Coronary venous ethanol infusion for the treatment of refractory ventricular tachycardia. Heart Rhythm. 2012;9:1637–1639. PubMed PMC

Kato K, Tanaka A, Hasegawa S, Kametani R. Successful ethanol injection into the anterior interventricular cardiac vein for ventricular premature contractions arising from the left ventricular summit. HeartRhythm Case Rep. 2018;4:310–313. PubMed PMC

Sharma A, Wong D, Weidlich G, et al. Noninvasive stereotactic radiosurgery (CyberHeart) for creation of ablation lesions in the atrium. Heart Rhythm. 2010;7:802–810. PubMed

Cuculich PS, Schill MR, Kashani R, et al. Noninvasive cardiac radiation for ablation of ventricular tachycardia. N Engl J Med. 2017;377:2325–2336. PubMed PMC

Loo BW, Jr, Soltys SG, Wang L, et al. Stereotactic ablative radiotherapy for the treatment of refractory cardiac ventricular arrhythmia. Circ Arrhythm Electrophysiol. 2015;8:748–750. PubMed

Lehmann HI, Graeff C, Simoniello P, et al. Feasibility study on cardiac arrhythmia ablation using high-energy heavy ion beams. Sci Rep. 2016;6:38895. PubMed PMC

Lehmann HI, Deisher AJ, Takami M, et al. External arrhythmia ablation using photon beams: ablation of the atrioventricular junction in an intact animal model. Circ Arrhythm Electrophysiol. 2017;10:e004304. PubMed

Maury P, Rollin A, Mondoly P, Duparc A. Management of outflow tract ventricular arrhythmias. Curr Opin Cardiol. 2015;30:50–57. PubMed

Bala R, Marchlinski FE. Electrocardiographic recognition and ablation of outflow tract ventricular tachycardia. Heart Rhythm. 2007;4:366–370. PubMed

Wang C, Zhang Y, Hong F, Huang Y. Pulmonary artery: a pivotal site for catheter ablation in idiopathic RVOT ventricular arrhythmias. Pacing Clin Electrophysiol. 2017;40:803–807. PubMed

Hutchinson MD, Garcia FC. An organized approach to the localization, mapping, and ablation of outflow tract ventricular arrhythmias. J Cardiovasc Electrophysiol. 2013;24:1189–1197. PubMed

Asirvatham SJ. Correlative anatomy for the invasive electrophysiologist: outflow tract and supravalvar arrhythmia. J Cardiovasc Electrophysiol. 2009;20:955–968. PubMed

Hai JJ, Lachman N, Syed FF, Desimone CV, Asirvatham SJ. The anatomic basis for ventricular arrhythmia in the normal heart: what the student of anatomy needs to know. Clin Anat. 2014;27:885–893. PubMed PMC

Ouyang F, Fotuhi P, Ho SY, et al. Repetitivemonomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation. J Am Coll Cardiol. 2002;39:500–508. PubMed

Dixit S, Marchlinski FE. Clinical characteristics and catheter ablation of left ventricular outflow tract tachycardia. Curr Cardiol Rep. 2001;3:305–313. PubMed

Joshi S, Wilber DJ. Ablation of idiopathic right ventricular outflow tract tachycardia: current perspectives. J Cardiovasc Electrophysiol. 2005;16(Suppl. 1):S52–S58. PubMed

Yamada T, Murakami Y, Yoshida N, et al. Preferential conduction across the ventricular outflow septum in ventricular arrhythmias originating from the aortic sinus cusp. J Am Coll Cardiol. 2007;50:884–891. PubMed

Zhang F, Chen M, Yang B, et al. Electrocardiographic algorithm to identify the optimal target ablation site for idiopathic right ventricular outflow tract ventricular premature contraction. Europace. 2009;11:1214–1220. PubMed

Yoshida N, Yamada T, McElderry HT, et al. A novel electrocardiographic criterion for differentiating a left fromright ventricular outflow tract tachycardia origin: the V2S/V3R index. J Cardiovasc Electrophysiol. 2014;25:747–753. PubMed

Hai JJ, Desimone CV, Vaidya VR, Asirvatham SJ. Endocavitary structures in the outflow tract: anatomy and electrophysiology of the conus papillary muscles. J Cardiovasc Electrophysiol. 2014;25:94–98. PubMed PMC

Gard JJ, Asirvatham S. Outflow tract ventricular tachycardia. Tex Heart Inst J. 2012;39:526–528. PubMed PMC

Tada H. Catheter ablation of tachyarrhythmias from the aortic sinuses of Valsalva—when and how? Circ J. 2012;76:791–800. PubMed

Scanavacca M, Lara S, Hardy C, Pisani CF. How to identify & treat epicardial origin of outflow tract tachycardias. J Atr Fibrillation. 2015;7:1195. PubMed PMC

Yoshida N, Inden Y, Uchikawa T, et al. Novel transitional zone index allows more accurate differentiation between idiopathic right ventricular outflow tract and aortic sinus cusp ventricular arrhythmias. Heart Rhythm. 2011;8:349–356. PubMed

Kaseno K, Tada H, Tanaka S, et al. Successful catheter ablation of left ventricular epicardial tachycardia originating from the great cardiac vein: a case report and review of the literature. Circ J. 2007;71:1983–1988. PubMed

Ebrille E, Chandra VM, Syed F, et al. Distinguishing ventricular arrhythmia originating from the right coronary cusp, peripulmonic valve area, and the right ventricular outflow tract: utility of lead I. J Cardiovasc Electrophysiol. 2014;25:404–410. PubMed

Wang YB, Ma J, Dong JZ, et al. Catheter ablation of premature ventricular contractions originating in the aortic sinus cusp or great cardiac vein: two QRS morphologies with one origin. Pacing Clin Electrophysiol. 2015;38:1029–1038. PubMed

Yamada T, Yoshida N, Doppalapudi H, Litovsky SH, McElderry HT, Kay GN. Efficacy of an anatomical approach in radiofrequency catheter ablation of idiopathic ventricular arrhythmias originating from the left ventricular outflow tract. Circ Arrhythm Electrophysiol. 2017;10:e004959. PubMed

Yamada T, Lau YR, Litovsky SH, et al. Prevalence and clinical, electrocardiographic, and electrophysiologic characteristics of ventricular arrhythmias originating from the noncoronary sinus of Valsalva. Heart Rhythm. 2013;10:1605–1612. PubMed

Vaidya V, Syed F, Desimone C, et al. Outflow tract ventricular tachycardia mapped to the coronary arteries: anatomical correlates and management strategies. J Cardiovasc Electrophysiol. 2013;24:1416–1422. PubMed

Andrade FM, Ribeiro DC, Babinski MA, Cisne R, Góes ML. Triangle of Brocq and Mouchet: anatomical study in Brazilian cadavers and clinical implications. J Morphol Sci. 2010;27:127–129.

Komatsu Y, Nogami A, Shinoda Y, et al. Idiopathic ventricular arrhythmias originating from the vicinity of the communicating vein of cardiac venous systems at the left ventricular summit. Circ Arrhythm Electrophysiol. 2018;11:e005386. PubMed

Muser D, Santangeli P. Ventricular arrhythmias linked to the left ventricular summit communicating veins: a new mapping approach for an old ablation problem. Circ Arrhythm Electrophysiol. 2018;11:e006105. PubMed

Chen Y-H, Lin J-F. Catheter ablation of idiopathic epicardial ventricular arrhythmias originating from the vicinity of the coronary sinus system. J Cardiovasc Electrophysiol. 2015;26:1160–1167. PubMed

Choi EK, Nagashima K, Lin KY, et al. Surgical cryoablation for ventricular tachyarrhythmia arising from the left ventricular outflow tract region. Heart Rhythm. 2015;12:1128–1136. PubMed

Mulpuru SK, Feld GK, Madani M, Sawhney NS. A novel minimally-invasive surgical approach for ablation of ventricular tachycardia originating near the proximal left anterior descending artery. Circ Arrhythm Electrophysiol. 2012;5:e95–e97. PubMed

Aziz Z, Moss JD, Jabbarzadeh M, Hellstrom J, Balkhy H, Tung R. Totally endoscopic robotic epicardial ablation of refractory left ventricular summit arrhythmia: first-in-man. Heart Rhythm. 2017;14:135–138. PubMed

Yamada T, McElderry HT, Doppalapudi H, Kay GN. Catheter ablation of ventricular arrhythmias originating in the vicinity of the His bundle: significance of mapping the aortic sinus cusp. Heart Rhythm. 2008;5:37–42. PubMed

Yokokawa M, Morady F, Bogun F. Injection of cold saline for diagnosis of intramural ventricular arrhythmias. Heart Rhythm. 2016;13:78–82. PubMed

Kawamura Y, Kikuchi K, Nadeau R, Page P, Cardinal R. Identification of deep septal ventricular tachycardia substrates from epicardial breakthrough characteristics. J Cardiol. 1995;26:349–355. PubMed

Yokokawa M, Jung DY, Hero AO, III, Baser K, Morady F, Bogun F. Single- and dual-site pace mapping of idiopathic septal intramural ventricular arrhythmias. Heart Rhythm. 2016;13:72–77. PubMed

Yue-Chun L, Wen-Wu Z, Na-Dan Z, et al. Idiopathic premature ventricular contractions and ventricular tachycardias originating from the vicinity of tricuspid annulus: results of radiofrequency catheter ablation in thirty-five patients. BMC Cardiovasc Disord. 2012;12:32. PubMed PMC

Abouezzeddine O, Suleiman M, Buescher T, et al. Relevance of endocavitary structures in ablation procedures for ventricular tachycardia. J Cardiovasc Electrophysiol. 2010;21:245–254. PubMed

Enriquez A, Supple GE, Marchlinski FE, Garcia FC. How to map and ablate papillary muscle ventricular arrhythmias. Heart Rhythm. 2017;14:1721–1728. PubMed

Bogun F, Desjardins B, Crawford T, et al. Post-infarction ventricular arrhythmias originating in papillary muscles. J Am Coll Cardiol. 2008;51:1794–1802. PubMed

Sternick EB, Correa F, Negri R, Scarpelli RB, Gerken LM. Reversible cardiomyopathy provoked by focal ventricular arrhythmia originating from the base of the posterior papillary muscle. J Interv Card Electrophysiol. 2009;25:67–72. PubMed

Santoro F, Di Biase L, Hranitzky P, et al. Ventricular fibrillation triggered by PVCs from papillary muscles: clinical features and ablation. J Cardiovasc Electrophysiol. 2014;25:1158–1164. PubMed

Yuan H-T, Yang M, Zhong L, et al. Ventricular premature contraction associated with mitral valve prolapse. Int J Cardiol. 2016;221:1144–1149. PubMed

Sriram CS, Syed FF, Ferguson ME, et al. Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest. J Am Coll Cardiol. 2013;62:222–230. PubMed

Basso C, Perazzolo Marra M, Rizzo S, et al. Arrhythmic mitral valve prolapse and sudden cardiac death. Circulation. 2015;132:556–566. PubMed

Naksuk N, Kapa S, Asirvatham SJ. Spectrum of ventricular arrhythmias arising from papillary muscle in the structurally normal heart. Card Electrophysiol Clin. 2016;8:555–565. PubMed

Itoh T, Yamada T. Usefulness of pace mapping in catheter ablation of left ventricular papillary muscle ventricular arrhythmias with a preferential conduction. J Cardiovasc Electrophysiol. 2018;29:889–899. PubMed

Mochizuki A, Nagahara D, Takahashi H, Saito R, Fujito T, Miura T. Worsening of mitral valve regurgitation after radiofrequency catheter ablation of ventricular arrhythmia originating from a left ventricular papillary muscle. HeartRhythm Case Rep. 2017;3:215–218. PubMed PMC

Desimone CV, Hu T, Ebrille E, et al. Catheter ablation related mitral valve injury: the importance of early recognition and rescue mitral valve repair. J Cardiovasc Electrophysiol. 2014;25:971–975. PubMed PMC

Guerot C, Valere PE, Castillo-Fenoy A, Tricot R. Tachycardia by branch-to-branch reentry. Arch Mal Coeur Vaiss. 1974;67:1–11. PubMed

Akhtar M, Damato AN, Batsford WP, Ruskin JN, Ogunkelu JB, Vargas G. Demonstration of re-entry within the His-Purkinje system in man. Circulation. 1974;50:1150–1162. PubMed

Lloyd EA, Zipes DP, Heger JJ, Prystowsky EN. Sustained ventricular tachycardia due to bundle branch reentry. Am Heart J. 1982;104:1095–1097. PubMed

Touboul P, Kirkorian G, Atallah G, Moleur P. Bundle branch reentry: a possible mechanism of ventricular tachycardia. Circulation. 1983;67:674–680. PubMed

Narasimhan C, Jazayeri MR, Sra J, et al. Ventricular tachycardia in valvular heart disease: facilitation of sustained bundle-branch reentry by valve surgery. Circulation. 1997;96:4307–4313. PubMed

Merino JL, Carmona JR, Fernandez-Lozano I, Peinado R, Basterra N, Sobrino JA. Mechanisms of sustained ventricular tachycardia in myotonic dystrophy: implications for catheter ablation. Circulation. 1998;98:541–546. PubMed

Negri SM, Cowan MD. Becker muscular dystrophy with bundle branch reentry ventricular tachycardia. J Cardiovasc Electrophysiol. 1998;9:652–654. PubMed

Takeda K, Takemoto M, Mukai Y, et al. Bundle branch re-entry ventricular tachycardia in a patient with myotonic dystrophy. J Cardiol. 2009;53:463–466. PubMed

Andress JD, Vander Salm TJ, Huang SK. Bidirectional bundle branch reentry tachycardia associated with Ebstein’s anomaly: cured by extensive cryoablation of the right bundle branch. Pacing Clin Electrophysiol. 1991;14:1639–1647. PubMed

Barra S, Moreno N, Providência R, Gonçalves H, Primo JJ. Incessant slow bundle branch reentrant ventricular tachycardia in a young patient with left ventricular noncompaction. Rev Port Cardiol. 2013;32:523–529. PubMed

Dora SK, Valaparambil A, Namboodiri N, Bohora SR, Tharakan J. Bundle branch reentry ventricular tachycardia in arrhythmogenic right ventricular dysplasia. J Interv Card Electrophysiol. 2008;21:215–218. PubMed

Rodriguez-Manero M, Sacher F, de Asmundis C, et al. Monomorphic ventricular tachycardia in patients with Brugada syndrome: amulticenter retrospective study. Heart Rhythm. 2016;13:669–682. PubMed

Blanck Z, Deshpande S, Jazayeri MR, Akhtar M. Catheter ablation of the left bundle branch for the treatment of sustained bundle branch reentrant ventricular tachycardia. J Cardiovasc Electrophysiol. 1995;6:40–43. PubMed

Phlips T, Ramchurn H, De Roy L. Reverse BBRVT in a structurally normal heart. Acta Cardiol. 2012;67:603–607. PubMed

Simons GR, Sorrentino RA, Zimerman LI, Wharton JM, Natale A. Bundle branch reentry tachycardia and possible sustained interfascicular reentry tachycardia with a shared unusual induction pattern. J Cardiovasc Electrophysiol. 1996;7:44–50. PubMed

Roberts JD, Gollob MH, Young C, et al. Bundle branch re-entrant ventricular tachycardia: novel genetic mechanisms in a life-threatening arrhythmia. JACC Clin Electrophysiol. 2017;3:276–288. PubMed

Cantillon DJ, Bianco C, Wazni OM, et al. Electrophysiologic characteristics and catheter ablation of ventricular tachyarrhythmias among patients with heart failure on ventricular assist device support. Heart Rhythm. 2012;9:859–864. PubMed

Wang CW, Sterba R, Tchou P. Bundle branch reentry ventricular tachycardia with two distinct left bundle branch block morphologies. J Cardiovasc Electrophysiol. 1997;8:688–693. PubMed

Wang PJ, Friedman PL. “Clockwise” and “counterclockwise” bundle branch reentry as a mechanism for sustained ventricular tachycardia masquerading as supraventricular tachycardia. Pacing Clin Electrophysiol. 1989;12:1426–1432. PubMed

Tchou P, Mehdirad AA. Bundle branch reentry ventricular tachycardia. Pacing Clin Electrophysiol. 1995;18:1427–1437. PubMed

Blanck Z, Akhtar M. Ventricular tachycardia due to sustained bundle branch reentry: diagnostic and therapeutic considerations. Clin Cardiol. 1993;16:619–622. PubMed

Mehdirad AA, Keim S, Rist K, Mazgalev T, Tchou P. Asymmetry of retrograde conduction and reentry within the His-Purkinje system: a comparative analysis of left and right ventricular stimulation. J Am Coll Cardiol. 1994;24:177–184. PubMed

Reddy CP, Harris B. Gap phenomenon in “the right and left bundle branch systems” during retrograde conduction in man. Am Heart J. 1979;97:216–224. PubMed

Akhtar M, Denker S, Lehmann MH, Mahmud R. Macro-reentry within the His Purkinje system. Pacing Clin Electrophysiol. 1983;6:1010–1028. PubMed

Fisher JD. Bundle branch reentry tachycardia: why is the HV interval often longer than in sinus rhythm? The critical role of anisotropic conduction. J Interv Card Electrophysiol. 2001;5:173–176. PubMed

Merino JL, Peinado R, Fernandez-Lozano I, Sobrino N, Sobrino JA. Transient entrainment of bundle-branch reentry by atrial and ventricular stimulation: elucidation of the tachycardia mechanism through analysis of the surface ECG. Circulation. 1999;100:1784–1790. PubMed

Merino JL, Peinado R, Fernandez-Lozano I, et al. Bundle-branch reentry and the postpacing interval after entrainment by right ventricular apex stimulation: a new approach to elucidate the mechanism of wide-QRScomplex tachycardia with atrioventricular dissociation. Circulation. 2001;103:1102–1108. PubMed

Reithmann C, Hahnefeld A, Oversohl N, Ulbrich M, Remp T, Steinbeck G. Reinitiation of ventricular macroreentry within the His-Purkinje system by back-up ventricular pacing: a mechanism of ventricular tachycardia storm. Pacing Clin Electrophysiol. 2007;30:225–235. PubMed

Berger RD, Orias D, Kasper EK, Calkins H. Catheter ablation of coexistent bundle branch and interfascicular reentrant ventricular tachycardias. J Cardiovasc Electrophysiol. 1996;7:341–347. PubMed

Crijns HJ, Kingma JH, Gosselink AT, Lie K. Comparison in the same patient of aberrant conduction and bundle branch reentry after dofetilide, a new selective class III antiarrhythmic agent. Pacing Clin Electrophysiol. 1993;16:1006–1016. PubMed

Nogami A. Purkinje-related arrhythmias. Part I:monomorphic ventricular achycardias. Pacing Clin Electrophysiol. 2011;34:624–650. PubMed

Nogami A. Idiopathic left ventricular tachycardia: assessment and treatment. Card Electrophysiol Rev. 2002;6:448–457. PubMed

Morishima I, Nogami A, Tsuboi H, Sone T. Verapamil-sensitive left anterior fascicular ventricular tachycardia associated with a healed myocardial infarction: changes in the delayed Purkinje potential during sinus rhythm. J Interv Card Electrophysiol. 2008;22:233–237. PubMed

Metzner A, Ouyang F, Wissner E, Kuck KH. Monomorphic and polymorphic ventricular tachycardias arising from the His-Purkinje system: what do we know? Futur Cardiol. 2011;7:835–846. PubMed

Markowitz SM, Stein KM, Engelstein ED, Lerman BB. AV nodal-His-Purkinje reentry: a novel form of tachycardia. J Cardiovasc Electrophysiol. 1995;6:400–9. PubMed

Tchou P, Jazayeri M, Denker S, Dongas J, Caceres J, Akhtar M. Transcatheter electrical ablation of right bundle branch: a method of treating macroreentrant ventricular tachycardia attributed to bundle branch reentry. Circulation. 1988;78:246–257. PubMed

Zipes DP, Foster PR, Troup PJ, Pedersen DH. Atrial induction of ventricular tachycardia: reentry versus triggered automaticity. Am J Cardiol. 1979;44:1–8. PubMed

Belhassen B, Rotmensch HH, Laniado S. Response of recurrent sustained ventricular tachycardia to verapamil. Br Heart J. 1981;46:679–682. PubMed PMC

Talib AK, Nogami A, Nishiuchi S, et al. Verapamil-sensitive upper septal idiopathic left ventricular tachycardia: prevalence, mechanism, and electrophysiological characteristics. JACC Clin Electrophysiol. 2015;1:369–380. PubMed

Nishiuchi S, Nogami A, Naito S. A case with occurrence of antidromic tachycardia after ablation of idiopathic left fascicular tachycardia: mechanism of left upper septal ventricular tachycardia. J Cardiovasc Electrophysiol. 2013;24:825–827. PubMed

Komatsu Y, Nogami A, Kurosaki K, et al. Fascicular ventricular tachycardia originating from papillary muscles: Purkinje network involvement in the reentrant circuit. Circ Arrhythm Electrophysiol. 2017;10:e004549. PubMed

Gallagher JJ, Selle JG, Svenson RH, et al. Surgical treatment of arrhythmias. Am J Cardiol. 1988;61:27A–44A. PubMed

Suwa M, Yoneda Y, Nagao H, et al. Surgical correction of idiopathic paroxysmal ventricular tachycardia possibly related to left ventricular false tendon. Am J Cardiol. 1989;64:1217–1220. PubMed

Thakur RK, Klein GJ, Sivaram CA, et al. Anatomic substrate for idiopathic left ventricular tachycardia. Circulation. 1996;93:497–501. PubMed

Maruyama M, Terada T, Miyamoto S, Ino T. Demonstration of the reentrant circuit of verapamil-sensitive idiopathic left ventricular tachycardia: direct evidence for macroreentry as the underlying mechanism. J Cardiovasc Electrophysiol. 2001;12:968–972. PubMed

Nogami A, Naito S, Tada H, et al. Demonstration of diastolic and presystolic Purkinje potential as critical potentials on a macroreentry circuit of verapamil-sensitive idiopathic left ventricular tachycardia. J Am Coll Cardiol. 2000;36:811–823. PubMed

Nogami A, Naito S, Tada H, et al. Verapamil-sensitive left anterior fascicular ventricular tachycardia: results of radiofrequency ablation in six patients. J Cardiovasc Electrophysiol. 1998;9:1269–1278. PubMed

Nogami A, Tada H. Ablation of idiopathic left and right ventricular and fascicular tachycardias. In: Huang SKS, Miler JM, editors. Catheter Ablation of Cardiac Arrhythmias. 3. Philadelphia: Elsevier Saunders; 2015. pp. 540–578.

Lerman BB, Stein KM, Markowitz SM. Mechanisms of idiopathic ventricular tachycardia. J Cardiovasc Electrophysiol. 1997;8:571–583. PubMed

Rodriguez LM, Smeets JL, Timmermans C, Trappe HJ, Wellens HJ. Radiofrequency catheter ablation of idiopathic ventricular tachycardia originating in the anterior fascicle of the left bundle branch. J Cardiovasc Electrophysiol. 1996;7:1211–1216. PubMed

de Bakker JM, Coronel R, Tasseron S, et al. Ventricular tachycardia in the infarcted, Langendorff-perfused human heart: role of the arrangement of surviving cardiac fibers. J Am Coll Cardiol. 1990;15:1594–1607. PubMed

de Bakker JM, van Capelle FJ, Janse MJ, et al. Macroreentry in the infarcted human heart: the mechanism of ventricular tachycardias with a “focal” activation pattern. J Am Coll Cardiol. 1991;18:1005–1014. PubMed

Downar E, Harris L, Mickleborough LL, Shaikh N, Parson ID. Endocardial mapping of ventricular tachycardia in the intact human ventricle: evidence for reentrant mechanisms. J Am Coll Cardiol. 1988;11:783–791. PubMed

Das MK, Scott LR, Miller JM. Focal mechanism of ventricular tachycardia in coronary artery disease. Heart Rhythm. 2010;7:305–311. PubMed

Wijnmaalen AP, Schalij MJ, von der Thusen JH, Klautz RJ, Zeppenfeld K. Early reperfusion during acute myocardial infarction affects ventricular tachycardia characteristics and the chronic electroanatomic and histological substrate. Circulation. 2010;121:1887–1895. PubMed

Piers SR, Wijnmaalen AP, Borleffs CJ, et al. Early reperfusion therapy affects inducibility, cycle length, and occurrence of ventricular tachycardia late after myocardial infarction. Circ Arrhythm Electrophysiol. 2011;4:195–201. PubMed

Watanabe M, de Riva M, Piers SRD, et al. Fast nonclinical ventricular tachycardia inducible after ablation in patients with structural heart disease: definition and clinical implications. Heart Rhythm. 2018;15:668–676. PubMed

Wrobleski D, Houghtaling C, Josephson ME, Ruskin JN, Reddy VY. Use of electrogram characteristics during sinus rhythm to delineate the endocardial scar in a porcine model of healed myocardial infarction. J Cardiovasc Electrophysiol. 2003;14:524–529. PubMed

Reddy VY, Wrobleski D, Houghtaling C, Josephson ME, Ruskin JN. Combined epicardial and endocardial electroanatomicmapping in a porcinemodel of healed myocardial infarction. Circulation. 2003;107:3236–3242. PubMed

Verma A, Marrouche NF, Schweikert RA, et al. Relationship between successful ablation sites and the scar border zone defined by substrate mapping for ventricular tachycardia post-myocardial infarction. J Cardiovasc Electrophysiol. 2005;16:465–471. PubMed

Yokokawa M, Desjardins B, Crawford T, Good E, Morady F, Bogun F. Reasons for recurrent ventricular tachycardia after catheter ablation of post-infarction ventricular tachycardia. J Am Coll Cardiol. 2013;61:66–73. PubMed

Komatsu Y, Daly M, Sacher F, et al. Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia. J Am Coll Cardiol. 2014;63:1416–1426. PubMed

McNally EM, Mestroni L. Dilated cardiomyopathy: genetic determinants and mechanisms. Circ Res. 2017;121:731–748. PubMed PMC

Ellenbogen KA, Levine JH, Berger RD. et al; defibrillators in non-ischemic cardiomyopathy treatment evaluation (DEFINITE) investigators. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation. 2006;113:776–782. PubMed

Kober L, Thune JJ, Nielsen JC, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med. 2016;375:1221–1230. PubMed

Gatzoulis KA, Vouliotis AI, Tsiachris D, et al. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol. 2013;6:504–512. PubMed

Aldhoon B, Tzou WS, Riley MP, et al. Nonischemic cardiomyopathy substrate and ventricular tachycardia in the setting of coronary artery disease. Heart Rhythm. 2013;10:1622–1627. PubMed

Soejima K, Stevenson WG, Sapp JL, Selwyn AP, Couper G, Epstein LM. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of lowvoltage scars. J Am Coll Cardiol. 2004;43:1834–1842. PubMed

Gulati A, Jabbour A, Ismail TF, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA. 2013;309:896–908. PubMed

Perazzolo Marra M, De Lazzari M, et al. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy. Heart Rhythm. 2014;11:856–863. PubMed

Piers SR, Everaerts K, van der Geest RJ, et al. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy. Heart Rhythm. 2015;12:2106–2114. PubMed

Piers SR, Tao Q, de Riva SM, et al. CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia. JACC Cardiovasc Imaging. 2014;7:774–784. PubMed

Njeim M, Yokokawa M, Frank L, et al. Value of cardiac magnetic resonance imaging in patients with failed ablation procedures for ventricular tachycardia. J Cardiovasc Electrophysiol. 2016;27:183–189. PubMed

Sasaki T, Miller CF, Hansford R, et al. Impact of nonischemic scar features on local ventricular electrograms and scar-related ventricular tachycardia circuits in patients with nonischemic cardiomyopathy. Circ Arrhythm Electrophysiol. 2013;6:1139–1147. PubMed PMC

Betensky BP, Dong W, D’Souza BA, Zado ES, Han Y, Marchlinski FE. Cardiac magnetic resonance imaging and electroanatomic voltage discordance in non-ischemic left ventricle ventricular tachycardia and premature ventricular depolarizations. J Interv Card Electrophysiol. 2017;49:11–19. PubMed

Kuhne M, Abrams G, Sarrazin JF, et al. Isolated potentials and pace-mapping as guides for ablation of ventricular tachycardia in various types of nonischemic cardiomyopathy. J Cardiovasc Electrophysiol. 2010;21:1017–1023. PubMed

Dinov B, Arya A, Schratter A, et al. Catheter ablation of ventricular tachycardia and mortality in patients with nonischemic dilated cardiomyopathy: can noninducibility after ablation be a predictor for reduced mortality? Circ Arrhythm Electrophysiol. 2015;8:598–605. PubMed

Piers SR, van Huls van Taxis CF, Tao Q, et al. Epicardial substrate mapping for ventricular tachycardia ablation in patients with non-ischaemic cardiomyopathy: a new algorithm to differentiate between scar and viable myocardium developed by simultaneous integration of computed tomography and contrast-enhanced magnetic resonance imaging. Eur Heart J. 2013;34:586–596. PubMed

Glashan CA, Androulakis AFA, Tao Q, et al. Whole human heart histology to validate electroanatomical voltage mapping in patients with non-ischaemic cardiomyopathy and ventricular tachycardia. Eur Heart J. 2018;39:2867–2875. PubMed

Spears DA, Suszko AM, Dalvi R, et al. Relationship of bipolar and unipolar electrogram voltage to scar transmurality and composition derived by magnetic resonance imaging in patients with nonischemic cardiomyopathy undergoing VT ablation. Heart Rhythm. 2012;9:1837–1846. PubMed

Dinov B, Schratter A, Schirripa V, et al. Procedural outcomes and survival after catheter ablation of ventricular tachycardia in relation to electroanatomical substrate in patients with nonischemic-dilated cardiomyopathy: the role of unipolar voltage mapping. J Cardiovasc Electrophysiol. 2015;26:985–993. PubMed

Frankel DS, Tschabrunn CM, Cooper JM, et al. Apical ventricular tachycardia morphology in left ventricular nonischemic cardiomyopathy predicts poor transplant-free survival. Heart Rhythm. 2013;10:621–626. PubMed

Maron BJ, Anan TJ, Roberts WC. Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation. 1981;63:882–894. PubMed

Maron BJ. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation. 2010;121:445–456. PubMed

Basso C, Thiene G, Corrado D, Buja G, Melacini P, Nava A. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol. 2000;31:988–998. PubMed

Almaas VM, Haugaa KH, Strom EH, et al. Increased amount of interstitial fibrosis predicts ventricular arrhythmias, and is associated with reduced myocardial septal function in patients with obstructive hypertrophic cardiomyopathy. Europace. 2013;15:1319–1327. PubMed

Rudolph A, Abdel-Aty H, Bohl S, et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol. 2009;53:284–291. PubMed

Satoh H, Matoh F, Shiraki K, et al. Delayed enhancement on cardiac magnetic resonance and clinical, morphological, and electrocardiographical features in hypertrophic cardiomyopathy. J Card Fail. 2009;15:419–427. PubMed

Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005;112:855–861. PubMed

Leonardi S, Raineri C, De Ferrari GM, et al. Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy. Eur Heart J. 2009;30:2003–2010. PubMed

Maron BJ, Spirito P, Shen WK, et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007;298:405–412. PubMed

Cha YM, Gersh BJ, Maron BJ, et al. Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2007;18:483–487. PubMed

Fananapazir L, Chang AC, Epstein SE, McAreavey D. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, holter, hemodynamic, and electrophysiological findings. Circulation. 1992;86:730–740. PubMed

Maron MS, Finley JJ, Bos JM, et al. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation. 2008;118:1541–1549. PubMed

Inada K, Seiler J, Roberts-Thomson KC, et al. Substrate characterization and catheter ablation for monomorphic ventricular tachycardia in patients with apical hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2011;22:41–48. PubMed

Kobayashi K, Ohata T, Ueda H, Miyamoto K. Recurrent sustained ventricular tachycardia, hypertrophic cardiomyopathy, and apical aneurysm: electroanatomic map-guided surgical ablation and left ventricular restoration. J Thorac Cardiovasc Surg. 2013;146:983–985. PubMed

Shimahara Y, Kobayashi J, Fujita T, Sato S. Transapical myectomy and surgical cryoablation for refractory ventricular tachycardia due to hypertrophic cardiomyopathy with apical aneurysm. Eur J Cardiothorac Surg. 2015;48:334–335. PubMed

Ergul Y, Ozyilmaz I, Bilici M, Ozturk E, Haydin S, Guzeltas A. Radiofrequency ablation of fast ventricular tachycardia causing an ICD storm in an infant with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 2018;41:425–428. PubMed

Nademanee K, Hocini M, Haissaguerre M. Epicardial substrate ablation for Brugada syndrome. Heart Rhythm. 2017;14:457–461. PubMed

Andorin A, Gourraud JB, Mansourati J, et al. The QUIDAMstudy: hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk. Heart Rhythm. 2017;14:1147–1154. PubMed

Vutthikraivit W, Rattanawong P, Putthapiban P, et al. Worldwide prevalence of Brugada syndrome: a systematic review and meta-analysis. Acta Cardiol Sin. 2018;34:267–277. PubMed PMC

Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992;20:1391–1396. PubMed

Bayes de Luna A, Brugada J, Baranchuk A, et al. Current electrocardiographic criteria for diagnosis of Brugada pattern: a consensus report. J Electrocardiol. 2012;45:433–442. PubMed

Viswanathan S, Aghoram R. Brugada syndrome in patients with acute febrile illness. Indian Heart J. 2018;70:416–420. PubMed PMC

Konigstein M, Rosso R, Topaz G, et al. Drug-induced Brugada syndrome: clinical characteristics and risk factors. Heart Rhythm. 2016;13:1083–1087. PubMed

Xu G, Gottschalk BH, Anselm DD, et al. Relation of the Brugada phenocopy to hyperkalemia (from the international registry on Brugada Phenocopy) Am J Cardiol. 2018;121:715–717. PubMed

Hunuk B, Kepez A, Erdogan O. Prevalence of Brugada-type electrocardiogram pattern by recording right precordial leads at higher intercostal spaces. Europace. 2013;15:590–594. PubMed

Holst AG, Tango M, Batchvarov V, et al. Specificity of elevated intercostal space ECG recording for the type 1 Brugada ECG pattern. Ann Noninvasive Electrocardiol. 2012;17:108–112. PubMed PMC

Dendramis G. Brugada syndrome and Brugada phenocopy. The importance of a differential diagnosis. Int J Cardiol. 2016;210:25–27. PubMed

Watanabe H, Minamino T. Genetics of Brugada syndrome. J Hum Genet. 2016;61:57–60. PubMed

Postema PG, van Dessel PF, Kors JA, et al. Local depolarization abnormalities are the dominant pathophysiologic mechanism for type 1 electrocardiogram in Brugada syndrome a study of electrocardiograms, vectorcardiograms, and body surface potential maps during ajmaline provocation. J Am Coll Cardiol. 2010;55:789–797. PubMed

Bueno-Orovio A, Cherry EM, Evans SJ, Fenton FH. Basis for the induction of tissue-level phase-2 reentry as a repolarization disorder in the Brugada syndrome. Biomed Res Int. 2015;2015:197586. PubMed PMC

Lambiase PD, Ahmed AK, Ciaccio EJ, et al. High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis. Circulation. 2009;120:106–117. PubMed

Ohkubo K, Watanabe I, Okumura Y, et al. Right ventricular histological substrate and conduction delay in patients with Brugada syndrome. Int Heart J. 2010;51:17–23. PubMed

Nademanee K, Veerakul G, Chandanamattha P, et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation. 2011;123:1270–1279. PubMed

Krieger K, Steinfurt J, Lenz C, Keweloh B. Catheter ablation ofBrugada syndrome: importance of repeated administration of ajmaline to unmask the entire epicardial substrate. JACC Clin Electrophysiol. 2017;3:1330–1332. PubMed

Chung FP, Raharjo SB, Lin YJ, et al. A novel method to enhance phenotype, epicardial functional substrates, and ventricular tachyarrhythmias in Brugada syndrome. Heart Rhythm. 2017;14:508–517. PubMed

Pappone C, Ciconte G, Manguso F, et al. Assessing the malignant ventricular arrhythmic substrate in patients with Brugada syndrome. J Am Coll Cardiol. 2018;71:1631–1646. PubMed

Shah AJ, Hocini M, Lamaison D, Sacher F, Derval N, Haissaguerre M. Regional substrate ablation abolishes Brugada syndrome. J Cardiovasc Electrophysiol. 2011;22:1290–1291. PubMed

Watanabe A, Fukushima Kusano K, Morita H, et al. Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome. Eur Heart J. 2006;27:1579–1583. PubMed

Omiya T, Shimizu A, Ueyama T, et al. Effects of isoproterenol and propranolol on the inducibility and frequency of ventricular fibrillation in patients with Brugada syndrome. J Cardiol. 2012;60:47–54. PubMed

Shan Q, Yang B, Chen M, et al. Short-term normalization of ventricular repolarization by transcatheter ablation in a patient with suspected Brugada syndrome. J Interv Card Electrophysiol. 2008;21:53–57. PubMed

Nakagawa E, Takagi M, Tatsumi H, Yoshiyama M. Successful radiofrequency catheter ablation for electrical storm of ventricular fibrillation in a patient with Brugada syndrome. Circ J. 2008;72:1025–1029. PubMed

Rodriguez-Manero M, Sacher F, de Asmundis C, et al. Monomorphic ventricular tachycardia in patients with Brugada syndrome: a multicenter retrospective study. Heart Rhythm. 2016;13:669–682. PubMed

Lim PCY, Nademanee K, Lee ECY, Teo WS. Epicardial ablation utilizing remote magnetic navigation in a patient with Brugada syndrome and inferior early repolarization. Pacing Clin Electrophysiol. 2018;41:214–217. PubMed

Lee A, Kohler H, Wright D, Haqqani HM. Epicardial Brugada syndrome ablation unmasking inferior J waves. Pacing Clin Electrophysiol. 2017;40:1308–1312. PubMed

Bansch D, Ouyang F, Antz M, et al. Successful catheter ablation of electrical storm after myocardial infarction. Circulation. 2003;108:3011–3016. PubMed

Marrouche NF, Verma A, Wazni O, et al. Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol. 2004;43:1715–1720. PubMed

Bode K, Hindricks G, Piorkowski C, et al. Ablation of polymorphic ventricular tachycardias in patients with structural heart disease. Pacing Clin Electrophysiol. 2008;31:1585–1591. PubMed

Basso C, Corrado D, Markus FI, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;373:1289–1300. PubMed

Boulos M, Lashevsky I, Reisner S, Gepstein L. Electroanatomic mapping of arrhythmogenic right ventricular dysplasia. J Am Coll Cardiol. 2001;38:2020–2027. PubMed

Te Riele AS, James CA, Philips B, et al. Mutation-positive arrhythmogenic right ventricular dysplasia/cardiomyopathy: the triangle of dysplasia displaced. J Cardiovasc Electrophysiol. 2013;24:1311–1320. PubMed PMC

Fernández-Armenta J, Andreu D, Penela D, et al. Sinus rhythm detection of conducting channels and ventricular tachycardia isthmus in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2014;11:747–754. PubMed

Sen-Chowdhry S, Syrris P, Prasad SK, et al. Left dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol. 2008;52:2175–2187. PubMed

Corrado D, Basso C, Leoni L, et al. Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation. 2005;111:3042–3050. PubMed

Santangeli P, Hamilton-Craig C, Dello Russo A, et al. Imaging of scar in patients with ventricular arrhythmias of right ventricular origin: cardiac magnetic resonance versus electroanatomic mapping. J Cardiovasc Electrophysiol. 2011;22:1359–1366. PubMed

Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation. 1992;86:29–37. PubMed

Marcus GM, Glidden DV, Polonsky B, et al. Multidisciplinary study of right ventricular dysplasia investigators. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the north American ARVC registry. J Am Coll Cardiol. 2009;54:609–615. PubMed PMC

Ermakov S, Gerstenfeld EP, Svetlichnaya Y, Scheinman MM. Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2017;14:564–569. PubMed

Fernández-Armenta J, Penela D, Acosta J, et al. Substrate modification or ventricular tachycardia induction, mapping, and ablation as the first step? A randomized study. Heart Rhythm. 2016;13:1589–1595. PubMed

Philips B, Madhavan S, James C, et al. High prevalence of catecholamine- facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Arrhythm Electrophysiol. 2013;6:160–166. PubMed

Roberts-Thomson KC, Steven D, Seiler J, et al. Coronary artery injury due to catheter ablation in adults: presentations and outcomes. Circulation. 2009;120:1465–1473. PubMed

Miyazaki A, Sakaguchi H, Ohuchi H, et al. Efficacy of Hemodynamicbased management of tachyarrhythmia after repair of tetralogy of Fallot. Circ J. 2012;76:2855–2862. PubMed

Karamlou T, Silber I, Lao R, et al. Outcomes after late reoperation in patients with repaired tetralogy of Fallot: the impact of arrhythmia and arrhythmia surgery. Ann Thorac Surg. 2006;81:1786–1793. PubMed

Downar E, Harris L, Kimber S, et al. Ventricular tachycardia after surgical repair of tetralogy of Fallot: results of intraoperative mapping studies. J Am Coll Cardiol. 1992;20:648–655. PubMed

Moore JP, Shannon KM, Gallotti RG, et al. Catheter ablation of ventricular arrhythmia for Ebstein’s anomaly in unoperated and post-surgical patients. JACC Clin Electrophysiol. 2018;4:1300–1307. PubMed

Kapel GFL, Laranjo S, Blom NA, et al. Impact of surgery on presence and dimensions of anatomical isthmuses in tetralogy of Fallot. Heart. 2018;104:1200–1207. PubMed

Okura Y, Dec GW, Hare JM, et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol. 2003;41:322–329. PubMed

Litovsky SH, Burke AP, Virmani R. Giant cell myocarditis: an entity distinct from sarcoidosis characterized by multiphasic myocyte destruction by cytotoxic T cells and histiocytic giant cells. Mod Pathol. 1996;9:1126–1134. PubMed

Trachtenberg BH, Hare JM. Inflammatory cardiomyopathic syndromes. Circ Res. 2017;121:803–818. PubMed

Kandolin R, Lehtonen J, Airaksinen J, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;131:624–632. PubMed

Chapelon-Abric C, Sene D, Saadoun D, et al. Cardiac sarcoidosis: diagnosis, therapeutic management and prognostic factors. Arch Cardiovasc Dis. 2017;110:456–465. PubMed

Pennell DJ. Cardiovascular magnetic resonance. Circulation. 2010;121:692–705. PubMed

Vasaiwala SC, Finn C, Delpriore J, et al. Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol. 2009;20:473–476. PubMed

Philips B, Madhavan S, James CA, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear. Circ Arrhythm Electrophysiol. 2014;7:230–236. PubMed

Dechering DG, Kochhaüser S, Wasmer K, et al. Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2013;10:158–164. PubMed

Steckman DA, Schneider PM, Schuller JL, et al. Utility of cardiac magnetic resonance imaging to differentiate cardiac sarcoidosis from arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol. 2012;110:575–579. PubMed

Schuller JL, Lowery CM, Zipse M, et al. Diagnostic utility of signal-averaged electrocardiography for detection of cardiac sarcoidosis. Ann Noninvasive Electrocardiol. 2011;16:70–76. PubMed PMC

Roberts WC, McAllister HA, Jr, Ferrans VJ. Sarcoidosis of the heart. a clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11) Am J Med. 1977;63:86–108. PubMed

Casella M, Pizzamiglio F, Dello Russo A, et al. Feasibility of combined unipolar and bipolar voltage maps to improve sensitivity of endomyocardial biopsy. Circ Arrhythm Electrophysiol. 2015;8:625–632. PubMed

Berte B, Eyskens B, Meyfroidt G, Willems R. Bidirectional ventricular tachycardia in fulminant myocarditis. Europace. 2008;10:767–768. PubMed

Park H, Park H, Lee D, et al. Increased phosphorylation of ca(2+) handling proteins as a proarrhythmic mechanism in myocarditis. Circ J. 2014;78:2292–2301. PubMed

Zeppenfeld K, Blom NA, Bootsma M, Schalij MJ. Incessant ventricular tachycardia in fulminant lymphocytic myocarditis: evidence for origin in the Purkinje system and successful treatment with ablation. Heart Rhythm. 2007;4:88–91. PubMed

Tai YT, Lau CP, Fong PC, Li JP, Lee KL. Incessant automatic ventricular tachycardia complicating acute coxsackie b myocarditis. Cardiology. 1992;80:339–344. PubMed

Yodogawa K, Seino Y, Ohara T, Takayama H, Katoh T, Mizuno K. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol. 2011;16:140–147. PubMed PMC

Stees CS, Khoo MSC, Lowery CM, Sauer WH. Ventricular tachycardia storm successfully treated with immunosuppression and catheter ablation in a patient with cardiac sarcoidosis. J Cardiovasc Electrophysiol. 2011;22:210–213. PubMed

Yazaki Y. IsobeM, Hiroe M, et al. Central Japan heart study group. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001;88:1006–1010. PubMed

Tzou WS, Rothstein PA, Cowherd M, et al. Repeat ablation of refractory ventricular arrhythmias in patients with nonischemic cardiomyopathy: impact of midmyocardial substrate and role of adjunctive ablation techniques. J Cardiovasc Electrophysiol. 2018;29:1403–1412. PubMed

Papageorgiou N, Providencia R, Bronis K, et al. Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review. Europace. 2017;20:682–691. PubMed

Bocchi EA, Bestetti RB, Scanavacca MI, Cunha Neto E, Issa VS. Chronic Chagas heart disease management: from etiology to cardiomyopathy treatment. J Am Coll Cardiol. 2017;70:1510–1524. PubMed

Healy C, Viles-Gonzalez JF, Sáenz LC, Soto M, Ramírez JD, d’Avila A. Arrhythmias in Chagasic cardiomyopathy. Card Electrophysiol Clin. 2015;7:251–268. PubMed

Scanavacca M, Sosa E. Epicardial ablation of ventricular tachycardia in Chagas heart disease. Card Electrophysiol Clin. 2010;2:55–67. PubMed

Scanavacca M, Sosa E, d’Avila A, De Lourdes Higuchi M. Radiofrequency ablation of sustained ventricular tachycardia related to the mitral isthmus in Chagas’ disease. Pacing Clin Electrophysiol. 2002;25:368–371. PubMed

Sarabanda AV, Gali WL, Gomes GG. Bundle branch reentry: a novel mechanism for sustained ventricular tachycardia in Chagas heart disease. HeartRhythm Case Rep. 2018;4:293–297. PubMed PMC

Saenz LC, Corrales FM, Bautista W, et al. Cardiac sympathetic denervation for intractable ventricular arrhythmias in Chagas disease. Heart Rhythm. 2016;13:1388–1394. PubMed

Soto-Becerra R, Bazan V, Bautista W, et al. Ventricular tachycardia in the setting of Chagasic cardiomyopathy: use of voltage mapping to characterize endoepicardial nonischemic scar distribution. Circ Arrhythm Electrophysiol. 2017;10:e004950. PubMed

Hasselberg NE, Haland TF, Saberniak J, et al. Lamin a/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation. Eur Heart J. 2018;39:853–860. PubMed PMC

van Berlo JH, de Voogt WG, van der Kooi AJ, et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do Lamin a/C mutations portend a high risk of sudden death? J Mol Med (Berl) 2005;83:79–83. PubMed

van Berlo JH, Duboc D, Pinto YM. Often seen but rarely recognised: cardiac complications of Lamin a/C mutations. Eur Heart J. 2004;25:812–814. PubMed

Hasselberg NE, Edvardsen T, Petri H, et al. Risk prediction of ventricular arrhythmias and myocardial function in Lamin a/C mutation positive subjects. Europace. 2014;16:563–571. PubMed

van Rijsingen IA, Arbustini E, Elliott PM, et al. Risk factors for malignant ventricular arrhythmias in Lamin a/C mutation carriers a European cohort study. J Am Coll Cardiol. 2012;59:493–500. PubMed

Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart. 2001;86:666–671. PubMed PMC

Murphy RT, Thaman R, Blanes JG, et al. Natural history and familial characteristics of isolated left ventricular non-compaction. Eur Heart J. 2005;26:187–192. PubMed

Muser D, Nucifora G, Gianfagna E, et al. Clinical spectrum of isolated left ventricular noncompaction: thromboembolic events, malignant left ventricular arrhythmias, and refractory heart failure. J Am Coll Cardiol. 2014;63:e39. PubMed

Muser D, Liang JJ, Witschey WR, et al. Ventricular arrhythmias associated with left ventricular noncompaction: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm. 2017;14:166–175. PubMed

Li Y, Xue Y, Yu J, et al. Electrophysiological characteristics and radiofrequency ablation of sustained monomorphic ventricular tachycardia in adult patients with isolated ventricular noncompaction. J Interv Card Electrophysiol. 2018;52:117–125. PubMed

Jackson N, King B, Viswanathan K, Downar E, Spears D. Case report: ablation of diffuse inter-trabecular substrate in a patient with isolated ventricular non-compaction. Indian Pacing Electrophysiol J. 2015;15:162–164. PubMed PMC

Paparella G, Capulzini L, de Asmundis C, et al. Electro-anatomical mapping in a patient with isolated left ventricular non-compaction and left ventricular tachycardia. Europace. 2009;11:1227–1229. PubMed

Ritter M, Oechslin E, Sutsch G, Attenhofer C, Schneider J, Jenni R. Isolated noncompaction of the myocardium in adults. Mayo Clin Proc. 1997;72:26–31. PubMed

Santoro F, Manuppelli V, Brunetti ND. Multiple morphology ventricular tachycardia in non-compaction cardiomyopathy: multi-modal imaging. Europace. 2013;15:304. PubMed

Ohlow MA. Congenital left ventricular aneurysms and diverticula: definition, pathophysiology, clinical relevance and treatment. Cardiology. 2006;106:63–72. PubMed

Ohlow MA. Congenital left ventricular aneurysms and diverticula: an entity in search of an identity. J Geriatr Cardiol. 2017;14:750–762. PubMed PMC

Ohlow MA, Secknus MA, Geller JC, von Korn H, Lauer B. Prevalence and outcome of congenital left ventricular aneurysms and diverticula in an adult population. Cardiology. 2009;112:287–293. PubMed

Haegeli LM, Ercin E, Steffel J, et al. Incidence and prognosis of ventricular arrhythmias in patients with congenital left ventricular aneurysms or diverticula. Am J Med. 2015;128:653.e1–653.e6. PubMed

Haegeli LM, Ercin E, Wolber T, et al. Arrhythmic manifestations in patients with congenital left ventricular aneurysms and diverticula. Am J Cardiol. 2011;108:1826–1830. PubMed

Ouyang F, Antz M, Deger FT, et al. An underrecognized subepicardial reentrant ventricular tachycardia attributable to left ventricular aneurysm in patients with normal coronary arteriograms. Circulation. 2003;107:2702–2709. PubMed

Ramdjan TT, Yaksh A, Roos-Hesselink JW, de Groot NM. Endovascular catheter ablation of ventricular tachycardia in a patient with a surgically repaired congenital left ventricular aneurysm. Neth Heart J. 2015;23:370–372. PubMed PMC

Santamaria M, Cireddu M, Riva S, Trevisi N, Della BP. Radiofrequency catheter ablation guided by noncontact mapping of ventricular tachycardia originating from an idiopathic left ventricular aneurysm. J Interv Card Electrophysiol. 2007;19:49–53. PubMed

Pedrotty DM, Rame JE, Margulies KB. Management of ventricular arrhythmias in patients with ventricular assist devices. Curr Opin Cardiol. 2013;28:360–368. PubMed

Yoruk A, Sherazi S, Massey HT, et al. Predictors and clinical relevance of ventricular tachyarrhythmias in ambulatory patients with a continuous flow left ventricular assist device. Heart Rhythm. 2016;13:1052–1056. PubMed

Enriquez AD, Calenda B, Miller MA, Anyanwu AC, Pinney SP. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol. 2013;6:668–674. PubMed

Ambardekar AV, Allen LA, Lindenfeld J, et al. Implantable cardioverterdefibrillator shocks in patients with a left ventricular assist device. J Heart Lung Transplant. 2010;29:771–776. PubMed

Bedi M, Kormos R, Winowich S, McNamara DM, Mathier MA, Murali S. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol. 2007;99:1151–1153. PubMed

Garan AR, Levin AP, Topkara V, et al. Early post-operative ventricular arrhythmias in patients with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2015;34:1611–1616. PubMed

Birati EY, Quiaoit Y, Wald J, et al. Ventricular assist device thrombosis: a wide spectrum of clinical presentation. J Heart Lung Transplant. 2015;34:613–615. PubMed

Raasch H, Jensen BC, Chang PP, et al. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. Am Heart J. 2012;164:373–378. PubMed

Sacher F, Reichlin T, Zado ES, et al. Characteristics of ventricular tachycardia ablation in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol. 2015;8:592–597. PubMed

Dandamudi G, Ghumman WS, Das MK, Miller JM. Endocardial catheter ablation of ventricular tachycardia in patients with ventricular assist devices. Heart Rhythm. 2007;4:1165–1169. PubMed

Moss JD, Flatley EE, Beaser AD, et al. Characterization of ventricular tachycardia after left ventricular assist device implantation as destination therapy: a single-center ablation experience. JACC Clin Electrophysiol. 2017;3:1412–1424. PubMed

Garan AR, Iyer V, Whang W, et al. Catheter ablation for ventricular tachyarrhythmias in patients supported by continuous-flow left ventricular assist devices. ASAIO J. 2014;60:311–316. PubMed

Herweg B, Ilercil A, Kristof-Kuteyeva O, et al. Clinical observations and outcome of ventricular tachycardia ablation in patients with left ventricular assist devices. Pacing Clin Electrophysiol. 2012;35:1377–1383. PubMed

Snipelisky D, Reddy YN, Manocha K, et al. Effect of ventricular arrhythmia ablation in patients with heart mate ii left ventricular assist devices: an evaluation of ablation therapy. J Cardiovasc Electrophysiol. 2017;28:68–77. PubMed

Anter E, Hutchinson MD, Deo R, et al. Surgical ablation of refractory ventricular tachycardia in patients with nonischemic cardiomyopathy. Circ Arrhythm Electrophysiol. 2011;4:494–500. PubMed

Emaminia A, Nagji AS, Ailawadi G, Bergin JD, Kern JA. Concomitant left ventricular assist device placement and cryoablation for treatment of ventricular tachyarrhythmias associated with heart failure. Ann Thorac Surg. 2011;92:334–336. PubMed

Mulloy DP, Bhamidipati CM, Stone ML, et al. Cryoablation during left ventricular assist device implantation reduces postoperative ventricular tachyarrhythmias. J Thorac Cardiovasc Surg. 2013;145:1207–1213. PubMed PMC

McIlvennan CK, Babu AN, Brieke A, Ambardekar AV. Concomitant surgical cryoablation for refractory ventricular tachycardia and left ventricular assist device placement: a dual remedy but a recipe for thrombosis? J Cardiothorac Surg. 2016;11:53. PubMed PMC

Krul SPJ, Berger WR, Veldkamp MW, et al. Treatment of atrial and ventricular arrhythmias through autonomic modulation. JACC Clin Electrophysiol. 2015;1:496–508. PubMed

Matsunari I, Aoki H, Nomura Y, et al. Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction. Circ Cardiovasc Imaging. 2010;3:595–603. PubMed

Krittayaphong R, Bhuripanyo K, Punlee K, Kangkagate C, Chaithiraphan S. Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study. Am Heart J. 2002;144:e10. PubMed

Schwartz PJ, Motolese M, Pollavini G, Italian Sudden Death Prevention Group et al. Prevention of sudden cardiac death after a first myocardial infarction by pharmacologic or surgical antiadrenergic interventions. J Cardiovasc Electrophysiol. 1992;3:2–16.

Nademanee K, Taylor R, Bailey WE, Rieders DE, Kosar EM. Treating electrical storm: sympathetic blockade versus advanced cardiac life support- guided therapy. Circulation. 2000;102:742–747. PubMed

Tanaka H, Kinoshita O, Uchikawa S, et al. Successful prevention of recurrent ventricular fibrillation by intravenous isoproterenol in a patient with Brugada syndrome. Pacing Clin Electrophysiol. 2001;24:1293–1294. PubMed

Aizawa Y, Chinushi M, Hasegawa K, et al. Electrical storm in idiopathic ventricular fibrillation is associated with early repolarization. J Am Coll Cardiol. 2013;62:1015–1019. PubMed

Bourke T, Vaseghi M, Michowitz Y, et al. Neuraxialmodulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation. 2010;121:2255–2262. PubMed PMC

Fudim M, Boortz-Marx R, Ganesh A, et al. Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias: a systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2017;28:1460–1467. PubMed

Vaseghi M, Gima J, Kanaan C, et al. Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. Heart Rhythm. 2014;11:360–366. PubMed PMC

Surman TL, Stuklis RG, Chan JC. Thoracoscopic sympathectomy for long QT syndrome: literature review and case study. Heart Lung Circ. 2019;28:486–494. PubMed

Olde Nordkamp LR, Driessen AH, Odero A, et al. Left cardiac sympathetic denervation in the Netherlands for the treatment of inherited arrhythmia syndromes. Neth Heart J. 2014;22:160–166. PubMed PMC

Vaseghi M, Barwad P, Malavassi Corrales FJ, et al. Cardiac sympathetic denervation for refractory ventricular arrhythmias. J Am Coll Cardiol. 2017;69:3070–3080. PubMed PMC

Ajijola OA, Lellouche N, Bourke T, et al. Bilateral cardiac sympathetic denervation for the management of electrical storm. J Am Coll Cardiol. 2012;59:91–92. PubMed PMC

Moss AJ, McDonald J. Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome. N Engl J Med. 1971;285:903–904. PubMed

Grimaldi R, de Luca A, Kornet L, Castagno D, Gaita F. Can spinal cord stimulation reduce ventricular arrhythmias? Heart Rhythm. 2012;9:1884–1887. PubMed

Schwartz PJ, Priori SG, Cerrone M, et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 2004;109:1826–1833. PubMed

Bos JM, Bos KM, Johnson JN, Moir C, Ackerman MJ. Left cardiac sympathetic denervation in long QT syndrome: analysis of therapeutic nonresponders. Circ Arrhythm Electrophysiol. 2013;6:705–711. PubMed

Hofferberth SC, Cecchin F, Loberman D, Fynn-Thompson F. Left thoracoscopic sympathectomy for cardiac denervation in patients with life-threatening ventricular arrhythmias. J Thorac Cardiovasc Surg. 2014;147:404–409. PubMed

Li J, Liu Y, Yang F, et al. Video-assisted thoracoscopic left cardiac sympathetic denervation: a reliable minimally invasive approach for congenital long-QT syndrome. Ann Thorac Surg. 2008;86:1955–1958. PubMed

De Ferrari GM, Dusi V, Spazzolini C, et al. Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation. Circulation. 2015;131:2185–2193. PubMed

Wilde AA, Bhuiyan ZA, Crotti L, et al. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med. 2008;358:2024–2029. PubMed

Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-ofprinciple cohort study. Lancet. 2009;373:1275–1281. PubMed

Ukena C, Bauer A, Mahfoud F, et al. Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol. 2012;101:63–67. PubMed

Hoffmann BA, Steven D, Willems S, Sydow K. Renal sympathetic denervation as an adjunct to catheter ablation for the treatment of ventricular electrical storm in the setting of acute myocardial infarction. J Cardiovasc Electrophysiol. 2013;24:1175–1178. PubMed

Remo BF, Preminger M, Bradfield J, et al. Safety and efficacy of renal denervation as a novel treatment of ventricular tachycardia stormin patients with cardiomyopathy. Heart Rhythm. 2014;11:541–546. PubMed PMC

Ukena C, Mahfoud F, Ewen S, et al. Renal denervation for treatment of ventricular arrhythmias: data from an international multicenter registry. Clin Res Cardiol. 2016;105:873–879. PubMed

Horowitz LN, Josephson ME, Farshidi A, Spielman SR, Michelson EL, Greenspan AM. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Circulation. 1978;58:986–997. PubMed

Kudenchuk PJ, Kron J, Walance CG, Cutler JE, Griffith KK, McAnulty JH. Day-to-day reproducibility of antiarrhythmic drug trials using programmed extrastimulus techniques for ventricular tachyarrhythmias associated with coronary artery disease. Am J Cardiol. 1990;66:725–730. PubMed

Essebag V, Joza J, Nery PB, et al. Prognostic value of noninducibility on outcomes of ventricular tachycardia ablation: a VANISH substudy. JACC Clin Electrophysiol. 2018;4:911–919. PubMed

Oloriz T, Baratto F, Nicola Trevisi N, et al. Defining the outcome of ventricular tachycardia ablation timing and value of programmed ventricular stimulation. Circ Arrhythm Electrophysiol. 2018;11:e005602. PubMed

Santangeli P, Frankel DS, Marchlinski FE. End points for ablation of scar-related ventricular tachycardia. Circ Arrhythm Electrophysiol. 2014;7:949–960. PubMed

Di Marco A, Oloriz Sanjuan T, Paglino G, et al. Late potentials abolition reduces ventricular tachycardia recurrence after ablation especially in higher-risk patients with a chronic total occlusion in an infarct-related artery. J Cardiovasc Electrophysiol. 2018;29:1119–1124. PubMed

Ren JF, Callans DJ, Michele JJ, Dillon SM, Marchlinski FE. Intracardiac echocardiographic evaluation of ventricular mural swelling from radiofrequency ablation in chronic myocardial infarction: irrigated-tip versus standard catheter. J Interv Card Electrophysiol. 2001;5:27–32. PubMed

Dickfeld T, Kato R, Zviman M, et al. Characterization of acute and subacute radiofrequency ablation lesions with nonenhanced magnetic resonance imaging. Heart Rhythm. 2007;4:208–214. PubMed PMC

Singh-Moon RP, Yao X, Iyer V, Marboe C, Whang W, Hendon CP. Realtime optical spectroscopic monitoring of non-irrigated lesion progression within atrial and ventricular tissues. J Biophotonics. 2018;11:e201800144. PubMed PMC

Sapp JL, Soejima K, Cooper JM, Epstein LM, Stevenson WG. Ablation lesion size correlates with pacing threshold: a physiological basis for use of pacing to assess ablation lesions. Pacing Clin Electrophysiol. 2004;27:933–937. PubMed

Jackson N, McGee M, Ahmed W, et al. Groin haemostasis with a purse string suture for patients following catheter ablation procedures (GITAR study). Heart Lung Circ. 2018 March 20. 10.1016/j.hlc.2018.03.011 [Epub ahead of print]. PubMed

Pracon R, Bangalore S, Henzel J, et al. A randomized comparison of modified subcutaneous “Z”-stitch versus manual compression to achieve hemostasis after large caliber femoral venous sheath removal. Catheter Cardiovasc Interv. 2018;91:105–112. PubMed

Ben-Dor I, Craig P, Torguson R, et al. MynxGrip vascular closure device versus manual compression for hemostasis of percutaneous transfemoral venous access closure: results from a prospective multicenter randomized study. Cardiovasc Revasc Med. 2018;19:418–422. PubMed

Aytemir K, Canpolat U, Yorgun H, et al. Usefulness of ‘figure-of-eight’ suture to achieve haemostasis after removal of 15-French calibre femoral venous sheath in patients undergoing cryoablation. Europace. 2016;18:1545–1550. PubMed

Lakshmanadoss U, Wong WS, Kutinsky I, Khalid MR, Williamson B, Haines DE. Figure-of-eight suture for venous hemostasis in fully anticoagulated patients after atrial fibrillation catheter ablation. Indian Pacing Electrophysiol J. 2017;17:134–139. PubMed PMC

Cilingiroglu M, Salinger M, Zhao D, Feldman T. Technique of temporary subcutaneous “figure-of-eight” sutures to achieve hemostasis after removal of large-caliber femoral venous sheaths. Catheter Cardiovasc Interv. 2011;78:155–160. PubMed

Okada M, Inoue K, Tanaka K, et al. Efficacy and safety of figure-of-eight suture for hemostasis after radiofrequency catheter ablation for atrial fibrillation. Circ J. 2018;82:956–964. PubMed

Akkaya E, Berkowitsch A, Zaltsberg S, et al. Safety and feasibility of percutaneous skin closure using purse-string suture compared with compression bandage after pulmonary vein isolation. J Cardiovasc Electrophysiol. 2017;28:1048–1057. PubMed

Shaw JA, Dewire E, Nugent A, Eisenhauer AC. Use of suture-mediated vascular closure devices for the management of femoral vein access after transcatheter procedures. Catheter Cardiovasc Interv. 2004;63:439–443. PubMed

Coto HA. Closure of the femoral vein puncture site after transcatheter procedures using Angio-seal. Catheter Cardiovasc Interv. 2002;55:16–19. PubMed

Dou E, Winokur RS, Sista AK. Venous access site closures using the VASCADE vascular closure system. J Vasc Interv Radiol. 2016;27:1885–1888. PubMed

Robertson L, Andras A, Colgan F, Jackson R. Vascular closure devices for femoral arterial puncture site haemostasis. Cochrane Database Syst Rev. 2016;3:CD009541. PubMed PMC

Jiang J, Zou J, Ma H, et al. Network meta-analysis of randomized trials on the safety of vascular closure devices for femoral arterial puncture site haemostasis. Sci Rep. 2015;5:13761. PubMed PMC

Dyrda K, Piers SR, van Huls van Taxis CF, Schalij MJ, Zeppenfeld K. Influence of steroid therapy on the incidence of pericarditis and atrial fibrillation after percutaneous epicardial mapping and ablation for ventricular tachycardia. Circ Arrhythm Electrophysiol. 2014;7:671–676. PubMed

d’Avila A, Neuzil P, Thiagalingam A, et al. Experimental efficacy of pericardial instillation of anti-inflammatory agents during percutaneous epicardial catheter ablation to prevent postprocedure pericarditis. J Cardiovasc Electrophysiol. 2007;18:1178–1183. PubMed

Sugrue A, Killu AM, Hodge DO, et al. Significance and clinical characteristics of atrial fibrillation post epicardial access. J Interv Card Electrophysiol. 2017;48:141–146. PubMed

Mahapatra S, LaPar DJ, Bhamidipati CM, et al. Incidence, risk factors, and consequences of new-onset atrial fibrillation following epicardial ablation for ventricular tachycardia. Europace. 2011;13:548–554. PubMed PMC

Siontis KC, Jame S, Sharaf Dabbagh G, et al. Thromboembolic prophylaxis protocol with warfarin after radiofrequency catheter ablation of infarct-related ventricular tachycardia. J Cardiovasc Electrophysiol. 2018;29:584–590. PubMed

Patel AA, Clyne CA, Henyan NN, et al. The use of protamine after radiofrequency catheter ablation: a pilot study. J Interv Card Electrophysiol. 2007;18:155–158. PubMed

Ghannam M, Chugh A, Dillon P, et al. Protamine to expedite vascular hemostasis after catheter ablation of atrial fibrillation: a randomized controlled trial. Heart Rhythm. 2018;15:1642–1647. PubMed

Katz DF, Turakhia MP, Sauer WH, et al. Safety of ventricular tachycardia ablation in clinical practice: findings from 9699 hospital discharge records. Circ Arrhythmia Electrophysiol. 2015;8:362–370. PubMed PMC

Pothineni NV, Deshmukh A, Padmanabhan D, et al. Complication rates of ventricular tachycardia ablation: comparison of safety outcomes derived from administrative databases and clinical trials. Int J Cardiol. 2015;201:529–531. PubMed

Liang JJ, Kodali S, Schaller RD, Birati EY, Marchlinski FE, Santangeli P. Intraprocedural slow continuous ultrafiltration: a novel strategy to prevent acute hemodynamic decompensation from volume overload during VT ablation. Pacing Clin Electrophysiol. 2018;41:1043–1044. PubMed

Muser D, Liang JJ, Castro SA, et al. Outcomes with prophylactic use of percutaneous left ventricular assist devices in high-risk patients undergoing catheter ablation of scar-related VT: a propensity-matched analysis. Heart Rhythm. 2018;15:1500–1506. PubMed

Piccione W, Jr, Goldin MD. Mitral valve dysfunction following papillary muscle cryoablation. Ann Thorac Surg. 1988;46:347–348. PubMed

Tokuda M, Tedrow UB, Kojodjojo P, et al. Cather ablation of ventricular tachycardia in nonischemic heart disease. Circ Arrhythm Electrophysiol. 2012;5:992–1000. PubMed

Biancari F, D’Andrea V, Di Marco C, Savino G, Tiozzo V, Catania A. Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty. Am Heart J. 2010;159:518–531. PubMed

Nikolsky E, Mehran R, Halkin A, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol. 2004;44:1200–1209. PubMed

Jongbloed MR, Bax JJ, van der Burg AE, van der Wall EE, Schalij MJ. Radiofrequency catheter ablation of ventricular tachycardia guided by intracardiac echocardiography. Eur J Echocardiogr. 2004;5:34–40. PubMed

Cheitlin MD, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the clinical application of echocardiography: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on clinical application of echocardiography) Circulation. 1997;95:1686–1744. PubMed

Segal OR, Chow AW, Markides V, Schilling RJ, Peters NS, Davies W. Long-term results after ablation of infarct-related ventricular tachycardia. Heart Rhythm. 2005;2:474–482. PubMed

Borger van der Burg AE, de Groot NM, van Erven L, Bootsma M, van der Wall EE, Schalij MJ. Long-term follow-up after radiofrequency catheter ablation of ventricular tachycardia: a successful approach? J Cardiovasc Electrophysiol. 2002;13:417–423. PubMed

O’Callaghan PA, Poloniecki J, Sosa-Suarez G, Ruskin JN, McGovern BA, Garan H. Long-term clinical outcome of patients with prior myocardial infarction after palliative radiofrequency catheter ablation for frequent ventricular tachycardia. Am J Cardiol. 2001;87:975–979. PubMed

Khan HH, Maisel WH, Ho C, et al. Effect of radiofrequency catheter ablation of ventricular tachycardia on left ventricular function in patients with prior myocardial infarction. J Interv Card Electrophysiol. 2002;7:243–247. PubMed

Reddy VY, ReynoldsMR NP, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl JMed. 2007;357:2657–2665. PubMed PMC

Liang JJ, Yang W, Santangeli P, et al. Amiodarone discontinuation or dose reduction following catheter ablation for ventricular tachycardia in structural heart disease. JACC Clin Electrophysiol. 2017;3:503–511. PubMed

Moss AJ, Schuger C, Beck CA, for the MADIT-RIT Trial Investigators et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367:2275–2283. PubMed

Gasparini M, Proclemer A, Klersy C, et al. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA. 2013;309:1903–1911. PubMed

Wilkoff BL, Fauchier L, Stiles MK, et al. 2015 HRS/EHRA/APHRS/ SOLAECE expert consensus statement on optimal implantable cardioverter defibrillator programming and testing. Heart Rhythm. 2016;13:e50–e86. PubMed

Slotwiner D, Varma N, Akar JG, et al. HRS expert consensus statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Heart Rhythm. 2015;12:e69–e100. PubMed

Souissi Z, Boule S, Hermida JS, et al. Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry. Europace. 2018;20:362–369. PubMed

Guerra F, Shkoza M, Scappini L, Flori M, Capucci A. Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis. Europace. 2014;16:347–353. PubMed

Rumsfeld JS, Alexander KP, Goff DC, Jr, et al. Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart Association. Circulation. 2013;127:2233–2249. PubMed

Anker SD, Agewall S, Borggrefe M, et al. The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials. Eur Heart J. 2014;35:2001–2009. PubMed

US Food and Drug Administration. Medical Device Development Tools. Qualified Tools. Available at: https://www.fda.gov/MedicalDevices/ScienceandResearch/MedicalDeviceDevelopmentToolsMDDT/default.htm. Accessed 18 Nov 2018.

Stehlik J, Estep JD, Selzman CH, ROADMAP Study Investigators et al. Patient-reported health-related quality of life is a predictor of outcomes in ambulatory heart failure patients treated with left ventricular assist device compared with medical management: results from the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management) Circ Heart Fail. 2017;10:e003910. PubMed

Gula LJ, Doucette S, Leong-Sit P, et al. Quality of life with ablation or medical therapy for ventricular arrhythmias: a substudy of VANISH. J Cardiovasc Electrophysiol. 2018;29:421–434. PubMed

Pokorney SD, Friedman DJ, Calkins H, et al. Catheter ablation of ventricular tachycardia: lessons learned from past clinical trials and implications for future clinical trials. Heart Rhythm. 2016;13:1748–1754. PubMed PMC

Vergara P, Tzou WS, Tung R, et al. Predictive score for identifying survival and recurrence risk profiles in patients undergoing ventricular tachycardia ablation. Circ Arrhythm Electrophysiol. 2018;11:e006730. PubMed PMC

Calkins H, Awtry EH, Bunch TJ, Kaul S, Miller JM, Tedrow UB. COCATS 4 task force 11: training in arrhythmia diagnosis and management, cardiac pacing, and electrophysiology. J Am Coll Cardiol. 2015;65:1854–1865. PubMed

Zipes DP, Calkins H, Daubert JP, et al. 2015 ACC/AHA/HRS advanced training statement on clinical cardiac electrophysiology (a revision of the ACC/AHA 2006 update of the clinical competence statement on invasive electrophysiology studies, catheter ablation, and cardioversion) Heart Rhythm. 2016;13:e3–e37. PubMed

Dubin AM, Walsh EP, Franklin W, et al. Task force 4: pediatric cardiology fellowship training in electrophysiology. SPCTPD/ACC/AAP/ AHA Circulation. 2015;132:e75–e80. PubMed

Walsh EP, Bar-Coehn Y, Batra AS, et al. Recommendations for advanced fellowship training in clinical pediatric and congenital electrophysiology: a report from the training and credentialing committee of the pediatric and congenital electrophysiology society. Heart Rhythm. 2013;10:775–781. PubMed

Maury P, Defaye P, Klug D, et al. Position paper concerning the competence, performance and environment required in the practice of complex ablation procedures. Arch Cardiovasc Dis. 2019;112:67–73. PubMed

Tracy CM, Crossley GH, Bunch TJ, et al. 2017 ACC/HRS lifelong learning statement for clinical cardiac electrophysiology specialists: a report of the ACC competency management committee. Heart Rhythm. 2018;15:e17–e34. PubMed

Accreditation Council for Graduate Medical Education. Clinical competency committees: a guidebook for programs. Available at https://www.acgme.org/Portals/0/ACGMEClinicalCompetencyCommittee Guidebook.pdf. Accessed 18 Nov 2018.

Fazel R, Gerber TC, Balter S, et al. Approaches to enhancing radiation safety in cardiovascular imaging: a scientific statement from the American Heart Association. Circulation. 2014;130:1730–1748. PubMed

Picano E, Vano E, Rehani MM, et al. The appropriate and justified use of medical radiation in cardiovascular imaging: a position document of the ESC associations of cardiovascular imaging, percutaneous cardiovascular interventions and electrophysiology. Eur Heart J. 2014;35:665–672. PubMed

Deneke T, Müller P, Krug J, et al. Catheter ablation in patients with electrical storm: benefit of a network of cooperating clinics. Herzschrittmacherther Elektrophysiol. 2014;25:105–108. PubMed

Siontis KC, Kim HM, Stevenson WG, et al. Prognostic impact of the timing of recurrence of infarct-related ventricular tachycardia after catheter ablation. Circ Arrhythm Electrophysiol. 2016;9:e004432. PubMed PMC

Parkash R, Nault I, Rivard L, et al. Effect of baseline antiarrhythmic drug on outcomes with ablation in ischemic ventricular tachycardia: a VANISH substudy (ventricular tachycardia ablation versus escalated antiarrhythmic drug therapy in ischemic heart disease) Circ Arrhythm Electrophysiol. 2018;11:e005663. PubMed

Coyle K, Coyle D, Nault I, et al. Cost effectiveness of ventricular tachycardia ablation versus escalation of antiarrhythmic drug therapy: the VANISH trial. JACC Clin Electrophysiol. 2018;4:660–668. PubMed

Calkins H, Bigger JT, Jr, Ackerman SJ, et al. Cost-effectiveness of catheter ablation in patients with ventricular tachycardia. Circulation. 2000;101:280–288. PubMed

Sivagangabalan G, Pouliopoulos J, Huang K, et al. Simultaneous biventricular noncontact mapping and ablation of septal ventricular tachycardia in a chronic ovine infarct model. Circ Arrhythm Electrophysiol. 2009;2:441–449. PubMed

Wang Y, Cuculich PS, Zhang J, et al. Noninvasive electroanatomic mapping of human ventricular arrhythmias with electrocardiographic imaging. Sci Transl Med 2011;3:98ra84. PubMed PMC

Cuculich PS, Zhang J, Wang Y, et al. The electrophysiological cardiac ventricular substrate in patients after myocardial infarction: noninvasive characterization with electrocardiographic imaging. J Am Coll Cardiol. 2011;58:1893–1902. PubMed PMC

Zhang J, Sacher F, Hoffmayer K, et al. Cardiac electrophysiological substrate underlying the ECG phenotype and electrogram abnormalities in Brugada syndrome patients. Circulation. 2015;131:1950–1959. PubMed PMC

Vijayakumar R, Silva JNA, Desouza KA, et al. Electrophysiologic substrate in congenital long QT syndrome: noninvasive mapping with electrocardiographic imaging (ECGI) Circulation. 2014;130:1936–1943. PubMed PMC

Zhang J, Hocini M, Strom M, et al. The electrophysiological substrate of early repolarization syndrome: noninvasive mapping in patients. JACC Clin Electrophysiol. 2017;3:894–904. PubMed PMC

Prakosa A, Arevalo HJ, Deng D, et al. Personalized virtual-heart technology for guiding the ablation of infarct-related ventricular tachycardia. Nat Biomed Eng. 2018;2:732–740. PubMed PMC